
<html lang="en"     class="pb-page"  data-request-id="4ee75bb7-a275-4603-bd82-c0e254aeedd9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b01031;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-23;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure–Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease" /></meta><meta name="dc.Creator" content="Banibrata  Das" /></meta><meta name="dc.Creator" content="Seenuvasan  Vedachalam" /></meta><meta name="dc.Creator" content="Dan  Luo" /></meta><meta name="dc.Creator" content="Tamara  Antonio" /></meta><meta name="dc.Creator" content="Maarten E. A.  Reith" /></meta><meta name="dc.Creator" content="Aloke K.  Dutta" /></meta><meta name="dc.Description" content="Our structure–activity relationship studies with N6-(2-(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine derivatives led to development of a lead comp..." /></meta><meta name="Description" content="Our structure–activity relationship studies with N6-(2-(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine derivatives led to development of a lead comp..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 30, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01031" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01031" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01031" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01031" /></link>
        
    
    

<title>Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure–Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01031" /></meta><meta property="og:title" content="Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure–Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0007.jpeg" /></meta><meta property="og:description" content="Our structure–activity relationship studies with N6-(2-(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine derivatives led to development of a lead compound (−)-21a which exhibited very high affinity (Ki, D2 = 16.4 nM, D3 = 1.15 nM) and full agonist activity (EC50 (GTPγS); D2 = 3.23 and D3 = 1.41 nM) at both D2 and D3 receptors. A partial agonist molecule (−)-34 (EC50 (GTPγS); D2 = 21.6 (Emax = 27%) and D3 = 10.9 nM) was also identified. In a Parkinson’s disease (PD) animal model, (−)-21a was highly efficacious in reversing hypolocomotion in reserpinized rats with a long duration of action, indicating its potential as an anti-PD drug. Compound (−)-34 was also able to elevate locomotor activity in the above PD animal model significantly, implying its potential application in PD therapy. Furthermore, (−)-21a was shown to be neuroprotective in protecting neuronal PC12 from toxicity of 6-OHDA. This report, therefore, underpins the notion that a multifunctional drug like (−)-21a might have the potential not only to ameliorate motor dysfunction in PD patients but also to modify disease progression by protecting DA neurons from progressive degeneration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01031"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01031">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01031&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01031&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01031&amp;href=/doi/10.1021/acs.jmedchem.5b01031" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9179-9195</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01018" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01047" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of a Highly Potent D<sub>2</sub>/D<sub>3</sub> Agonist and a Partial Agonist from Structure–Activity Relationship Study of <i>N</i><sup>6</sup>-(2-(4-(1<i>H</i>-Indol-5-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Banibrata++Das">Banibrata Das</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seenuvasan++Vedachalam">Seenuvasan Vedachalam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Luo">Dan Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tamara++Antonio">Tamara Antonio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maarten+E.+A.++Reith">Maarten E. A. Reith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aloke+K.++Dutta">Aloke K. Dutta</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Psychiatry, New York University, New York, New York 10016, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Biochemistry and Molecular Pharmacology, New York University, New York, New York 10016, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 1-313-577-1064. Fax: 1-313-577-2033. E-mail: <a href="/cdn-cgi/l/email-protection#bbdadfcecfcfdafbccdac2d5de95dedfce"><span class="__cf_email__" data-cfemail="8beaeffeffffeacbfceaf2e5eea5eeeffe">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01031&amp;href=/doi/10.1021%2Facs.jmedchem.5b01031" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9179–9195</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 10, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 July 2015</li><li><span class="item_label"><b>Published</b> online</span>30 November 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01031" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01031</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9179%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBanibrata%2BDas%252C%2BSeenuvasan%2BVedachalam%252C%2BDan%2BLuo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D23%26contentID%3Dacs.jmedchem.5b01031%26title%3DDevelopment%2Bof%2Ba%2BHighly%2BPotent%2BD2%252FD3%2BAgonist%2Band%2Ba%2BPartial%2BAgonist%2Bfrom%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudy%2Bof%2BN6-%25282-%25284-%25281H-Indol-5-yl%2529piperazin-1-yl%2529ethyl%2529-N6-propyl-4%252C5%252C6%252C7-tetrahydrobenzo%255Bd%255Dthiazole-2%252C6-diamine%2BAnalogues%253A%2BImplication%2Bin%2Bthe%2BTreatment%2Bof%2BParkinson%25E2%2580%2599s%2BDisease%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9195%26publicationDate%3DDecember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01031"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1794</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01031" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure–Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Banibrata&quot;,&quot;last_name&quot;:&quot;Das&quot;},{&quot;first_name&quot;:&quot;Seenuvasan&quot;,&quot;last_name&quot;:&quot;Vedachalam&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Tamara&quot;,&quot;last_name&quot;:&quot;Antonio&quot;},{&quot;first_name&quot;:&quot;Maarten&quot;,&quot;last_name&quot;:&quot;E. A. Reith&quot;},{&quot;first_name&quot;:&quot;Aloke&quot;,&quot;last_name&quot;:&quot;K. Dutta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;9179-9195&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01031&quot;},&quot;abstract&quot;:&quot;Our structure–activity relationship studies with N6-(2-(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine derivatives led to development of a lead compound (−)-21a which exhibited very high affinity (Ki, D2 = 16.4 nM, D3 = 1.15 nM) and full agonist activity (EC50 (GTPγS); D2 = 3.23 and D3 = 1.41 nM) at both D2 and D3 receptors. A partial agonist molecule (−)-34 (EC50 (GTPγS); D2 = 21.6 (Emax = 27%) and D3 = 10.9 nM) was also identified. In a Parkinson’s disease (PD) animal model, (−)-21a was highly efficacious in reversing hypolocomotion in reserpinized rats with a long duration of action, indicating its potential as an anti-PD drug. Compound (−)-34 was also able to elevate locomotor activity in the above PD animal model significantly, implying its potential application in PD therapy. Furthermore, (−)-21a was shown to be neuroprotective in protecting neuronal PC12 from toxicity of 6-OHDA. This report, therefore, underpins the notion that a multifunctional drug lik&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01031&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01031" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01031&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01031" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01031&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01031" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01031&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01031&amp;href=/doi/10.1021/acs.jmedchem.5b01031" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01031" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01031" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01031%26sid%3Dliteratum%253Aachs%26pmid%3D26555041%26genre%3Darticle%26aulast%3DDas%26date%3D2015%26atitle%3DDevelopment%2Bof%2Ba%2BHighly%2BPotent%2BD2%252FD3%2BAgonist%2Band%2Ba%2BPartial%2BAgonist%2Bfrom%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudy%2Bof%2BN6-%25282-%25284-%25281H-Indol-5-yl%2529piperazin-1-yl%2529ethyl%2529-N6-propyl-4%252C5%252C6%252C7-tetrahydrobenzo%255Bd%255Dthiazole-2%252C6-diamine%2BAnalogues%253A%2BImplication%2Bin%2Bthe%2BTreatment%2Bof%2BParkinson%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D23%26spage%3D9179%26epage%3D9195%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/jmcmar.2015.58.issue-23/20151210/jmcmar.2015.58.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Our structure–activity relationship studies with <i>N</i><sup>6</sup>-(2-(4-(1<i>H</i>-indol-5-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine derivatives led to development of a lead compound (−)-<b>21a</b> which exhibited very high affinity (<i>K</i><sub>i</sub>, D<sub>2</sub> = 16.4 nM, D<sub>3</sub> = 1.15 nM) and full agonist activity (EC<sub>50</sub> (GTPγS); D<sub>2</sub> = 3.23 and D<sub>3</sub> = 1.41 nM) at both D<sub>2</sub> and D<sub>3</sub> receptors. A partial agonist molecule (−)-<b>34</b> (EC<sub>50</sub> (GTPγS); D<sub>2</sub> = 21.6 (<i>E</i><sub>max</sub> = 27%) and D<sub>3</sub> = 10.9 nM) was also identified. In a Parkinson’s disease (PD) animal model, (−)-<b>21a</b> was highly efficacious in reversing hypolocomotion in reserpinized rats with a long duration of action, indicating its potential as an anti-PD drug. Compound (−)-<b>34</b> was also able to elevate locomotor activity in the above PD animal model significantly, implying its potential application in PD therapy. Furthermore, (−)-<b>21a</b> was shown to be neuroprotective in protecting neuronal PC12 from toxicity of 6-OHDA. This report, therefore, underpins the notion that a multifunctional drug like (−)-<b>21a</b> might have the potential not only to ameliorate motor dysfunction in PD patients but also to modify disease progression by protecting DA neurons from progressive degeneration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease (PD) is a multifaceted neurodegenerative disorder affecting 1.5% of the global population over 65 years of age and is characterized primarily by the deterioration of motor activities that are controlled by the nigrostriatal system. Among the clinical features of PD are motor impairments involving tremors at rest, rigidity, bradykinesia, and postural instability along with nonmotor symptoms such as autonomic, cognitive, and psychiatric problems.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The neuropathogenesis of PD is characterized by progressive, selective, and irreversible loss of dopaminergic neurons in the midbrain substantia nigra pars compacta (SNpc), which can eventually deplete the striatum of adequate levels of dopamine (DA), resulting in cardinal motor deficits.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Although extensive research on the basic and clinical aspects of PD has been done to elucidate the underlying molecular events leading to neuronal death, the exact etiology of the disease remains to be completely understood and thus PD remains a progressive and incurable condition.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> There is a plethora of evidence to support the hypothesis that environmental factors converging on oxidative stress, mitochondrial dysfunction, nigral iron elevation, and aberrant protein aggregation account for most cases of PD.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> The generally accepted hypothesis is that oxidative stress, via the generation of reactive oxygen species (ROS), is the major contributor in PD pathogenesis that harmfully affects proteins, lipids, and nucleic acids.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> One of the major sources of ROS generation comes from inhibition of complex I of the mitochondrial electron transport chain, thereby generating superoxide and hydroxyl radical which cumulatively perturb cellular redox homeostasis and produce oxidative stress.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In addition, a common pathological hallmark of sporadic PD is the Lewy body, a rounded eosinophilic inclusion that is comprised mainly of a filamentous presynaptic protein, α-synuclein.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> While α-synuclein is a natively unfolded protein, the monomeric form can misfold and aggregate into larger oligomeric and protofibrillar neurotoxic species.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> α-synuclein protofibrils can cause vesicular dopamine leakage leading to increased oxidative stress, which might also promote protein misfolding and exacerbate α-synuclein aggregation in the cytoplasm.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Collectively, increased oxidative stress, elevated iron levels, compromised natural antioxidant defense, protein aggregation, and impaired mitochondrial functions are the mainstream predisposing factors implicated in the pathogenesis of PD.</div><div class="NLM_p">DA exhibits a variety of pharmacological actions in the central nervous system (CNS) and also in the periphery. The DA receptor systems have been targeted for the development of pharmacotherapeutic agents for a number of CNS related disorders, including drug addiction, schizophrenia, depression, and PD. These effects are mediated by five DA receptors (D<sub>1</sub>–D<sub>5</sub>) grouped into D<sub>1</sub>-like (D<sub>1</sub> and D<sub>5</sub>) and D<sub>2</sub>-like (D<sub>2</sub>, D<sub>3</sub> and D<sub>4</sub>) receptor subtypes which transduce signals via the effector molecule adenylate cyclase. Upon receptor activation, D<sub>1</sub>-like receptors activate adenylate cyclase, whereas D<sub>2</sub>-like receptors inhibit it.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The D<sub>1</sub> and D<sub>5</sub> receptors exhibit 80% homology in their transmembrane region. The sequence alignment between D<sub>2</sub>-like receptors revealed overall 50% similarity between D<sub>2</sub> and D<sub>3</sub> receptors, and it increases up to 90% at the ligand binding site.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">Modulation of multiple targets along the same biological pathway can potentially lead to disease modification rather than just control of symptoms. For the successful treatment of multifactorial CNS diseases, like PD, a new paradigm has arisen to correct the underlying pathway, according to which multifunctional drugs having multiple pharmacological activities can be employed to address more than one pathological factor.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Currently, the mainstay treatment of PD focuses on the DA replacement strategies, which include levodopa (L-dopa, the precursor of DA) and DA receptor agonists as well as monoamine oxidase B (MAOB) inhibitors and catechol-<i>O</i>-methyltransferase inhibitors, thereby alleviating only the symptoms without affecting the course of the disease progression.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> L-Dopa usage is unfortunately associated with the side effects including dyskinesia, and its long-term use can produce sudden “on–off” effects.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> It has also been reported that the eventual oxidation of DA derived from L-dopa further augments oxidative stress leading to enhanced disease progression.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Therefore, beyond symptomatic relief, treatments that have neuroprotective or disease-modifying properties remain a critical unmet medical need. Unfortunately, no neuroprotective drugs have been identified or approved by the FDA so far for the treatment of PD,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> thereby necessitating research for a breakthrough development.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Our approach in developing such agents involves alleviating symptoms of PD along with slowing or halting the neurodegeneration process. With this in mind, we initiated our drug discovery approach aimed at identifying novel multifunctional agents possessing D<sub>2</sub>/D<sub>3</sub> agonist activity along with antioxidant, iron chelating, and neuroprotective properties. In this regard, we have recently reported the development of such multifunctional D<sub>2</sub>/D<sub>3</sub> agonists derived from a novel molecular template which exhibited in vivo efficacy in PD animal models.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36">(26-36)</a> Some of our lead multifunctional D<sub>2</sub>/D<sub>3</sub> agonist molecules, such as (<i>S</i>)-<i>N</i><sup>6</sup>-(2-(4-([1,1′-biphenyl]-4-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (D-264) and <b>1</b> (D-512) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), exhibited neuroprotection in in vitro and in vivo experiments.<a onclick="showRef(event, 'ref30 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref33 ref34">(30, 33, 34)</a> Additionally, we have reported development of multifunctional brain penetrant iron chelators with agonist activity at D<sub>2</sub>/D<sub>3</sub> receptors.<a onclick="showRef(event, 'ref29 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref31">(29, 31)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structures of D<sub>2</sub>/D<sub>3</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As part of our continued endeavor to design and develop D<sub>2</sub>/D<sub>3</sub> receptor agonists based on our hybrid structure template,<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> which combines an agonist binding moiety (aminotetralin or bioisosteric equivalent) with arylpiperazine fragments via a linker of suitable length, we have recently reported a novel neuroprotective D<sub>2</sub>/D<sub>3</sub> agonist, <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), comprising an indole substituent that is expected to occupy the accessory binding site of the receptor.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As the compound turned out to be a promising candidate for PD through a number of experiments,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> we further wanted to delve into a comprehensive structure–activity relationship (SAR) study and accordingly introduce, in the current work, several indole derivatives on the piperazine ring with varying chain length and position of attachment in the indole aromatic ring. We have also introduced a propargyl group in our core hybrid structure to shed light on its role in interacting with DA D<sub>2</sub>/D<sub>3</sub> receptors. The lead molecule in this study not only exhibits potent in vivo activity in a PD animal model but also displays an array of interrelated activities pertinent to neuroprotection, such as potent antioxidant activity and inhibition of 6-hydroxydopamine (6-OHDA)-induced neuronal cell death.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first series of compounds discussed in the present work were prepared by combining the agonist headgroup with various halo-and methoxy-substituted indole derivatives in which the indole moieties were attached to the piperazine fragment via a methylene linker (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> describes the synthesis of final compounds (±)-<b>5a</b> and (±)-<b>5b</b>. <i>tert</i>-Butyl 3-formyl-5-methoxy-1<i>H</i>-indole-1-carboxylate (<b>3a</b>), prepared according to a procedure described previously,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> was selectively condensed with <i>N</i><sup>6</sup>-(2-(piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]- thiazole-2,6-diamine<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> under reductive amination condition in the presence of sodium triacetoxyborohydride to give compound <b>4a</b>. Finally, the amine protecting <i>t</i>-Boc group was removed by using trifluoroacetic acid (TFA) to furnish the final compound (±)-<b>5a</b>. In a similar way, aldehyde <b>3b</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> was reductively alkylated with the secondary amine to afford <b>4b</b>, which was then treated with TFA to give the final compound (±)-<b>5b</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, 4-DMAP, THF, rt, overnight; (b) NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h; (c) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, overnight; (b) (i) POCl<sub>3</sub>, DMF, 0–40 °C, 1.5 h, (ii) ice, 2 M NaOH, (iii) reflux, 5 min; (c) (Boc)<sub>2</sub>O, 4-DMAP, THF, rt, overnight; (d) <b>6</b>, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h; (e) <i>n</i>-Bu<sub>4</sub>NF, THF, 0 °C to rt, 2 h; (f) SO<sub>3</sub>·py, CH<sub>2</sub>Cl<sub>2</sub>:DMSO (2:1), Et<sub>3</sub>N, 0 °C to rt, 1.5 h; (g) (±)-pramipexole, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h;( h) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 3 h.</p></p></figure><div class="NLM_p">The syntheses of the target compounds (±)-<b>14a</b>, (±)-<b>14b</b>, (±)-<b>14c</b>, and (±)-<b>14d</b> are outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The starting compound <b>6</b> was obtained by alkylating piperazine with (2-bromoethoxy)-<i>tert-</i>butyl-dimethylsilane in the presence of K<sub>2</sub>CO<sub>3</sub> under reflux. Various commercially available indole derivatives were formylated in the presence of phosphorus oxychloride to give <b>8a</b>–<b>8d</b>, which were then <i>N</i>-protected using di-<i>tert</i>-butyl dicarbonate in the presence of 4-dimethylaminopyridine (4-DMAP) to afford <b>9a</b>–<b>9d</b>. Condensation of amine <b>6</b> with intermediates <b>9a</b>–<b>9d</b>, using NaBH(OAc)<sub>3</sub> as the reducing agent, yielded compounds <b>10a</b>–<b>10d</b>. The silyl groups of compounds <b>10a</b>–<b>10d</b> were removed by treatment with <i>n</i>-Bu<sub>4</sub>NF (TBAF) in THF to afford compounds <b>11a</b>–<b>11d</b>. Subsequent oxidation of the hydroxyl groups using pyridine-sulfur trioxide furnished the corresponding aldehydes,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> which were subsequently condensed with racemic pramipexole<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> under reductive amination conditions to give the penultimate compounds <b>13a</b>–<b>13d</b>. Finally, the amine protecting <i>t</i>-Boc groups were removed by treatment with TFA to furnish the final compounds (±)-<b>14a</b>, (±)-<b>14b</b>, (±)-<b>14c</b>, and (±)-<b>14d</b> as TFA salts.</div><div class="NLM_p"><a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a> depict the syntheses of another series of compounds where the indole groups are directly attached to the piperazine moieties. As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, commercially available 6-bromoindole was <i>N</i>-protected with di-<i>tert</i>-butyl dicarbonate to give <b>16a</b>. Palladium-catalyzed cross coupling of <b>16a</b> with amine <b>6</b> in the presence of Cs<sub>2</sub>CO<sub>3</sub> and BINAP in toluene under refluxing condition yielded intermediate <b>17a</b>, which on TBDMS deprotection afforded alcohol <b>18a</b> in excellent yield. Compound <b>18a</b> was then oxidized under Swern oxidation conditions<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> to aldehyde <b>19a</b>, which was subsequently condensed with <i>S</i>-(−)- pramipexole<a onclick="showRef(event, 'ref27 ref42'); return false;" href="javascript:void(0);" class="ref ref27 ref42">(27, 42)</a> under reductive amination conditions to give the compound (−)-<b>20a</b>. It is interesting to note that while carrying out the Swern oxidation reaction, a chlorine atom got inserted in the 7-position of indole aromatic ring of <b>19a</b>, a phenomenon observed previously by us and others.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> The possible reaction mechanism might involve electrophilic chlorination of indole aromatic ring in the presence of excess dimethylchlorosulfonium chloride, the reactive intermediate formed during Swern oxidation.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Finally, deprotection of the indole moiety of (−)-<b>20a</b> under acidic condition afforded the target compound (−)-<b>21a</b> as TFA salt. Another final compound (−)-<b>21b</b> was also prepared in a similar fashion as described for (−)-<b>21a</b>, where 4-bromoindole was used as the starting material.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, 4-DMAP, THF, rt, overnight; (b) <b>6</b>, Pd(OAc)<sub>2</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, reflux, 15 h; (c) <i>n</i>-Bu<sub>4</sub>NF, THF, 0 °C to rt, 2 h; (d) oxalyl chloride, DMSO, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 2 h; (e) (−)-pramipexole, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h; (f) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 3 h.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, 4-DMAP, THF, rt, overnight; (b) <b>6</b>, Pd(OAc)<sub>2</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, reflux, 15 h; (c) <i>n</i>-Bu<sub>4</sub>NF, THF, 0 °C to rt, 2 h; (d) SO<sub>3</sub>·py, CH<sub>2</sub>Cl<sub>2</sub>:DMSO (2:1), Et<sub>3</sub>N, 0 °C to rt, 1.5 h; (e) (−)-pramipexole, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h; (f) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 3 h.</p></p></figure><div class="NLM_p">The synthesis of another target molecule (−)-<b>27</b> is shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The secondary amine of 5-bromo-7-fluoro-1<i>H</i>-indole was first protected with (Boc)<sub>2</sub>O to give <b>22</b>. The <i>N</i>-arylation was next performed by refluxing the mixture of <b>6</b>, <b>22</b>, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, and Pd(OAc)<sub>2</sub> in toluene to give <b>23</b> in moderate yield. The silyl group of compound <b>23</b> was removed by treatment with TBAF in THF to afford alcohol <b>24</b>, which on subsequent oxidation in the presence of pyridine-sulfur trioxide yielded the corresponding aldehyde <b>25</b>. The aldehyde was then condensed with <i>S</i>-(−)- pramipexole<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> in the presence of NaBH(OAc)<sub>3</sub> to afford the compound (−)-<b>26</b>. Finally, deprotection of the indole amine of (−)-<b>26</b> was accomplished by treating with TFA to furnish the final compound (−)-<b>27</b>.</div><div class="NLM_p"><a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a> shows the synthesis of the final series of compounds in which the <i>N</i>-propyl group of pramipexole is replaced with a propargyl moiety. The starting diamine <b>28</b>, prepared according to a procedure described previously,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> was first treated with nitrobenzenesulfonyl chloride to selectively protect the aliphatic primary amine of <b>28</b> to afford <b>29</b>, which was next reacted with propargyl bromide in the presence of a base to give the intermediate <b>30</b>. Deprotection of the nitrobenzenesulfonyl group was achieved by treatment with thioglycolic acid to furnish optically active compound <b>31</b>. Secondary amine of <b>31</b> was next reductively alkylated with the aldehyde <b>32</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> in the presence of NaBH(OAc)<sub>3</sub> to afford the compound (−)-<b>33</b>. Finally, removal of the Boc protecting group was accomplished under acidic condition to afford the target compound (−)-<b>34</b> as TFA salt. Another final compound (−)-<b>36</b> was also prepared in a similar fashion as described for (−)-<b>34</b>, where aldehyde <b>19a</b> was used as the partner for the reductive amination reaction with amine <b>31</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-nitrobenzenesulfonyl chloride, Et<sub>3</sub>N, THF, −10 °C to rt, 1.5 h; (b) propargyl bromide, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 50 °C, overnight; (c) thioglycolic acid, K<sub>2</sub>CO<sub>3</sub>, DMF, 0 °C to rt to 50 °C, 16 h; (d) NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 40 h; (e) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Affinity and Agonism at DA D<sub>2</sub> and D<sub>3</sub> Receptors</h3><div class="NLM_p">Our current study is aimed at investigating the molecular and chemical flexibility of the arylpiperazine fragment of our hybrid template as it relates to D<sub>2</sub>/D<sub>3</sub> receptor binding and functional activity. The present series of compounds comprise various indole derivatives, as our previous studies have indicated that an indole substituent in the arylpiperazine region is well tolerated, producing molecules with high D<sub>2</sub>/D<sub>3</sub> affinity and in number of instances a preference for D<sub>3</sub> receptor.<a onclick="showRef(event, 'ref32 ref48'); return false;" href="javascript:void(0);" class="ref ref32 ref48">(32, 48)</a> The structural modifications are mainly centered on the direct attachment of the piperazine nitrogen atom, distal to the agonist headgroup, to various positions of the indole ring. Other molecular alterations include substitution of the indole nucleus with halogen and methoxy group at different positions along with changes in linker length connecting the piperazine and indole moieties. We have carried out our binding studies with rat DA D<sub>2</sub> and D<sub>3</sub> (rD<sub>2</sub> and rD<sub>3</sub>) receptors expressed in HEK-293 cells and functional characterization with human D<sub>2</sub> and D<sub>3</sub> receptors (hD<sub>2</sub> and hD<sub>3</sub>) expressed in CHO cells. In our own findings, we did not see appreciable differences in the affinity of compounds for rat or human DA D<sub>2</sub>/D<sub>3</sub> receptors, expressed in either HEK-293 or CHO cells (unpublished results and see also Zhen et al. 2015).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> It has been shown that an overall high degree of homology exists between the two species; 95% for D<sub>2</sub> and greater than 78% for D<sub>3</sub>, with a somewhat shorter third intracellular loop in the human version of the D<sub>3</sub> receptor.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a></div><div class="NLM_p">To evaluate receptor binding of the final compounds, a radioligand competition assay was conducted and the binding affinity profiles were compared with that of the reference agent (<i>S</i>)-5-OH-DPAT (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Binding potency was determined by inhibition of [<sup>3</sup>H]spiroperidol binding to rat DA D<sub>2</sub> and D<sub>3</sub> receptors expressed in HEK-293 cells as described by us previously.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a><a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> summarizes the binding data for analogues that were synthesized. Compounds <b>5a</b>–<b>b</b> as well as <b>14a</b>–<b>d</b>, which incorporate the 2-aminothiazole headgroup and a methylene unit connecting piperazine ring to the 3 position of a variety of substituted indole ring, displayed high affinity for D<sub>3</sub> and low affinity for D<sub>2</sub> receptors. In this series of analogues, we introduced halogen or methoxy group either at the 4- or 5-position of the indole moiety to study the electronic effects of electron-withdrawing or donating groups on the indole nucleus as well as their possible effects on binding interactions in this region with D<sub>2</sub> and D<sub>3</sub> receptors. The 2-aminothiazole derived 5-methoxy indole derivative <b>5a</b> displayed high affinity and selectivity for the D<sub>3</sub> receptor (<i>K</i><sub>i</sub>, D<sub>2</sub> = 1636 nM, D<sub>3</sub> = 15.9 nM, D<sub>2</sub>/D<sub>3</sub> = 101), while for the 5-bromo and 5-fluoro derivatives <b>5b</b> and <b>14a</b>, D<sub>2</sub> affinity improved and D<sub>3</sub> affinity remained the same (<i>K</i><sub>i</sub>, D<sub>2</sub> = 376 nM, D<sub>3</sub> = 12.9 nM, D<sub>2</sub>/D<sub>3</sub> = 29 and D<sub>2</sub> = 854 nM, D<sub>3</sub> = 12.1 nM, D<sub>2</sub>/D<sub>3</sub> = 71 for <b>5b</b> and <b>14a</b>, respectively). This data demonstrates the effect of halogen substitution at the 5-position of indole on imparting better interaction with D<sub>2</sub> receptor as opposed to 5-methoxy substituent in which, we speculate, the bulkier methoxy group or the unfavorable electronic effect might be producing some difficulty to interact with the D<sub>2</sub> receptor. Next, isomeric 4-substituted indole derivatives <b>14b</b>–<b>d</b> were synthesized. The 4-methoxy analogue <b>14b</b> exhibited low affinity for D<sub>2</sub> (<i>K</i><sub>i</sub>, D<sub>2</sub> = 1883 nM, D<sub>3</sub> = 25 nM, D<sub>2</sub>/D<sub>3</sub> = 75) as observed with <b>5a</b>, while the 4-fluoro substituted compound <b>14d</b> (<i>K</i><sub>i</sub>, D<sub>2</sub> = 992 nM, D<sub>3</sub> = 8.87 nM, D<sub>2</sub>/D<sub>3</sub> = 112) was similar in its binding profile for D<sub>2</sub>/D<sub>3</sub> receptors as its isomeric counterpart <b>14a</b>. Compound <b>14c</b>, structurally different from <b>14d</b> only in having a chloride instead of a fluoride substituent, displayed <b>14d</b>-like affinities for D<sub>2</sub>/D<sub>3</sub> receptors. Thus, affinity for the D<sub>2</sub> receptor varied among the isomeric compounds, with halo-substituted derivatives showing relatively higher affinity while maintaining similar D<sub>3</sub> selectivity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition Constants Determined by Competition Experiments Assessing [<sup>3</sup>H]Spiroperidol Binding to Cloned Rat D<sub>2L</sub> and D<sub>3</sub> Receptors Expressed in HEK-293 Cells<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (cLogP and tPSA Values Are Calculated Using ChemDraw)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0006.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>K</i><sub><i>i</i></sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2L</sub>, [<sup>3</sup>H]spiroperidol</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>3</sub>, [<sup>3</sup>H]spiroperidol</th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2L</sub>/D<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th><th class="colsep0 rowsep0" align="center" char=".">tPSA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">990 ± 198</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 14.9</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-5-OH-DPAT</td><td class="colsep0 rowsep0" align="char" char="±">153 ± 32</td><td class="colsep0 rowsep0" align="char" char="±">2.07 ± 0.38</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D-443<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">1503 ± 67</td><td class="colsep0 rowsep0" align="char" char="±">4.17 ± 0.30</td><td class="colsep0 rowsep0" align="char" char=".">360</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">39.0 ± 5.0</td><td class="colsep0 rowsep0" align="char" char="±">2.19 ± 0.39</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">5.1443</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5a</b></td><td class="colsep0 rowsep0" align="char" char="±">1636 ± 219</td><td class="colsep0 rowsep0" align="char" char="±">15.9 ± 1.2</td><td class="colsep0 rowsep0" align="char" char=".">101</td><td class="colsep0 rowsep0" align="char" char=".">4.5221</td><td class="colsep0 rowsep0" align="char" char=".">69.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5b</b></td><td class="colsep0 rowsep0" align="char" char="±">376 ± 38</td><td class="colsep0 rowsep0" align="char" char="±">12.9 ± 0.30</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">5.5321</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>14a</b></td><td class="colsep0 rowsep0" align="char" char="±">854 ± 51</td><td class="colsep0 rowsep0" align="char" char="±">12.1 ± 3.2</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">4.8121</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>14b</b></td><td class="colsep0 rowsep0" align="char" char="±">1883 ± 250</td><td class="colsep0 rowsep0" align="char" char="±">25.0 ± 2.4</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">4.5221</td><td class="colsep0 rowsep0" align="char" char=".">69.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>14c</b></td><td class="colsep0 rowsep0" align="char" char="±">1164 ± 214</td><td class="colsep0 rowsep0" align="char" char="±">13.8 ± 1.6</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">5.3821</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>14d</b></td><td class="colsep0 rowsep0" align="char" char="±">992 ± 82</td><td class="colsep0 rowsep0" align="char" char="±">8.87 ± 0.78</td><td class="colsep0 rowsep0" align="char" char=".">112</td><td class="colsep0 rowsep0" align="char" char=".">4.8121</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>21a</b></td><td class="colsep0 rowsep0" align="char" char="±">16.4 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">1.15 ± 0.19</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">5.1443</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>21b</b></td><td class="colsep0 rowsep0" align="char" char="±">74.5 ± 6.7</td><td class="colsep0 rowsep0" align="char" char="±">0.87 ± 0.13</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">5.1443</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>27</b></td><td class="colsep0 rowsep0" align="char" char="±">156 ± 34</td><td class="colsep0 rowsep0" align="char" char="±">3.66 ± 0.66</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">4.5743</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>34</b></td><td class="colsep0 rowsep0" align="char" char="±">86.5 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">14.4 ± 1.0</td><td class="colsep0 rowsep0" align="char" char=".">5.99</td><td class="colsep0 rowsep0" align="char" char=".">4.5063</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>36</b></td><td class="colsep0 rowsep0" align="char" char="±">172 ± 16</td><td class="colsep0 rowsep0" align="char" char="±">0.145 ± 0.035</td><td class="colsep0 rowsep0" align="char" char=".">1186</td><td class="colsep0 rowsep0" align="char" char=".">4.5063</td><td class="colsep0 rowsep0" align="char" char=".">60.13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Results are the means ± SEM for 3–6 experiments each performed in triplicate.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Data obtained under almost identical assay conditions and taken from ref <a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">49</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Data taken from ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>.</p></div></div></div><div class="NLM_p">Next, we investigated the effect of a methylene linker connecting the piparazine fragment, distal to the agonist headgroup, with the indole nucleus and compared it with a carbonyl linker containing compound (4-(2-((2-amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]-thiazol-6-yl)(propyl)amino)ethyl)piperazin-1-yl)(1<i>H</i>-indol-3-yl)methanone (D-443) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) we reported earlier. It was found that the introduction of a carbonyl group between piperazine and indole resulted in very high affinity and selectivity for D<sub>3</sub> receptor, and we hypothesized that an electronic effect of the carbonyl group might play an important role in deciphering the observed selectivity for the D<sub>3</sub> receptor.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In contrast, the present series of compounds <b>5a</b>–<b>b</b> and <b>14a</b>–<b>d</b> carrying a methylene rather than carbonyl linker also revealed low nanomolar and preferential affinity for the D<sub>3</sub> receptor comparable to that of the reference compound (<i>K</i><sub>i</sub>, D<sub>2</sub> = 1503 nM, D<sub>3</sub> = 4.17 nM, D<sub>2</sub>/D<sub>3</sub> = 360; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This result indicated that introduction of an additional carbon, irrespective of any electronic effect, in the distal region of the hybrid structure might facilitate an enhanced access to the accessory binding sites in the D<sub>3</sub> receptor and thereby impart a significant effect in D<sub>3</sub> receptor affinity.</div><div class="NLM_p">Our previous reports consistently demonstrated that in the 2-aminothiazole series of hybrid compounds, the (−)-isomeric version exhibited higher affinity for D<sub>2</sub>/D<sub>3</sub> receptors compared to the (+)-isomer. Because the current SAR study is based on the promising results observed with <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), we were interested in preparing only the (−)-isomeric version of a series of halogen-substituted indole analogues connected directly to the piperazine moiety. Among the molecules in this series, the 6-substituted indole derivative (−)-<b>21a</b> displayed the highest affinity for both D<sub>2</sub> and D<sub>3</sub> receptors along with low selectivity (<i>K</i><sub>i</sub>, D<sub>2</sub> = 16.4 nM, D<sub>3</sub> = 1.15 nM, D<sub>2</sub>/D<sub>3</sub> = 14, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and the binding affinities were somewhat higher than the parent compound <b>1</b> (<i>K</i><sub>i</sub>, D<sub>2</sub> = 39 nM, D<sub>3</sub> = 2.19 nM, D<sub>2</sub>/D<sub>3</sub> = 18). It is worth mentioning that the position of chlorine substitution imparted a trivial effect in DA receptor binding (7-chloro in (−)-<b>21a</b> vs 4-chloro in <b>1</b>). Thus, the direct attachment of the piperazine moiety at either 5- or 6-position of the indole nucleus did not result in a significant difference in terms of their affinity for D<sub>2</sub>/D<sub>3</sub> receptors. In contrast, when the point of connection is at 4 position of indole as in the case of (−)-<b>21b</b>, the binding affinity for the D<sub>2</sub> receptor was reduced and that for the D<sub>3</sub> receptor was retained (<i>K</i><sub>i</sub>, D<sub>2</sub> = 74.5 nM, D<sub>3</sub> = 0.87 nM, D<sub>2</sub>/D<sub>3</sub> = 86) compared to (−)-<b>21a</b>; however, the selectivity was increased by 6-fold (D<sub>2</sub>/D<sub>3</sub>, 86 vs 14 for (−)-<b>21b</b> vs (−)-<b>21a</b>). This suggests that the indole moiety alone does not give rise to selectivity for either receptor subtype but the position of connectivity to the piperazine fragment does. To further compare the effect of halogen substituent on the indole ring with the parent molecule, we next synthesized 5-substituted indole derivative (−)-<b>27</b> with a fluorine atom attached to the 7 position of the ring. As shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, compound (−)-<b>27</b> displayed moderate affinity and selectivity for D<sub>2</sub>/D<sub>3</sub> receptors (<i>K</i><sub>i</sub>, D<sub>2</sub> = 156 nM, D<sub>3</sub> = 3.66 nM, D<sub>2</sub>/D<sub>3</sub> = 43) as opposed to the parent 4-chloro derivative <b>1</b>, which in comparison revealed low nanomolar affinity for both receptors along with 2.5-fold reduced selectivity. Taken altogether, chloro-derivatives have shown somewhat higher binding profiles than the corresponding fluoro-substituted compound.</div><div class="NLM_p">To gain an insight into the effect of propargyl moiety on DA receptor binding, propargyl group was incorporated into 2-aminothiazole agonist headgroup to design compounds (−)-<b>34</b> and (−)-<b>36</b>. Interestingly, introduction of the propargyl group resulted in a diminished binding affinity for D<sub>2</sub>/D<sub>3</sub> receptors (<i>K</i><sub>i</sub>, D<sub>2</sub> = 86.5 nM, D<sub>3</sub> = 14.4 nM for (−)-<b>34</b>) compared to the parent molecule <b>1</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), probably due to a less efficient interaction with the propyl binding cleft of the receptors.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Similarly, in comparing (−)-<b>36</b> with corresponding molecule (−)-<b>21a</b> also revealed lower binding affinity for the D<sub>2</sub> receptor; however, D<sub>3</sub> receptor affinity was increased suggesting a different role for the propyl binding cleft in D<sub>2</sub> and D<sub>3</sub> receptors.</div><div class="NLM_p">On the basis of the binding results, functional activities of the optically active lead compounds for human DA D<sub>2</sub> and D<sub>3</sub> receptors expressed in CHO cells were measured by monitoring stimulation of [<sup>35</sup>S]GTPγS binding in comparison to stimulation by the endogenous ligand DA. Comparison with the maximum stimulation (<i>E</i><sub>max</sub>), produced by the full agonist DA, indicates whether the compound is a full agonist, a partial agonist, or an antagonist. As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, (−)-<b>21a</b> demonstrated a very high potency (EC<sub>50</sub> (GTPγS); D<sub>2</sub> = 3.23 and D<sub>3</sub> = 1.41 nM), correlating well with binding data, and full agonist activity at both D<sub>2</sub> and D<sub>3</sub> receptors (<i>E</i><sub>max</sub> > 100%). Compound (−)-<b>21b</b> was also found to be potent and efficacious in stimulating both receptors (EC<sub>50</sub> (GTPγS); D<sub>2</sub> = 32.7 and D<sub>3</sub> = 3.93 nM; <i>E</i><sub>max</sub> = 88–104%). None of the compounds displayed appreciable selectivity for D<sub>3</sub> vs D<sub>2</sub>, and their selectivity for D<sub>3</sub> receptor dropped considerably when compared to the binding data (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The propargyl compound (−)-<b>34</b> displayed high functional potency for both the receptors (EC<sub>50</sub> (GTPγS); D<sub>2</sub> = 21.6 and D<sub>3</sub> = 10.9 nM) but was less potent compared to the corresponding <b>1</b>. Similar profile was also observed for (−)-<b>36</b> when compared with the corresponding (−)-<b>21a</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Interestingly, (−)-<b>34</b> showed partial agonist activity at D<sub>2</sub> receptor (<i>E</i><sub>max</sub> = 27%) while exhibiting full agonism at D<sub>3</sub> receptor (<i>E</i><sub>max</sub> = 94%). Thus, full agonist <b>1</b> was transformed into a potent partial agonist (−)-<b>34</b> upon replacement of the propyl group by a propargyl group. On the other hand, compound (−)-<b>36</b> revealed full agonist activity at both D<sub>2</sub> and D<sub>3</sub> receptors (<i>E</i><sub>max</sub> ∼ 100%) and the selectivity for the D<sub>3</sub> receptor was also increased significantly (D<sub>2</sub>/D<sub>3</sub> = 47) as expected from the binding data. This data indicates the effect of subtle structural variations resulting in alteration in receptor activation. In comparing results from functional GTPγS assays with [<sup>3</sup>H]spiroperidol binding data, a number of factors need to be considered such as the sensitivity of agonist potency to receptor conformational state promoted by the binding buffer used<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and the effect of receptor reserve in reducing a functional EC<sub>50</sub> of a full agonist.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The D<sub>2</sub> and D<sub>3</sub> cell lines used in this work can show receptor reserve for full agonists such as dopamine; as alluded to in our recent report,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> dopamine D<sub>2</sub> and D<sub>3</sub> receptor reserves in these cell lines are indicated by <i>K</i><sub>i</sub>/EC<sub>50</sub> ratios for dopamine greater than unity (8.5 and 31.3, respectively). More work is needed to assess whether some of the full agonists identified in the present cell lines are partial agonists in brain tissue. It is well-known that in assays with cells heterologously expressing a receptor, partial agonism may not be observed as compared with in situ brain tissue preparations where receptor concentrations are generally lower in relation to available G proteins (for this phenomenon for dopamine receptors see Tadori et al. 2009).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Stimulation of [<sup>35</sup>S]GTPγS Binding to Cloned Human D<sub>2</sub> and D<sub>3</sub> Receptors Expressed in CHO Cells<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">hCHO–D<sub>2</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">hCHO–D<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">[<sup>35</sup>S]GTPγS EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char="±">[<sup>35</sup>S]GTPγS EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2</sub>/D<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine (DA)</td><td class="colsep0 rowsep0" align="char" char="±">183 ± 14</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="char" char="±">5.34 ± 1.43</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="char" char=".">34.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-3PPP<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">163 ± 6</td><td class="colsep0 rowsep0" align="center">19.8 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">51.9 ± 3.6</td><td class="colsep0 rowsep0" align="center">52.0 ± 3.6</td><td class="colsep0 rowsep0" align="char" char=".">3.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">2.96 ± 0.3</td><td class="colsep0 rowsep0" align="center">107 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">1.26 ± 0.2</td><td class="colsep0 rowsep0" align="center">93.1 ± 4.4</td><td class="colsep0 rowsep0" align="char" char=".">2.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>21a</b></td><td class="colsep0 rowsep0" align="char" char="±">3.23 ± 0.78</td><td class="colsep0 rowsep0" align="center">101 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">1.41 ± 0.08</td><td class="colsep0 rowsep0" align="center">113 ± 7</td><td class="colsep0 rowsep0" align="char" char=".">2.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>21b</b></td><td class="colsep0 rowsep0" align="char" char="±">32.7 ± 7.6</td><td class="colsep0 rowsep0" align="center">87.6 ± 4.1</td><td class="colsep0 rowsep0" align="char" char="±">3.93 ± 1.12</td><td class="colsep0 rowsep0" align="center">104 ± 9</td><td class="colsep0 rowsep0" align="char" char=".">8.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>34</b></td><td class="colsep0 rowsep0" align="char" char="±">21.6 ± 9.6</td><td class="colsep0 rowsep0" align="center">26.7 ± 6.4</td><td class="colsep0 rowsep0" align="char" char="±">10.9 ± 2.4</td><td class="colsep0 rowsep0" align="center">94 ± 3.5</td><td class="colsep0 rowsep0" align="char" char=".">1.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>36</b></td><td class="colsep0 rowsep0" align="char" char="±">39.4 ± 6.3</td><td class="colsep0 rowsep0" align="center">86.8 ± 3.8</td><td class="colsep0 rowsep0" align="char" char="±">0.84 ± 0.05</td><td class="colsep0 rowsep0" align="center">93.4 ± 3.6</td><td class="colsep0 rowsep0" align="char" char=".">46.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub> is the concentration producing half maximal stimulation. For each compound, maximal stimulation (<i>E</i><sub>max</sub>) is expressed as a percent of the <i>E</i><sub>max</sub> observed with 1 mM (D<sub>2</sub>) or 100 μM (D<sub>3</sub>) of the full agonist DA (<i>E</i><sub>max</sub>, %). Results are the mean ± SEM for 3–6 experiments, each performed in triplicate.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Data from our previous study Zhen et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (see Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_001.pdf" class="ext-link">Tables S1a and S1b</a>)</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Data from our previous study Johnson et al.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></div></div><div class="NLM_p last">We have also calculated the cLogP and tPSA values for all the compounds (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The values are almost similar for all of the compounds. In general, the values indicate that these compounds should produce in vivo efficacy which we observed in case of (−)-<b>21a</b> and (−)-<b>34</b> (discussed later). Therefore, our current SAR results of a series of indole compounds indicate that the affinity and selectivity for the D<sub>2</sub>/D<sub>3</sub> receptors are governed by the nature of linking moieties, molecular structure, as well as substitution groups in the indole nucleus. When piperazine and indole are connected via a methylene unit, as in the case of compounds <b>5a</b>–<b>b</b> and <b>14a</b>–<b>d</b>, the affinity and selectivity for D<sub>3</sub> receptor is appreciable. On the other hand, direct linking of piperazine and indole moieties results in compounds that have relatively increased D<sub>2</sub> receptor affinities. Moreover, halogen substitution on the indole ring somewhat increases D<sub>2</sub> affinity as compared with the corresponding methoxy substituent. We have also observed that incorporation of a propargyl group in the agonist part of structure resulted in the potent D<sub>2</sub> partial agonist compound, (−)-<b>34</b>.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Characterization of the Partial Agonist (−)-<b>34</b> for its Antagonist Activity at D<sub>2</sub></h3><div class="NLM_p">Experiments were conducted to assess the potency of compound (−)-<b>34</b> in antagonizing the action of the full agonist dopamine at D<sub>2</sub>. This was done in “shift” experiments yielding the antagonist <i>K</i><sub>e</sub> value based on the test compound’s ability to reduce the apparent potency of dopamine in stimulating [<sup>35</sup>S]GTPγS binding in CHO-D<sub>2</sub> cells.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, 50 and 300 nM of compound (−)-<b>34</b> shifted the dopamine activation curve to the right as compared to the dopamine curve with vehicle (with corresponding EC<sub>50</sub> values for DA of 423 ± 39 nM and 3.93 μM compared with 225 ± 45 nM, respectively, mean ± SEM), as did 200 nM and 1 μM of the well-known partial agonist (−)-3PPP (with corresponding EC<sub>50</sub> values for DA of 376 ± 54 nM and 844 ± 63 nM compared with 225 ± 45 nM, respectively). The <i>K</i><sub>e</sub> values derived from these experiments are 29.0 nM for (−)-<b>34</b> and 372 nM for (−)-3PPP. These values are the average of the <i>K</i><sub>e</sub> values obtained at the two separate fixed concentrations of (−)-<b>34</b>, 50 and 300 nM: 37.2 ± 10.5 nM (<i>n</i> = 6) and 20.9 ± 2.8 nM (<i>n</i> = 5) (statistically not different, <i>P</i> = 0.203, Student’s <i>t</i> test). At the two fixed concentrations of (−)-3PPP, 200 nM and 1 μM, the <i>K</i><sub>e</sub> values were 362 ± 89 nM (<i>n</i> = 7) and 383 ± 47 nM (<i>n</i> = 4) (statistically not different, <i>P</i> = 0.870, Student’s <i>t</i> test). Antagonist activity of a partial agonist can be pharmacologically meaningful in attenuating the action of endogenous transmitter, in this case dopamine. While the partial agonist reduces the dopamine effect, it does not completely abolish it, but rather it has some effect itself in activating dopamine receptors, modulating dopamine transmission in a more subtle way than completely shutting it down. The antagonist <i>K</i><sub>e</sub> as computed in this work provides a measure of potency of the antagonist effect, whereas the <i>E</i><sub>max</sub> measured in the functional assay reflects the degree to which dopamine receptors can still be activated. The observed <i>K</i><sub>e</sub> values (average of 29.0 nM and 372 nM for (−)-<b>34</b> and (−)-3PPP, respectively) are somewhat greater than the EC<sub>50</sub> values for partial agonism (21.6 and 163 nM,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). In comparing EC<sub>50</sub> and <i>K</i><sub>e</sub> values, one should consider that, in principle, for a functional response by the full agonist dopamine not all receptors need to be occupied; in fact, in the CHO-D<sub>2</sub> cells used here, there is substantial receptor reserve for DA (see two paragraphs higher up).</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rightward shift in dopamine curves for stimulation of [<sup>35</sup>S]GTPγS binding in CHO-hD<sub>2</sub> cells by 50 nM and 300 nM (−)-<b>34</b> (A), or 200 nM and 1 μM (−)-3PPP (B). The indicated fixed concentrations of test compound were copresent with increasing concentrations of dopamine (colored curves). The two test compounds and vehicle with dopamine were tested in 4–7 independent experiments (carried out in triplicate); in order to show the shifts without clutter, the drugs are shown in separate panels (A,B) along with the same dopamine curve (averaged from all DA data obtained in two sets of experiments). The EC<sub>50</sub> values calculated from the right-shifted curves were significantly larger than the EC<sub>50</sub> of dopamine observed in the same set of experiments (<i>P</i> < 0.05, one-tailed Student’s <i>t</i> test). For <i>K</i><sub>e</sub> values calculated from these shifts, see text. Data points are mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Reversal of Reserpine-Induced Hypolocomotion in Rats by (−)-<b>21a</b>, (−)-<b>34</b>, (−)-Pramipexole, and Ropinirole</h3><div class="NLM_p">Reserpine induces depletion of catecholamine in nerve terminals, resulting in a cataleptic condition in rats, which is a well-established animal model for PD.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58, 59)</a> Significant inhibition of locomotion of rats was observed 18 h after the administration of reserpine (5 mg/kg, sc), which indicated the development of akinesia (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Compound (−)-<b>21a</b> at the dose of 10 μMol/kg, ip, was not only highly efficacious in reversing akinesia in rats, compared to reserprine treatment alone, but also demonstrated significant enhancement of locomotion for the entire duration of the study of 6 h. Similar trend was also observed with the reference drug pramipexole; however, treatment with another reference drug ropinirole at the dose of 10 μMol/kg produced a quick onset of locomotor activation compared to control but with a much shorter duration of action compared with (−)-<b>21a</b>. The mechanism of the locomotor stimulation in this reserpine model is likely to be mediated by postsynaptic D<sub>2</sub>/D<sub>3</sub> receptor activation by (−)-<b>21a</b>. When the reserpinized rats were administered with partial agonist compound (−)-<b>34</b> at similar dosage, locomotor activity was enhanced compared to control but was less than that observed with (−)-<b>21a</b>. While being a partial agonist, significant activation of locomotion by (−)-<b>34</b> is impressive, indicating functional implication of this compound in an enviromment lacking little or no endogenous agonist. Such property will have a significant importance in PD therapy. Thus, the results suggest that these compounds behave like potent agonists, which cross the blood–brain barrier effectively and provide a sustained effect in the PD animal model.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of different drugs upon reserpine (5.0 mg/kg, sc, 18 h pretreatment) induced hypolocomotion in rats. Each point represents the mean ± SEM for three rats. Horizontal activity was measured as described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Representation of horizontal locomotor activity is at discrete 30 min intervals after the administration of (−)-<b>21a</b> (10 μMol/kg), (−)-<b>34</b> (10 μMol/kg), (−)-Pramipexole (10 μMol/kg), and Ropinirole (10 μMol/kg) compared to control rats, 18 h after reserpine treatment. Differences among treatments were significant by one-way ANOVA analysis (<i>F</i> (4, 60) = 31.62 (<i>P</i> < 0.0001)): (****) <i>P</i> < 0.001 ((−)-<b>21a</b>), (**) <i>P</i> < 0.05 ((−)-<b>34</b>) or (****) <i>P</i> < 0.001 Pramipexole compared to reserpine control (Dunnett’s multiple comparison test after one-way ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Neuroprotection Against 6-OHDA-Induced Toxicity</h3><div class="NLM_p">To investigate the multifunctional property of the target molecules, we carried out in vitro antioxidant assay using 1,1-diphenyl-2-picrylhydrazyl (DPPH) (see the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_001.pdf" class="ext-link">Supporting Information</a> for details). As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_001.pdf" class="ext-link">Figure S1</a> in the Supporting Information, the target compound (−)-<b>21a</b> inhibited DPPH radical activity dose-dependently with an EC<sub>50</sub> value of 21.72 μM. On the basis of the results of the in vivo activity as well as antioxidant assay, we next embarked on exploring the neuroprotective effect of (−)-<b>21a</b> in dopaminergic rat adrenal pheochromocytoma PC12 cells against 6-OHDA-induced cytotoxicity. 6-OHDA is a widely used toxin that mimics the generation of oxidative stress observed in PD and it induces neurotoxicity via its autooxidation and subsequent hydrogen peroxide generation.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> Treatment of PC12 cells with 6-OHDA for 24 h resulted in a significant dose-dependent neurotoxicity and the cell viability was significantly decreased to ∼50% in cells exposed to 75 μM of 6-OHDA, and this concentration was used in subsequent in vitro experiments (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a). In contrast, cells treated with increasing concentrations of (−)-<b>21a</b> alone (0.01–30 μM) showed no cell loss at all compared to untreated controls and induced some cell proliferation instead at higher concentrations (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b), indicating the nontoxic profile of the compound at the doses tested. The potential neuroprotective effect of (−)-<b>21a</b> on 6-OHDA-induced toxicity was evaluated following pretreatment with the drug. Thus, when the cells were pretreated with (−)-<b>21a</b> for 24 h followed by exposure to 6-OHDA treatment for 24 h, the compound dose-dependently protected the cells from the neurotoxic insult and the greatest protective effect was obtained at concentration of 20 μM, which increased the cell survival by 30% compared to 6-OHDA (75 μM) treated alone (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>c). These data strongly suggest the neuroprotective effect of (−)-<b>21a</b> on PC12 cell loss induced by 6-OHDA.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose-dependent effect on the viability of PC12 cells by the  pretreatment of the cells with different concentrations of (−)-<b>21a</b> followed by treatment with 75 μM 6-OHDA. (a) PC12 cells were treated with different concentrations of 6-OHDA (25–100 μM). (b) Dose-dependent effect of (−)-<b>21a</b> on cell viability. (c) PC12 cells were pretreated with varying concentrations of (−)-<b>21a</b> for 24 h and then the media was replaced with fresh culture media followed by treatment with 75 μM 6-OHDA for another 24 h. The values shown are the mean ± SD of at least three independent experiments performed in four to six replicates. One way ANOVA analysis <i>F</i> (4, 30) = 313.6, <i>p</i> < 0.0001 for <b>4a</b>, <i>F</i> (3, 24) = 18.23, <i>p</i> < 0.0001 for <b>4b</b>, and <i>F</i> (3, 18) = 118.7, <i>p</i> < 0.0001 for <b>4c</b>. ANOVA was followed by Tukey’s multiple comparison post hoc test (****<i>p</i> < 0.0001, ***<i>p</i> < 0.001, **<i>p</i> < 0.01 compared to control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In binding and functional assays, the lead compound (−)-<b>21a</b> exhibited very high affinity and full agonist activity at both D<sub>2</sub> and D<sub>3</sub> receptors. It has also displayed efficient free radical quenching property, indicating its potent antioxidant activity. An interesting finding worth mentioning here that none of the methylene unit containing compounds showed any appreciable antioxidant property (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_001.pdf" class="ext-link">Figures S1 and S2</a> in the Supporting Information). In a PD animal model, (−)-<b>21a</b> was highly efficacious in augmenting locomotor activity with a long duration of action, indicating its potential as an anti-PD drug. The partial agonist compound (−)-<b>34</b> was also able to elevate locomotion significantly, implying its application in PD therapy. The data presented here also shows that (−)-<b>21a</b> is neuroprotective in an in vitro model of dopaminergic PC12 cells treated with the neurotoxin 6-OHDA. This report, therefore, underpins the notion that a multifunctional drug like (−)-<b>21a</b> has the potential not only to ameliorate motor dysfunction in PD patients but also to modify disease progression by protecting DA neurons from neurotoxic insults in addition to restoring their function. Further mechanistic studies to ascertain the disease-modifying effects of the compound are currently underway and will be published in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reagents and solvents were purchased from commercial suppliers and used as received unless otherwise noted. Dry solvent was obtained following the standard procedure. All reactions were performed under N<sub>2</sub> atmosphere unless otherwise indicated. Analytical silica gel 60 F<sub>254</sub>-coated TLC plates were purchased from EMD Chemicals, Inc. and were visualized with UV light or by treatment with phosphomolybdic acid (PMA), Dragendorff’s reagent, or ninhydrin. Whatman Purasil 60A silica gel 230–400 mesh was used for flash column chromatographic purifications. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were measured on Varian 400 and 600 MHz NMR spectrometer, using tetramethylsilane (TMS) as an internal standard. The NMR solvent used was either CDCl<sub>3</sub> or CD<sub>3</sub>OD unless otherwise indicated. Optical rotations were recorded on Autopol III automatic polarimeter (Rudolph Research Analytical). Melting points were recorded using a MEL-TEMP II (Laboratory Devices Inc., U.S.) capillary melting point apparatus. Purity of the compounds was determined by elemental analysis and was within ±0.4% of the theoretical value (≥95% purity). Elemental analyses were performed by Atlantic Microlab, Inc., GA, USA. Selected compounds were furher analyzed by reverse phase HPLC (Waters 2489 Alliance Integrated System, USA) to check for purity.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Procedure A: <i>tert</i>-Butyl 3-((4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)ethyl)piperazin-1-yl)methyl)-5-methoxy-1<i>H</i>-indole-1-carboxylate (<b>4a</b>)</h3><div class="NLM_p">Into a stirring solution of <i>N</i><sup>6</sup>-(2-(piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (0.1 g, 0.30 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added <i>tert</i>-butyl 3-formyl-5-methoxy-1<i>H</i>-indole-1-carboxylate (<b>3a</b>) (0.09 g, 0.32 mmol). After the mixture was stirred for 1.5 h, NaBH(OAc)<sub>3</sub> (0.13 g, 0.61 mmol) was added portionwise and the mixture was stirred for 48 h at room temperature. The reaction mixture was quenched with a saturated solution of NaHCO<sub>3</sub> at 0 °C and extracted with dicholoromethane (3 × 20 mL). The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. Crude product was purified by column chromatography (EtOAc/MeOH, 20:1) to give compound <b>4a</b> (0.10 g, 60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.99 (s, 1H), 7.45 (s, 1H), 7.16 (d, <i>J</i> = 2.4 Hz, 1H), 6.89 (dd, <i>J</i><sub>1</sub> = 8.8 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 1H), 5.21 (bs, −NH<sub>2</sub>, 2H), 3.84 (s, 3H), 3.60 (s, 2H), 3.01–2.97 (m, 1H), 2.69–2.41 (m, 18H), 1.99–1.96 (m, 1H), 1.67–1.65 (m, 1H), 1.63 (s, 9H), 1.48–1.43 (m, 2H), 0.87 (t, <i>J</i> = 7.2 Hz, 3H).</div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> <i>tert</i>-Butyl 3-((4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)-ethyl)piperazin-1-yl)methyl)-5-bromo-1<i>H</i>-indole-1-carboxylate (<b>4b</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl 5-bromo-3-formyl-1<i>H</i>-indole-1-carboxylate (<b>3b</b>) (0.11 g, 0.31 mmol) was reacted with <i>N</i><sup>6</sup>-(2-(piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (0.1 g, 0.3 mmol) and NaBH(OAc)<sub>3</sub> (0.13 g, 0.61 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) according to procedure A. Crude product was purified by column chromatography (EtOAc/MeOH, 20:1) to give compound <b>4b</b> (0.097 g, 50%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.97 (s, 1H), 7.83 (d, <i>J</i> = 1.8 Hz, 1H), 7.45 (s, 1H), 7.37 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 4.71 (bs, −NH<sub>2</sub>, 2H), 3.58 (s, 2H), 3.0 (m, 1H), 2.71–2.39 (m, 17H), 1.96–1.94 (m, 1H), 1.74–1.65 (m, 1H), 1.63 (s, 9H), 0.87 (t, <i>J</i> = 7.2 Hz, 3H).</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Procedure B: <i>N</i><sup>6</sup>-(2-(4-((5-Methoxy-1<i>H</i>-indol-3-yl)methyl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>5a</b>) (D-586)</h3><div class="NLM_p">Into a stirred solution of <b>4a</b> (0.03 g, 0.05 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) at 0 °C, trifluoroacetic acid (3 mL) was added slowly and the reaction mixture was stirred for another 2 h at room temperature. Unreacted TFA and solvent were removed under reduced pressure, and the obtained TFA salt was washed with ether for several times followed by drying to yield <b>5a</b> (0.042 g, 90%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.46 (s, 1H), 7.32 (d, <i>J</i> = 9 Hz, 1H), 7.20 (d, <i>J</i> = 2.4 Hz, 1H), 6.84 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 1H), 4.52 (s, 2H), 3.83 (s, 3H), 3.51–3.49 (m, 3H), 3.41–3.31 (m, 2H), 3.26–3.15 (m, 8H), 3.04–3.01 (m, 1H), 2.88–2.65 (m, 7H), 2.49 (q, <i>J</i> = 12 Hz, 2H), 2.32–2.31 (m, 1H), 1.80–1.74 (m, 2H), 0.97 (t, <i>J</i> = 7.8 Hz, 3H). HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd for C<sub>26</sub>H<sub>38</sub>N<sub>6</sub>OSH, 483.2906; found, 483.2907; Anal. Calcd for C<sub>26</sub>H<sub>38</sub>N<sub>6</sub>OS·3CF<sub>3</sub>COOH·CH<sub>2</sub>Cl<sub>2</sub>: C, 43.57; H, 4.76; N, 9.24. Found: C, 44.39; H, 5.05; N, 8.83.</div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>N</i><sup>6</sup>-(2-(4-((5-Bromo-1<i>H</i>-indol-3-yl)methyl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>5b</b>) (D-589)</h4><div class="NLM_p last">Compound <b>4b</b> (0.02 g, 0.03 mmol) was treated with trifluoroacetic acid (3 mL) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) according to procedure B to furnish <b>5b</b> (0.027 g, 91%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.91 (s, 1H), 7.55 (s, 1H), 7.38 (d, <i>J</i> = 8.4 Hz, 1H), 7.29 (dd, <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 4.52 (s, 2H), 3.88 (s, 1H), 3.49–3.23 (m, 11H), 3.04–3.02 (m, 1H), 2.88–2.31 (m, 8H), 1.80–1.76 (m, 2H), 0.99 (t, <i>J</i> = 7.2 Hz, 3H); Anal. Calcd for C<sub>25</sub>H<sub>35</sub>BrN<sub>6</sub>S·3CF<sub>3</sub>COOH·CH<sub>2</sub>Cl<sub>2</sub>: C, 40.10; H, 4.21; N, 8.77. Found: C, 40.79; H, 4.15; N, 8.65.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 1-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl)piperazine (<b>6</b>)</h4><div class="NLM_p last">A suspension of piperazine (10.0 g, 116.09 mmol), potassium carbonate (48.13 g, 348.27 mmol), and (2-bromoethoxy)(<i>tert</i>-butyl)dimethylsilane (11.1 g, 46.4 mmol) in acetonitrile (100 mL) was refluxed under N<sub>2</sub> for 15 h. The reaction mixture was filtered off, and the filtrate was evaporated under reduced pressure. The residue was then diluted with ether, washed with water, dried over sodium sulfate, filtered, and concentrated to afford the product <b>6</b> as a white colorless liquid (10.7 g, 95%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 3.73 (t, <i>J</i> = 6.0 Hz, 2H), 2.86 (t, <i>J</i> = 4.8 Hz, 4H), 2.50–2.46 (m, 6H), 0.86 (s, 9H), 0.03 (s, 6H).</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Procedure C: 5-Fluoro-1<i>H</i>-indole-3-carbaldehyde (<b>8a</b>)</h3><div class="NLM_p">Phosphorus oxychloride (0.25 mL, 2.66 mmol) was added dropwise to a stirred mixture of <i>N</i>,<i>N</i>-dimethylformamide (1.03 mL, 13.32 mmol) and indole <b>7a</b> (0.3 g, 2.2 mmol) at 0 °C. The resulting mixture was stirred at 0 °C for 0.5 h then at 40 °C for 1 h. Ice was added, followed by a solution of sodium hydroxide (2 M), and the mixture was heated under reflux for 5 min. On cooling, the solution was extracted with ethyl acetate (3 × 20 mL). The combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Column chromatography with hexane:ethyl acetate (1:1) gave a white solid (0.30 g, 85%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.86 (s, 1H), 7.86 (dd, <i>J</i> = 6.6, 2.4 Hz, 1H), 7.81 (s, 1H), 7.31 (q, <i>J</i> = 4.2 Hz, 1H), 6.97 (td, <i>J</i> = 9.0, 2.4 Hz, 1H).</div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-Methoxy-1<i>H</i>-indole-3-carbaldehyde (<b>8b</b>)</h4><div class="NLM_p last">Indole <b>7b</b> (0.3 g, 2.04 mmol) was reacted with phosphorus oxychloride (0.23 mL, 2.45 mmol) in DMF (0.95 mL, 12.23 mmol) according to procedure C. The crude material was pure enough for use in the next step (0.27 g, 76%).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 4-Chloro-1<i>H</i>-indole-3-carbaldehyde (<b>8c</b>)</h4><div class="NLM_p last">Indole <b>7c</b> (0.6 g, 3.96 mmol) was reacted with phosphorus oxychloride (0.44 mL, 4.75 mmol) in DMF (1.84 mL, 23.75 mmol) according to procedure C. The crude material was pure enough for use in the next step (0.61 g, 86%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 10.72 (s, 1H), 8.05 (s, 1H), 7.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.28 (d, <i>J</i> = 8.4 Hz, 1H), 7.17 (t, <i>J</i> = 7.8 Hz, 1H).</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Procedure D: <i>tert</i>-Butyl 5-Fluoro-3-formyl-1<i>H</i>-indole-1-carboxylazte (<b>9a</b>)</h3><div class="NLM_p">Into a stirring solution of amine <b>8a</b> (0.3 g, 1.84 mmol) in THF (7 mL) were added (Boc)<sub>2</sub>O (0.44 g, 2.02 mmol) and DMAP (0.25 g, 2.02 mmol) at room temperature. The reaction mixture was stirred at the same temperature for 12 h. The crude mixture was evaporated under reduced pressure, followed by extraction with EtOAc (3 × 20 mL) in water. The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by column chromatography over silica gel using hexane:ethyl acetate (5:1) as solvent to give compound <b>9a</b> (0.485 g, 100%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 10.05 (s, 1H), 8.24 (s, 1H), 8.09 (q, <i>J</i> = 4.2 Hz, 1H), 7.96 (dd, <i>J</i> = 6.0, 2.4 Hz, 1H), 7.13 (td, <i>J</i> = 9.0, 2.4 Hz, 1H), 1.69 (s, 9H).</div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>tert</i>-Butyl 3-Formyl-4-methoxy-1<i>H</i>-indole-1-carboxylate (<b>9b</b>)</h4><div class="NLM_p last">Amine <b>8b</b> (0.25 g, 1.43 mmol) was reacted with (Boc)<sub>2</sub>O (0.34 g, 1.57 mmol) and DMAP (0.19 g, 1.57 mmol) in THF (5 mL) according to procedure D. The crude material was purified by silica gel column chromatography (hexane:EtOAc = 5:1) to yield compound <b>9b</b> (0.38 g, 95%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 10.54 (s, 1H), 8.22 (s, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.31 (t, <i>J</i> = 8.4 Hz, 1H), 6.80 (d, <i>J</i> = 8.4 Hz, 1H), 3.99 (s, 3H), 1.66 (s, 9H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl 4-Chloro-3-formyl-1<i>H</i>-indole-1-carboxylate (<b>9c</b>)</h4><div class="NLM_p last">Amine <b>8c</b> (0.6 g, 3.34 mmol) was reacted with (Boc)<sub>2</sub>O (0.8 g, 3.68 mmol) and DMAP (0.45 g, 3.68 mmol) in THF (15 mL) according to procedure D. The crude material was purified by silica gel column chromatography (hexane:EtOAc = 5:1) to yield compound <b>9c</b> (0.86 g, 92%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 10.80 (s, 1H), 8.38 (s, 1H), 8.22 (d, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 7.32 (t, <i>J</i> = 7.8 Hz, 1H), 1.69 (s, 9H).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl 3-((4-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl)piperazin-1-yl)methyl)-5-fluoro-1<i>H</i>-indole-1-carboxylate (<b>10a</b>)</h4><div class="NLM_p last">Aldehyde <b>9a</b> (0.475 g, 1.8 mmol) was reacted with amine <b>6</b> (0.44 g, 1.8 mmol) and NaBH(OAc)<sub>3</sub> (0.69 g, 3.25 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) according to procedure A. The crude product was purified by silica gel column chromatography (hexane:EtOAc = 1:1) to yield compound <b>10a</b> (0.83 g, 94%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.04 (bs, 1H), 7.50 (s, 1H), 7.39 (dd, <i>J</i> = 6.6, 2.4 Hz, 1H), 7.01 (td, <i>J</i> = 9.0, 2.4 Hz, 1H), 3.73 (t, <i>J</i> = 6.6 Hz, 2H), 3.57 (s, 2H), 2.52 (bt, <i>J</i> = 6.6 Hz, 10H), 1.64 (s, 9H), 0.87 (s, 9H), 0.03 (s, 6H).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>tert</i>-Butyl 3-((4-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl)piperazin-1-yl)methyl)-4-methoxy-1<i>H</i>-indole-1-carboxylate (<b>10b</b>)</h4><div class="NLM_p last">Aldehyde <b>9b</b> (0.29 g, 1.05 mmol) was reacted with amine <b>6</b> (0.26 g, 1.05 mmol) and NaBH(OAc)<sub>3</sub> (0.4 g, 1.9 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) according to procedure A. The crude material was purified by silica gel column chromatography (hexane:EtOAc = 2:3) to yield compound <b>10b</b> (0.435 g, 82%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.74 (bs, 1H), 7.38 (s, 1H), 7.18 (t, <i>J</i> = 8.4 Hz, 1H), 6.63 (d, <i>J</i> = 7.8 Hz, 1H), 3.88 (s, 3H), 3.85 (s, 2H), 3.74 (t, <i>J</i> = 6.6 Hz, 2H), 2.64–2.50 (m, 10H), 1.64 (s, 9H), 0.87 (s, 9H), 0.04 (s, 6H).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>tert</i>-Butyl 3-((4-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl)piperazin-1-yl)methyl)-4-chloro-1<i>H</i>-indole-1-carboxylate (<b>10c</b>)</h4><div class="NLM_p last">Aldehyde <b>9c</b> (0.41 g, 1.47 mmol) was reacted with amine <b>6</b> (0.36 g, 1.47 mmol) and NaBH(OAc)<sub>3</sub> (0.63 g, 2.94 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) according to procedure A. The crude material was purified by silica gel column chromatography (hexane:EtOAc = 3:2) to yield compound <b>10c</b> (0.54 g, 72%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.09 (bs, 1H), 7.51 (s, 1H), 7.18–7.17 (m, 2H), 3.85 (s, 2H), 3.76 (t, <i>J</i> = 6.6 Hz, 2H), 2.66–2.53 (m, 10H), 1.66 (s, 9H), 0.89 (s, 9H), 0.06 (s, 6H).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>tert</i>-Butyl 3-((4-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl)piperazin-1-yl)methyl)-4-fluoro-1<i>H</i>-indole-1-carboxylate (<b>10d</b>)</h4><div class="NLM_p last">Aldehyde <b>9d</b><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (0.4 g, 1.52 mmol) was reacted with amine <b>6</b> (0.41 g, 1.67 mmol) and NaBH(OAc)<sub>3</sub> (0.64 g, 3.02 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) according to procedure A. The crude material was purified by silica gel column chromatography (hexane:EtOAc = 20:1) to yield compound <b>10d</b> (0.55 g, 73%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.90 (s, 1H), 7.43 (s, 1H), 7.21–7.19 (m, 1H), 6.87 (dd, <i>J</i><sub>1</sub> = 7.2 Hz, <i>J</i><sub>2</sub> = 5.2 Hz, 1H), 3.74–3.72 (m, 4H), 2.57 (bs, 8H), 2.51 (t, <i>J</i> = 7.8 Hz, 2H), 1.69 (s, 9H), 0.86 (s, 9H), 0.03 (s, 6H).</div></div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Procedure E: <i>tert</i>-Butyl 5-Fluoro-3-((4-(2-hydroxyethyl)piperazin-1-yl)methyl)-1<i>H</i>-indole-1-carboxylate (<b>11a</b>)</h3><div class="NLM_p">Into a stirring solution of compound <b>10a</b> (0.69 g, 1.4 mmol) in THF (15 mL) was added <i>n</i>-tetrabutylammonium fluoride (2.2 mL, 2.1 mmol, 1.0 M solution in THF) at 0 °C. The reaction mixture was then stirred at room temperature for 2 h. THF was evaporated in vacuo, and the residue was diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and washed with a saturated solution of NaHCO<sub>3</sub>. The water layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure. The crude product was purified by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 9:1) to yield compound <b>11a</b> (0.495 g, 94%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.06 (bs, 1H), 7.52 (s, 1H), 7.39 (dd, <i>J</i> = 6.6, 2.4 Hz, 1H), 7.03 (td, <i>J</i> = 9.0, 2.4 Hz, 1H), 3.61 (t, <i>J</i> = 5.4 Hz, 2H), 3.60 (s, 2H), 2.56 (bt, <i>J</i> = 5.4 Hz, 10H), 1.66 (s, 9H).</div><div id="sec5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>tert</i>-Butyl 3-((4-(2-Hydroxyethyl)piperazin-1-yl)methyl)-4-methoxy-1<i>H</i>-indole-1-carboxylate (<b>11b</b>)</h4><div class="NLM_p last">Compound <b>10b</b> (0.335 g, 0.67 mmol) was reacted with <i>n</i>-tetrabutylammonium fluoride (1.0 mL, 1.01 mmol, 1.0 M solution in THF) in THF (10 mL) according to procedure E. The crude product was purified by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 9:1) to give compound <b>11b</b> (0.195 g, 75%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.76 (bs, 1H), 7.41 (s, 1H), 7.21 (t, <i>J</i> = 8.4 Hz, 1H), 6.66 (d, <i>J</i> = 7.8 Hz, 1H), 3.91 (s, 3H), 3.90 (s, 2H), 3.61 (t, <i>J</i> = 5.4 Hz, 2H), 2.70–2.56 (m, 10H), 1.66 (s, 9H).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>tert</i>-Butyl 4-Chloro-3-((4-(2-hydroxyethyl)piperazin-1-yl)methyl)-1<i>H</i>-indole-1-carboxylate (<b>11c</b>)</h4><div class="NLM_p last">Compound <b>10c</b> (0.52 g, 1.02 mmol) was reacted with <i>n</i>-tetrabutylammonium fluoride (2.1 mL, 2.05 mmol, 1.0 M solution in THF) in THF (8 mL) according to procedure E. The crude product was purified by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 9:1) to give compound <b>11c</b> (0.38 g, 93%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.09 (bs, 1H), 7.52 (s, 1H), 7.20–7.18 (m, 2H), 3.86 (s, 2H), 3.63 (t, <i>J</i> = 5.4 Hz, 2H), 2.70–2.55 (m, 10H), 1.67 (s, 9H).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>tert</i>-Butyl 4-Fluoro-3-((4-(2-hydroxyethyl)piperazin-1-yl)methyl)-1<i>H</i>-indole-1-carboxylate (<b>11d</b>)</h4><div class="NLM_p last">Compound <b>10d</b> (0.72 g, 1.46 mmol) was treated with <i>n</i>-tetrabutylammonium fluoride (2.1 mL, 2.10 mmol, 1.0 M solution in THF) in THF (15 mL) according to procedure E. The crude product was purified by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 19:1) to give compound <b>11d</b> (0.49 g, 89%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.92 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (s, 1H), 7.24–7.18 (m, 1H), 6.91 (dd, <i>J</i><sub>1</sub> = 10.8 Hz, <i>J</i><sub>2</sub> = 8 Hz, 1H), 3.76 (s, 2H), 3.59 (t, <i>J</i> = 4.8 Hz, 2H), 2.56–2.53 (m, 10H), 1.66 (s, 9H).</div></div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Procedure F. <i>tert</i>-Butyl 5-fluoro-3-((4-(2-oxoethyl)piperazin-1-yl)methyl)-1<i>H</i>-indole-1-carboxylate (<b>12a</b>)</h3><div class="NLM_p">Into a stirring solution of compound <b>11a</b> (0.2 g, 0.53 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4.5 mL) and DMSO (2.25 mL) was added Et<sub>3</sub>N (0.52 mL, 3.71 mmol) at 0 °C. The reaction mixture was stirred for 5 min, followed by addition of SO<sub>3</sub>·py complex (0.422 g, 2.65 mmol) at 0 °C. Ice bath was removed, and the reaction mixture was stirred at room temperature for 1.5 h. The reaction mixture was quenched by addition of water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 25 mL). The combined organic layer was dried using Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. Column chromatography with EtOAc:MeOH (19:1) afforded compound <b>12a</b> (0.17 g, 83%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.50 (s, 1H), 7.86 (bs, 1H), 7.33 (s, 1H), 7.21–7.19 (m, 1H), 6.84–6.81 (m, 1H), 4.46–4.42 (m, 2H), 3.47–3.41 (m, 2H), 3.22–3.16 (m, 2H), 3.00–2.99 (m, 1H), 2.55–2.31 (m, 5H), 1.48 (s, 9H).</div><div id="sec5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>tert</i>-Butyl 4-Methoxy-3-((4-(2-oxoethyl)piperazin-1-yl)methyl)-1<i>H</i>-indole-1-carboxylate (<b>12b</b>)</h4><div class="NLM_p last">Alcohol <b>11b</b> (0.19 g, 0.49 mmol) was oxidized using SO<sub>3</sub>·py complex (0.39 g, 2.45 mmol), DMSO (2 mL), and Et<sub>3</sub>N (0.48 mL, 3.41 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) according to procedure F. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 19:1) to give aldehyde <b>12b</b> (0.16 g, 82%). The purified aldehyde was used immediately for next step. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.71 (s, 1H), 7.75 (bs, 1H), 7.38 (s, 1H), 7.20 (t, <i>J</i> = 8.4 Hz, 1H), 6.66 (d, <i>J</i> = 7.8 Hz, 1H), 3.90 (s, 3H), 3.87 (s, 2H), 3.38 (s, 2H), 2.62 (s, 8H), 1.66 (s, 9H).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>tert</i>-Butyl 4-Chloro-3-((4-(2-oxoethyl)piperazin-1-yl)methyl)-1<i>H</i>-indole-1-carboxylate (<b>12c</b>)</h4><div class="NLM_p last">Alcohol <b>11c</b> (0.35 g, 0.89 mmol) was oxidized using SO<sub>3</sub>·py complex (0.707 g, 4.44 mmol), DMSO (3.5 mL), and Et<sub>3</sub>N (0.87 mL, 6.22 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (7 mL) according to procedure F. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 19:1) to give aldehyde <b>12c</b> (0.29 g, 83%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.71 (s, 1H), 8.09 (bs, 1H), 7.51 (s, 1H), 7.19–7.17 (m, 2H), 4.66–4.61 (m, 2H), 3.86–3.84 (m, 2H), 3.43–3.38 (m, 2H), 3.19–3.18 (m, 1H), 2.63–2.61 (m, 5H), 1.67 (s, 9H).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>tert</i>-Butyl 4-Fluoro-3-((4-(2-oxoethyl)piperazin-1-yl)methyl)-1<i>H</i>-indole-1-carboxylate (<b>12d</b>)</h4><div class="NLM_p last">Alcohol <b>11d</b> (0.25 g, 0.66 mmol) was oxidized using SO<sub>3</sub>·py complex (0.525 g, 3.30 mmol), DMSO (3 mL), and Et<sub>3</sub>N (0.64 mL, 4.62 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) according to procedure F. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 9:1) to give aldehyde <b>12d</b> (0.18 g, 72%). The purified aldehyde was used immediately for next step. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.71 (s, 1H), 7.91 (d, <i>J</i> = 8.0 Hz, 1H), 7.42 (s, 1H), 7.22–7.17 (m, 1H), 6.93 (dd, <i>J</i><sub>1</sub> = 10.8 Hz, <i>J</i><sub>2</sub> = 8 Hz, 1H), 3.75 (s, 2H), 3.39 (s, 2H), 2.62–2.57 (m, 8H), 1.66 (s, 9H).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>tert</i>-Butyl 3-((4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)-ethyl)piperazin-1-yl)methyl)-5-fluoro-1<i>H</i>-indole-1-carboxylate (<b>13a</b>)</h4><div class="NLM_p last">Compound <b>12a</b> (0.16 g, 0.43 mmol) was reacted with (±)-pramipexole (0.09 g, 0.43 mmol) and NaBH(OAc)<sub>3</sub> (0.16 g, 0.77 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) according to procedure A. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 4:1) to afford compound <b>13a</b> (0.14 g, 56%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.05 (bs, 1H), 7.51 (s, 1H), 7.39 (dd, <i>J</i> = 6.4, 2.4 Hz, 1H), 7.02 (td, <i>J</i> = 9.0, 2.4 Hz, 1H), 5.17 (bs, 2H), 3.59 (s, 2H), 3.04–2.98 (m, 1H), 2.72–2.41 (m, 18H), 1.97–1.94 (m, 1H), 1.71–1.61 (m, 10H), 1.49–1.40 (m, 2H), 0.87 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>tert</i>-Butyl 3-((4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)-ethyl)piperazin-1-yl)methyl)-4-methoxy-1<i>H</i>-indole-1-carboxylate (<b>13b</b>)</h4><div class="NLM_p last">Compound <b>12b</b> (0.15 g, 0.39 mmol) was reacted with (±)-pramipexole (0.07 g, 0.35 mmol) and NaBH(OAc)<sub>3</sub> (0.16 g, 0.78 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) according to procedure A. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 4:1) to afford compound <b>13b</b> (0.08 g, 39%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.76 (bs, 1H), 7.42 (bs, 1H), 7.20 (t, <i>J</i> = 8.4 Hz, 1H), 6.65 (d, <i>J</i> = 7.8 Hz, 1H), 4.85 (bs, 2H), 3.90 (s, 3H), 3.89 (s, 2H), 3.03–2.98 (m, 1H), 2.75–2.42 (m, 18H), 1.97–1.96 (m, 1H), 1.70–1.62 (m, 10H), 1.48–1.42 (m, 2H), 0.87 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>tert</i>-Butyl 3-((4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)-ethyl)piperazin-1-yl)methyl)-4-chloro-1<i>H</i>-indole-1-carboxylate (<b>13c</b>)</h4><div class="NLM_p last">Compound <b>12c</b> (0.2 g, 0.51 mmol) was reacted with (±)-pramipexole (0.1 g, 0.46 mmol) and NaBH(OAc)<sub>3</sub> (0.22 g, 1.02 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) according to procedure A. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 5:1) to afford compound <b>13c</b> (0.12 g, 43%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.09 (bs, 1H), 7.51 (s, 1H), 7.20–7.16 (m, 2H), 5.05 (bs, 2H), 3.86 (s, 2H), 3.03–2.98 (m, 1H), 2.71–2.42 (m, 18H), 1.98–1.96 (m, 1H), 1.71–1.66 (m, 10H), 1.48–1.42 (m, 2H), 0.87 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>tert</i>-Butyl 3-((4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)-ethyl)piperazin-1-yl)methyl)-4-fluoro-1<i>H</i>-indole-1-carboxylate (<b>13d</b>)</h4><div class="NLM_p last">Compound <b>12d</b> (0.11 g, 0.26 mmol) was reacted with (±)-pramipexole (0.06 g, 0.26 mmol) and NaBH(OAc)<sub>3</sub> (0.13 g, 0.62 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) according to procedure A. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 20:1) to afford compound <b>13d</b> (0.09 g, 60%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.90 (s, 1H), 7.43 (s, 1H), 7.21–7.18 (m, 1H), 6.87 (dd, <i>J</i><sub>1</sub> = 10.8 Hz, <i>J</i><sub>2</sub> = 8.4 Hz, 1H), 4.67 (bs, −NH<sub>2</sub>, 2H), 3.75 (s, 2H), 3.02 (bs, 2H), 2.65–2.45 (m, 18H), 1.96–1.94 (m, 1H), 1.65 (s, 9H), 1.43–1.41 (m, 2H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i><sup>6</sup>-(2-(4-((5-Fluoro-1<i>H</i>-indol-3-yl)methyl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>14a</b>) (D-587)</h4><div class="NLM_p last">Compound <b>13a</b> (0.12 g, 0.21 mmol) was treated with trifluoroacetic acid (2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) according to procedure B to furnish the TFA salt of <b>14a</b> (0.18 g, 90%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.59 (s, 1H), 7.43 (td, <i>J</i> = 8.8, 2.4 Hz, 2H), 6.98 (td, <i>J</i> = 8.8, 2.4 Hz, 1H), 4.53 (s, 2H), 3.90–3.88 (m, 1H), 3.51–3.34 (m, 4H), 3.28–3.03 (m, 7H), 2.92–2.72 (m, 5H), 2.52–2.51 (m, 2H), 2.36–2.33 (m, 1H), 2.11–2.03 (m, 1H), 1.83–1.77 (m, 2H), 1.00 (t, <i>J</i> = 7.2 Hz, 3H). HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd for C<sub>25</sub>H<sub>35</sub>FN<sub>6</sub>SH, 471.2706; found, 471.2722; Anal. Calcd for C<sub>25</sub>H<sub>35</sub>FN<sub>6</sub>S·3CF<sub>3</sub>COOH·CH<sub>2</sub>Cl<sub>2</sub>: C, 42.82; H, 4.49; N, 9.36. Found: C, 43.37; H, 4.74; N, 9.33.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i><sup>6</sup>-(2-(4-((4-Methoxy-1<i>H</i>-indol-3-yl)methyl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>14b</b>) (D-623)</h4><div class="NLM_p last">Compound <b>13b</b> (0.02 g, 0.034 mmol) was treated with trifluoroacetic acid (1.5 mL) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) according to procedure B to furnish the TFA salt of <b>14b</b> (0.03 g, 91%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.30 (d, <i>J</i> = 4.8 Hz, 1H), 7.05–7.02 (m, 1H), 6.98–6.96 (m, 1H), 6.55–6.53 (m, 1H), 4.59 (s, 2H), 3.89 (s, 3H), 3.88 (s, 2H), 3.45–3.26 (m, 5H), 3.18–2.94 (m, 6H), 2.82–2.61 (m, 6H), 2.49–2.45 (m, 2H), 2.26–2.25 (m, 1H), 2.01–1.95 (m, 1H), 1.74–1.66 (m, 2H), 0.92 (t, <i>J</i> = 7.2 Hz, 3H); Anal. Calcd for C<sub>26</sub>H<sub>38</sub>N<sub>6</sub>OS·4CF<sub>3</sub>COOH·H<sub>2</sub>O: C, 42.68; H, 4.64; N, 8.78. Found: C, 42.69; H, 4.73; N, 8.45.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i><sup>6</sup>-(2-(4-((4-Chloro-1<i>H</i>-indol-3-yl)methyl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>14c</b>) (D-624)</h4><div class="NLM_p last">Compound <b>13c</b> (0.08 g, 0.13 mmol) was treated with trifluoroacetic acid (2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) according to procedure B to furnish the TFA salt of <b>14c</b> (0.11 g, 91%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.55 (bs, 1H), 7.34 (d, <i>J</i> = 7.8 Hz, 1H), 7.08–7.04 (m, 2H), 5.11 (bs, 2H), 4.75 (s, 2H), 3.84–3.81 (m, 1H), 3.49–3.28 (m, 6H), 3.19–2.96 (m, 6H), 2.82–2.60 (m, 6H), 2.29–2.27 (m, 1H), 2.02–1.95 (m, 1H), 1.76–1.70 (m, 2H), 0.93 (t, <i>J</i> = 7.2 Hz, 3H); Anal. Calcd for C<sub>25</sub>H<sub>35</sub>ClN<sub>6</sub>S·3CF<sub>3</sub>COOH·H<sub>2</sub>O: C, 43.95; H, 4.76; N, 9.92. Found: C, 44.19; H, 4.75; N, 9.45.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i><sup>6</sup>-(2-(4-((4-Fluoro-1<i>H</i>-indol-3-yl)methyl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>14d</b>) (D-590)</h4><div class="NLM_p last">Compound <b>13d</b> (0.07 g, 0.12 mmol) was treated with trifluoroacetic acid (5 mL) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) according to procedure B to furnish the TFA salt of <b>14d</b> (0.1 g, 90%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.53 (s, 1H), 7.27 (d, <i>J</i> = 8.4 Hz, 1H), 7.14 (d, <i>J</i> = 4.8 Hz, 1H), 6.82 (dd, <i>J</i><sub>1</sub> = 11.2 Hz, <i>J</i><sub>2</sub> = 7.6 Hz, 1H), 4.60 (s, 2H), 3.51–3.01 (m, 10H), 3.01–2.52 (m, 11H), 2.31–1.77 (m, 4H), 0.98 (t, <i>J</i> = 6.4 Hz, 3H); Anal. Calcd for C<sub>25</sub>H<sub>35</sub>FN<sub>6</sub>S·3CF<sub>3</sub>COOH·CH<sub>2</sub>Cl<sub>2</sub>: C, 42.82; H, 4.49; N, 9.36. Found: C, 43.11; H, 4.74; N, 9.05.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>tert</i>-Butyl 6-Bromo-1<i>H</i>-indole-1-carboxylate (<b>16a</b>)</h4><div class="NLM_p last">6-Bromo-1<i>H</i>-indole <b>15a</b> (2.0 g, 10.2 mmol) was reacted with (Boc)<sub>2</sub>O (2.45 g, 11.22 mmol) and DMAP (1.37 g, 11.22 mmol) in THF (20 mL) according to procedure D. The crude material was purified by silica gel column chromatography (hexane:EtOAc = 19:1) to afford compound <b>16a</b> (2.98 g, 99%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.36 (bs, 1H), 7.55 (s, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 7.33 (dd, <i>J</i> = 7.2, 1.2 Hz, 1H), 6.52 (d, <i>J</i> = 4.2 Hz, 1H), 1.67 (s, 9H).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>tert</i>-Butyl 4-Bromo-1<i>H</i>-indole-1-carboxylate (<b>16b</b>)</h4><div class="NLM_p last">4-Bromo-1<i>H</i>-indole <b>15b</b> (1.0 g, 5.1 mmol) was reacted with (Boc)<sub>2</sub>O (1.22 g, 5.61 mmol) and DMAP (0.69 g, 5.61 mmol) in THF (10 mL) according to procedure D. The crude material was used in the next step without any further purification (1.45 g, 96%).</div></div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Procedure G. <i>tert</i>-Butyl 6-(4-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate (<b>17a</b>)</h3><div class="NLM_p">To a mixture of compound <b>16a</b> (0.75 g, 2.53 mmol), <b>6</b> (1.24 g, 5.07 mmol), BINAP (0.16 g, 0.25 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (2.48 g, 7.60 mmol), toluene (12 mL) was added under N<sub>2</sub> atmosphere. The reaction mixture was degassed by bubbling N<sub>2</sub> for 5 min, and then Pd(OAc)<sub>2</sub> (0.043 g, 0.19 mmol) was added quickly. The system was degassed again and refluxed for 15 h under inert condition. The reaction mixture was cooled to room temperature, filtered through a pad of Celite, washed with dichloromethane, and concentrated in vacuo. The crude material was purified by silica gel column chromatography (hexane:EtOAc = 7:3) to give compound <b>17a</b> as light-brown oil (0.72 g, 62%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.77 (bs, 1H), 7.44 (s, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 6.93 (dd, <i>J</i> = 6.6, 2.4 Hz, 1H), 6.45 (d, <i>J</i> = 3.6 Hz, 1H), 3.81 (t, <i>J</i> = 6.6 Hz, 2H), 3.25 (t, <i>J</i> = 4.8 Hz, 4H), 2.72 (t, <i>J</i> = 4.8 Hz, 4H), 2.60 (t, <i>J</i> = 6.0 Hz, 2H), 1.65 (s, 9H), 0.91 (s, 9H), 0.08 (s, 6H).</div><div id="sec5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>tert</i>-Butyl 4-(4-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate (<b>17b</b>)</h4><div class="NLM_p last">A mixture of <b>16b</b> (1.0 g, 3.38 mmol), <b>6</b> (1.24 g, 5.08 mmol), Pd(OAc)<sub>2</sub> (0.03 g, 0.16 mmol), BINAP (0.16 g, 0.25 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (3.3 g, 10.16 mmol) in toluene (12 mL) was heated at 110 °C for 15 h according to procedure G. The crude residue was dissolved in ethyl acetate, washed with water, and evaporated to afford compound <b>17b</b>, which was purified by column chromatography (hexane:EtOAc = 5:1) (1.19 g, 76%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.76 (d, <i>J</i> = 7.2 Hz, 1H), 7.43 (d, <i>J</i> = 3.0 Hz, 1H), 7.17 (t, <i>J</i> = 7.8 Hz, 1H), 6.70 (d, <i>J</i> = 7.8 Hz, 1H), 6.54 (d, <i>J</i> = 3.6 Hz, 1H), 3.77 (t, <i>J</i> = 6.0 Hz, 2H), 3.15 (t, <i>J</i> = 3.6 Hz, 4H), 2.72 (t, <i>J</i> = 3.6 Hz, 4H), 2.59 (t, <i>J</i> = 6.6 Hz, 1H), 1.62 (s, 9H), 0.86 (s, 9H), 0.04 (s, 6H).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>tert</i>-Butyl 6-(4-(2-Hydroxyethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate (<b>18a</b>)</h4><div class="NLM_p last">Compound <b>17a</b> (0.7 g, 1.52 mmol) was reacted with <i>n</i>-tetrabutylammonium fluoride (3.0 mL, 3.05 mmol, 1.0 M solution in THF) in THF (10 mL) according to procedure E. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 5:1) to give compound <b>18a</b> (0.44 g, 84%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.78 (bs, 1H), 7.45 (s, 1H), 7.41 (dd, <i>J</i> = 5.4, 3.0 Hz, 1H), 6.93–6.91 (m, 1H), 6.45 (d, <i>J</i> = 3.6 Hz, 1H), 3.68 (t, <i>J</i> = 6.0 Hz, 2H), 3.26–3.25 (m, 4H), 2.73–2.72 (m, 4H), 2.64–2.60 (m, 2H), 1.66 (s, 9H).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>tert</i>-Butyl 4-(4-(2-Hydroxyethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate (<b>18b</b>)</h4><div class="NLM_p last">Compound <b>17b</b> (1.1 g, 2.39 mmol) was reacted with <i>n</i>-tetrabutylammonium fluoride (4.8 mL, 4.78 mmol, 1.0 M solution in THF) in THF (15 mL) according to procedure E. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 9:1) to yield compound <b>18b</b> (0.71 g, 86%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 7.2 Hz, 1H), 7.55 (d, <i>J</i> = 3.0 Hz, 1H), 7.23 (t, <i>J</i> = 7.8 Hz, 1H), 6.74 (d, <i>J</i> = 7.8 Hz, 1H), 6.58 (d, <i>J</i> = 3.6 Hz, 1H), 3.69 (t, <i>J</i> = 5.4 Hz, 2H), 3.21 (s, 4H), 2.77 (s, 4H), 2.66 (t, <i>J</i> = 5.4 Hz, 2H), 1.66 (s, 9H).</div></div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Procedure H. <i>tert</i>-Butyl 7-Chloro-6-(4-(2-oxoethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate (<b>19a</b>)</h3><div class="NLM_p">Into a stirring solution of oxalyl chloride (0.22 mL, 2.55 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL) at −78 °C was added DMSO (0.33 mL, 4.63 mmol). The reaction mixture was stirred for 0.5 h, followed by addition of compound <b>18a</b> (0.4 g, 1.16 mmol, in 5 mL of CH<sub>2</sub>Cl<sub>2</sub>). The reaction mixture was stirred at the same temperature for 0.5 h, followed by addition of Et<sub>3</sub>N (0.97 mL, 6.95 mmol), and stirring was continued for another 1.5 h while allowing the reaction mixture to reach room temperature. The reaction mixture was quenched by addition of a saturated solution of NaHCO<sub>3</sub> at 0 °C and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 25 mL). The combined organic layer was dried using Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography (hexane/EtOAc, 3:2) to afford compound <b>19a</b> (0.21 g, 48%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.76 (s, 1H), 7.44 (d, <i>J</i> = 3.6 Hz, 1H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.02 (d, <i>J</i> = 8.4 Hz, 1H), 6.49 (d, <i>J</i> = 3.6 Hz, 1H), 3.29–3.24 (m, 4H), 3.20 (m, 4H), 2.76 (m, 2H), 1.64 (s, 9H).</div><div id="sec5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>tert</i>-Butyl 5-Chloro-4-(4-(2-oxoethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate (<b>19b</b>)</h4><div class="NLM_p last">Alcohol <b>18b</b> (0.2 g, 0.58 mmol) was oxidized with oxalyl chloride (0.11 mL, 1.27 mmol), DMSO (0.16 mL, 2.32 mmol), and Et<sub>3</sub>N (0.48 mL, 3.47 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (7 mL) using procedure H. The crude residue was purified by column chromatography (hexane/EtOAc, 3:2) to afford compound <b>19b</b> (0.07 g, 32%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.78 (s, 1H), 7.86 (d, <i>J</i> = 7.8 Hz, 1H), 7.55 (d, <i>J</i> = 3.0 Hz, 1H), 7.27 (d, <i>J</i> = 9.0 Hz, 1H), 6.77 (d, <i>J</i> = 4.2 Hz, 1H), 3.41 (s, 4H), 3.28 (s, 2H), 2.73 (s, 4H), 1.66 (s, 9H).</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>S</i>)-<i>tert</i>-Butyl 6-(4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)ethyl)piperazin-1-yl)-7-chloro-1<i>H</i>-indole-1-carboxylate (<b>20a</b>)</h4><div class="NLM_p last">Compound <b>19a</b> (0.18 g, 0.46 mmol) was reacted with (−)-pramipexole (0.09 g, 0.43 mmol) and NaBH(OAc)<sub>3</sub> (0.2 g, 0.93 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) according to procedure A. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 5:1) to afford compound <b>20a</b> (0.14 g, 56%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.43 (d, <i>J</i> = 3.6 Hz, 1H), 7.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 1H), 6.48 (d, <i>J</i> = 3.6 Hz, 1H), 5.13 (bs, 2H), 3.24–3.15 (m, 4H), 3.07–3.03 (m, 1H), 2.77–2.66 (m, 8H), 2.57–2.46 (m, 6H), 2.01–1.99 (m, 1H), 1.75–1.71 (m, 1H), 1.64 (s, 9H), 1.51–1.45 (m, 2H), 0.90 (t, <i>J</i> = 7.2 Hz, 3H). [α]<sub>D</sub><sup>25</sup> = −35.3 (<i>c</i> = 1.0 in CH<sub>3</sub>OH).</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>S</i>)-<i>tert</i>-Butyl 4-(4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)ethyl)piperazin-1-yl)-5-chloro-1<i>H</i>-indole-1-carboxylate (<b>20b</b>)</h4><div class="NLM_p last">Compound <b>19b</b> (0.07 g, 0.18 mmol) was reacted with (−)-pramipexole (0.04 g, 0.18 mmol) and NaBH(OAc)<sub>3</sub> (0.08 g, 0.37 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) according to procedure A. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 9:1) to afford compound <b>20b</b> (0.07 g, 64%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.84 (d, <i>J</i> = 7.2 Hz, 1H), 7.53 (d, <i>J</i> = 3.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.4 Hz, 1H), 6.77 (d, <i>J</i> = 3.0 Hz, 1H), 5.36 (bs, 2H), 3.37 (s, 4H), 3.09–3.05 (m, 1H), 2.80–2.67 (m, 8H), 2.61–2.47 (m, 6H), 2.02–2.00 (m, 1H), 1.76–1.69 (m, 1H), 1.65 (s, 9H), 1.52–1.46 (m, 2H), 0.90 (t, <i>J</i> = 7.2 Hz, 3H). [α]<sub>D</sub><sup>25</sup> = −33.8 (<i>c</i> = 1.0 in CH<sub>3</sub>OH).</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>S</i>)-<i>N</i><sup>6</sup>-(2-(4-(7-Chloro-1<i>H</i>-indol-6-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>21a</b>) (D-616)</h4><div class="NLM_p last">Compound <b>20a</b> (0.07 g, 0.13 mmol) was treated with trifluoroacetic acid (2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) according to procedure B to furnish the TFA salt of <b>21a</b> (0.11 g, 91%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.44 (d, <i>J</i> = 8.4 Hz, 1H), 7.24 (d, <i>J</i> = 3.0 Hz, 1H), 6.91 (d, <i>J</i> = 8.4 Hz, 1H), 6.44 (d, <i>J</i> = 3.0 Hz, 1H), 3.60 (m, 1H), 3.51–3.42 (m, 8H), 3.29 (s, 4H), 2.97–2.89 (m, 3H), 2.78–2.66 (m, 3H), 2.24–2.22 (m, 1H), 1.97–1.95 (m, 1H), 1.74–1.67 (m, 2H), 0.99 (t, <i>J</i> = 7.2 Hz, 3H). [α]<sub>D</sub><sup>25</sup> = −25.2 (<i>c</i> = 1.0 in CH<sub>3</sub>OH). Anal. Calcd for C<sub>24</sub>H<sub>33</sub>ClN<sub>6</sub>S·4CF<sub>3</sub>COOH: C, 41.36; H, 4.01; N, 9.04. Found: C, 41.38; H, 4.34; N, 9.16.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>S</i>)-<i>N</i><sup>6</sup>-(2-(4-(5-Chloro-1<i>H</i>-indol-4-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>21b</b>) (D-617)</h4><div class="NLM_p last">Compound <b>20b</b> (0.07 g, 0.119 mmol) was treated with trifluoroacetic acid (2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) according to procedure B to furnish the TFA salt of <b>21b</b> (0.1 g, 95%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.23 (d, <i>J</i> = 3.6 Hz, 1H), 7.15 (d, <i>J</i> = 8.4 Hz, 1H), 7.05 (d, <i>J</i> = 7.8 Hz, 1H), 6.61 (d, <i>J</i> = 3.0 Hz, 1H), 3.56 (s, 4H), 3.45–3.41 (m, 7H), 3.29 (m, 3H), 2.92–2.80 (m, 3H), 2.74–2.70 (m, 2H), 2.21–2.20 (m, 1H), 1.92 (m, 1H), 1.68–1.62 (m, 2H), 0.97 (t, <i>J</i> = 7.2 Hz, 3H). [α]<sub>D</sub><sup>25</sup> = −23.9 (<i>c</i> = 1.0 in CH<sub>3</sub>OH). Anal. Calcd for C<sub>24</sub>H<sub>33</sub>ClN<sub>6</sub>S·3CF<sub>3</sub>COOH·H<sub>2</sub>O: C, 43.25; H, 4.60; N, 10.09. Found: C, 42.89; H, 4.69; N, 9.85.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>tert</i>-Butyl 5-Bromo-7-fluoro-1<i>H</i>-indole-1-carboxylate (<b>22</b>)</h4><div class="NLM_p last">5-Bromo-7-fluoro-1<i>H</i>-indole (0.48 g, 2.22 mmol) was reacted with (Boc)<sub>2</sub>O (0.53 g, 2.44 mmol) and DMAP (0.3 g, 2.44 mmol) in THF (5 mL) according to procedure D. The crude material was purified by silica gel column chromatography (hexane:EtOAc = 19:1) to afford compound <b>22</b> in quantitative yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.64 (d, <i>J</i> = 3.6 Hz, 1H), 7.47 (d, <i>J</i> = 1.8 Hz, 1H), 7.17 (dd, <i>J</i> = 10.8, 1.2 Hz, 1H), 6.52 (q, <i>J</i> = 1.8 Hz, 1H), 1.65 (s, 9H).</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>tert</i>-Butyl 5-(4-(2-((<i>tert</i>-Butyldimethylsilyl)oxy)ethyl)piperazin-1-yl)-7-fluoro-1<i>H</i>-indole-1-carboxylate (<b>23</b>)</h4><div class="NLM_p last">A mixture of <b>22</b> (0.69 g, 2.196 mmol), <b>6</b> (0.94 g, 3.84 mmol), Pd(OAc)<sub>2</sub> (0.04 g, 0.17 mmol), BINAP (0.14 g, 0.22 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (2.15 g, 6.59 mmol) in toluene (10 mL) was heated at 110 °C for 15 h according to procedure G. The crude residue was purified by column chromatography (hexane:EtOAc = 7:3) to afford compound <b>23</b> (0.61 g, 58%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.56 (d, <i>J</i> = 3.6 Hz, 1H), 6.79 (d, <i>J</i> = 1.8 Hz, 1H), 6.71 (dd, <i>J</i> = 12.6, 2.4 Hz, 1H), 6.46 (q, <i>J</i> = 1.8 Hz, 1H), 3.80 (t, <i>J</i> = 6.0 Hz, 2H), 3.19 (t, <i>J</i> = 4.8 Hz, 4H), 2.71 (t, <i>J</i> = 4.8 Hz, 4H), 2.60 (t, <i>J</i> = 6.0 Hz, 2H), 1.63 (s, 9H), 0.91 (s, 9H), 0.08 (s, 6H).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>tert</i>-Butyl 7-Fluoro-5-(4-(2-hydroxyethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate (<b>24</b>)</h4><div class="NLM_p last">Compound <b>23</b> (0.35 g, 0.73 mmol) was reacted with <i>n</i>-tetrabutylammonium fluoride (1.45 mL, 1.46 mmol, 1.0 M solution in THF) in THF (7 mL) according to procedure E. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 5:1) to give compound <b>24</b> (0.23 g, 85%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.57 (d, <i>J</i> = 3.6 Hz, 1H), 6.79 (d, <i>J</i> = 1.8 Hz, 1H), 6.71 (dd, <i>J</i> = 12.6, 2.4 Hz, 1H), 6.47 (q, <i>J</i> = 1.8 Hz, 1H), 3.67 (t, <i>J</i> = 6.0 Hz, 2H), 3.20 (t, <i>J</i> = 4.8 Hz, 4H), 2.82 (bs, 1H), 2.69 (t, <i>J</i> = 4.8 Hz, 4H), 2.62 (t, <i>J</i> = 6.0 Hz, 2H), 1.63 (s, 9H).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>tert</i>-Butyl 7-Fluoro-5-(4-(2-oxoethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate (<b>25</b>)</h4><div class="NLM_p last">Alcohol <b>24</b> (0.15 g, 0.41 mmol) was oxidized using SO<sub>3</sub>·py complex (0.33 g, 2.06 mmol), DMSO (2 mL), and Et<sub>3</sub>N (0.40 mL, 2.89 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) according to procedure F. The crude product was purified by silica gel column chromatography using ethyl acetate as solvent to give aldehyde <b>25</b> (0.12 g, 84%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.75 (s, 1H), 7.57 (d, <i>J</i> = 3.6 Hz, 1H), 6.81–6.79 (m, 1H), 6.71 (dd, <i>J</i> = 13.2, 1.8 Hz, 1H), 6.47 (q, <i>J</i> = 1.8 Hz, 1H), 3.27–3.19 (m, 6H), 2.73–2.70 (m, 4H), 1.63 (s, 9H).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>S</i>)-<i>tert</i>-Butyl 5-(4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(propyl)amino)ethyl)piperazin-1-yl)-7-fluoro-1<i>H</i>-indole-1-carboxylate (<b>26</b>)</h4><div class="NLM_p last">Aldehyde <b>25</b> (0.12 g, 0.33 mmol) was reacted with (−)-pramipexole (0.06 g, 0.30 mmol) and NaBH(OAc)<sub>3</sub> (0.14 g, 0.66 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (7 mL) according to procedure A. The crude product was purified by silica gel column chromatography (EtOAc:MeOH = 9:1) to afford compound <b>26</b> (0.09 g, 51%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.56 (d, <i>J</i> = 3.0 Hz, 1H), 6.79 (d, <i>J</i> = 2.4 Hz, 1H), 6.70 (dd, <i>J</i> = 13.8, 1.8 Hz, 1H), 6.46 (q, <i>J</i> = 1.8 Hz, 1H), 5.11 (bs, 2H), 3.19 (t, <i>J</i> = 4.8 Hz, 4H), 3.07–3.03 (m, 1H), 2.76–2.66 (m, 8H), 2.58–2.46 (m, 6H), 2.01–1.99 (m, 1H), 1.76–1.69 (m, 1H), 1.63 (s, 9H), 1.51–1.45 (m, 2H), 0.89 (t, <i>J</i> = 7.2 Hz, 3H). [α]<sub>D</sub><sup>25</sup> = −36.4 (<i>c</i> = 1.0 in CH<sub>3</sub>OH).</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>S</i>)-<i>N</i><sup>6</sup>-(2-(4-(7-Fluoro-1<i>H</i>-indol-5-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>27</b>) (D-615)</h4><div class="NLM_p last">Compound <b>26</b> (0.08 g, 0.14 mmol) was treated with trifluoroacetic acid (2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) according to procedure B to furnish the TFA salt of <b>27</b> (0.11 g, 85%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.21 (d, <i>J</i> = 3.0 Hz, 1H), 6.94 (s, 1H), 6.69 (d, <i>J</i> = 13.2 Hz, 1H), 6.41 (t, <i>J</i> = 3.0 Hz, 1H), 3.57–3.53 (m, 1H), 3.30–3.16 (m, 7H), 3.09–2.85 (m, 9H), 2.76–2.69 (m, 2H), 2.16–2.15 (m, 1H), 1.96–1.89 (m, 1H), 1.71–1.65 (m, 2H), 0.98 (t, <i>J</i> = 7.2 Hz, 3H). [α]<sub>D</sub><sup>25</sup> = −26.6 (<i>c</i> = 1.0 in CH<sub>3</sub>OH). Anal. Calcd for C<sub>24</sub>H<sub>33</sub>FN<sub>6</sub>S·3CF<sub>3</sub>COOH·2H<sub>2</sub>O: C, 43.17; H, 4.83; N, 10.07. Found: C, 42.95; H, 4.67; N, 9.62.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>S</i>)-<i>N</i>-(2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)-2-nitrobenzenesulfonamide (<b>29</b>)</h4><div class="NLM_p last">2-Nitrobenzenesulfonyl chloride (1.2 g, 5.41 mmol) was dissolved in 20 mL of THF, and the solution was cooled to approximately −10 °C. Et<sub>3</sub>N (3.4 mL, 24.37 mmol) and (<i>S</i>)-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine <b>28</b><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (1.0 g, 5.96 mmol) were added, and the resulting suspension was heated during mixing to approximately 25 °C and allowed to react for 1.5 h. Precipitated triethylammonium chloride was filtered off, and the filtrate was concentrated. Water was added and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The combined organic layer was dried using Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure to obtain sulfonamide <b>29</b> (1.8 g, 5.08 mmol) as a pale-yellow solid with a yield of 94%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.05–8.02 (m, 1H), 7.93–7.91 (m, 1H), 7.84–7.81 (m, 2H), 6.63 (s, 2H), 3.53–3.48 (m, 1H), 2.60–2.56 (m, 1H), 2.45–2.41 (m, 2H), 2.37–2.32 (m, 1H), 1.76–1.64 (m, 2H).</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-<i>N</i>-(2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)-2-nitro-<i>N</i>-(prop-2-yn-1-yl)benzene-sulfonamide (<b>30</b>)</h4><div class="NLM_p last">Compound <b>29</b> (1.26 g, 3.56 mmol), potassium carbonate (3.44 g, 24.89 mmol) and propargyl bromide (0.54 mL, 7.11 mmol) were suspended in 20 mL of acetonitrile. The mixture was heated during stirring to about 50 °C and left to react overnight. The reaction mixture was cooled to room temperature; water was added and extracted with EtOAc (3 × 35 mL). The combined organic layer was dried using Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. Column chromatography with EtOAc:MeOH (19:1) afforded compound <b>30</b> (0.97 g, 69%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.17 (dd, <i>J</i> = 6.0, 1.2 Hz, 1H), 7.75–7.67 (m, 3H), 5.20 (bs, 2H), 4.29–4.24 (m, 1H), 4.20 (s, 2H), 3.01 (t, <i>J</i> = 12.6 Hz, 1H), 2.78 (dd, <i>J</i> = 10.8, 4.8 Hz, 1H), 2.72–2.63 (m, 2H), 2.23 (t, <i>J</i> = 2.4 Hz, 1H), 2.08–2.06 (m, 2H).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>S</i>)-<i>N</i><sup>6</sup>-(Prop-2-yn-1-yl)-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>31</b>)</h4><div class="NLM_p last">Into a mixture of potassium carbonate (3.8 g, 27.52 mmol) in 15 mL of DMF, thioglycolic acid (1.09 mL, 15.29 mmol) was added slowly at 0 °C. The mixture was stirred at room temperature for approximately 1 h, followed by addition of compound <b>30</b> (1.2 g, 3.06 mmol, in 5 mL of DMF). The reaction mixture was heated during stirring to about 50 °C and allowed to react for an additional 15 h, after which it was quenched by addition of 1N NaOH and extracted with EtOAc (4 × 25 mL). The combined organic layer was dried using Na<sub>2</sub>SO<sub>4</sub>, and the solvent was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (5–10% MeOH in EtOAc) to give compound <b>31</b> (0.43 g, 67%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 5.20 (bs, 2H), 3.55–3.49 (m, 2H), 3.28–3.22 (m, 1H), 2.86–2.83 (m, 1H), 2.67–2.57 (m, 2H), 2.43–2.39 (m, 1H), 2.24 (s, 1H), 2.02–1.96 (m, 1H), 1.75–1.69 (m, 1H). [α]<sub>D</sub><sup>25</sup> = −89.4 (<i>c</i> = 1.0 in CH<sub>3</sub>OH).</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-<i>tert</i>-Butyl 5-(4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(prop-2-yn-1-yl)amino)ethyl)piperazin-1-yl)-4-chloro-1<i>H</i>-indole-1-carboxylate (<b>33</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl 4-chloro-5-(4-(2-oxoethyl)piperazin-1-yl)-1<i>H</i>-indole-1-carboxylate <b>32</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (0.22 g, 0.58 mmol) was reacted with the compound <b>31</b> (0.11 g, 0.52 mmol) and NaBH(OAc)<sub>3</sub> (0.25 g, 1.16 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) according to procedure A. The crude product was purified by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 19:1) to afford compound <b>33</b> (0.08 g, 29%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.98 (bs, 1H), 7.59 (s, 1H), 7.09 (dd, <i>J</i> = 6.6, 2.4 Hz, 1H), 6.67 (d, <i>J</i> = 3.6 Hz, 1H), 5.07 (bs, 2H), 3.58 (d, <i>J</i> = 2.4 Hz, 2H), 3.15–3.11 (m, 5H), 2.89–2.82 (m, 3H), 2.74–2.68 (m, 4H), 2.65–2.56 (m, 4H), 2.51 (s, 1H), 2.24 (t, <i>J</i> = 2.4 Hz, 1H), 2.14–2.12 (m, 1H), 1.78–1.71 (m, 1H), 1.66 (s, 10H). [α]<sub>D</sub><sup>25</sup> = −28.3 (<i>c</i> = 1.0 in CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>S</i>)-<i>N</i><sup>6</sup>-(2-(4-(4-Chloro-1<i>H</i>-indol-5-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-(prop-2-yn-1-yl)-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>34</b>) (D-614)</h4><div class="NLM_p last">Compound <b>33</b> (0.07 g, 0.12 mmol) was treated with trifluoroacetic acid (3 mL) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) according to procedure B to furnish the TFA salt of <b>34</b> (0.1 g, 90%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.29 (dd, <i>J</i> = 6.0, 3.0 Hz, 1H), 7.24 (dd, <i>J</i> = 6.6, 3.0 Hz, 1H), 7.00 (q, <i>J</i> = 8.4 Hz, 1H), 6.47 (d, <i>J</i> = 3.0 Hz, 1H), 3.59 (d, <i>J</i> = 2.4 Hz, 2H), 3.33 (s, 1H), 3.15–3.10 (m, 5H), 2.99–2.95 (m, 5H), 2.85–2.77 (m, 3H), 2.67–2.66 (m, 1H), 2.64–2.59 (m, 2H), 2.53–2.48 (m, 2H), 2.13–2.11 (m, 1H), 1.80–1.72 (m, 1H). [α]<sub>D</sub><sup>25</sup>= −19.6 (<i>c</i> = 1.0 in CH<sub>3</sub>OH). LRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd for C<sub>24</sub>H<sub>29</sub>ClN<sub>6</sub>SH, 469.19; found, 469.19. Anal. Calcd for C<sub>24</sub>H<sub>29</sub>ClN<sub>6</sub>S·3CF<sub>3</sub>COOH·CH<sub>2</sub>Cl<sub>2</sub>: C, 41.55; H, 3.82; N, 9.38. Found: C, 41.80; H, 4.21; N, 9.39.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>S</i>)-<i>tert</i>-Butyl 6-(4-(2-((2-Amino-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-6-yl)(prop-2-yn-1-yl)amino)ethyl)piperazin-1-yl)-7-chloro-1<i>H</i>-indole-1-carboxylate (<b>35</b>)</h4><div class="NLM_p last">Aldehyde <b>19a</b> (0.2 g, 0.53 mmol) was reacted with <b>31</b> (0.1 g, 0.48 mmol) and NaBH(OAc)<sub>3</sub> (0.22 g, 1.06 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) according to procedure A. The crude product was purified by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 9:1) to afford compound <b>35</b> (0.06 g, 23%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.43 (d, <i>J</i> = 3.0 Hz, 1H), 7.39 (d, <i>J</i> = 7.8 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 1H), 6.48 (d, <i>J</i> = 3.6 Hz, 1H), 4.77 (bs, 2H), 3.58 (d, <i>J</i> = 2.4 Hz, 2H), 3.16–3.10 (m, 5H), 2.88–2.83 (m, 3H), 2.73–2.59 (m, 9H), 2.23 (t, <i>J</i> = 1.8 Hz, 1H), 2.15–2.13 (m, 1H), 1.79–1.73 (m, 1H), 1.64 (s, 9H). [α]<sub>D</sub><sup>25</sup> = −28.0 (<i>c</i> = 1.0 in CH<sub>3</sub>OH).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>S</i>)-<i>N</i><sup>6</sup>-(2-(4-(7-Chloro-1<i>H</i>-indol-6-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-(prop-2-yn-1-yl)-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine (<b>36</b>) (D-635)</h4><div class="NLM_p last">Compound <b>35</b> (0.017 g, 0.03 mmol) was treated with trifluoroacetic acid (2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) according to procedure B to furnish the TFA salt of <b>36</b> (0.017 g, 79%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.48 (d, <i>J</i> = 7.8 Hz, 1H), 7.26 (d, <i>J</i> = 3.0 Hz, 1H), 6.95 (d, <i>J</i> = 8.4 Hz, 1H), 6.45 (d, <i>J</i> = 3.6 Hz, 1H), 3.63 (d, <i>J</i> = 2.4 Hz, 2H), 3.42 (t, <i>J</i> = 6.0 Hz, 2H), 3.34 (s, 3H), 3.30–3.29 (m, 5H), 3.24–3.18 (m, 3H), 2.80 (dd, <i>J</i> = 15.6, 4.8 Hz, 1H), 2.78 (t, <i>J</i> = 2.4 Hz, 1H), 2.71–2.67 (m, 2H), 2.62–2.58 (m, 1H), 2.19 (d, <i>J</i> = 10.8 Hz, 1H), 1.91–1.84 (m, 1H). [α]<sub>D</sub><sup>25</sup> = −21.3 (<i>c</i> = 1.0 in CH<sub>3</sub>OH). HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: calcd for C<sub>24</sub>H<sub>29</sub>ClN<sub>6</sub>SH, 469.1941; found, 469.1930. Anal. Calcd for C<sub>24</sub>H<sub>29</sub>ClN<sub>6</sub>S·2CF<sub>3</sub>COOH·2H<sub>2</sub>O: C, 45.87; H, 4.81; N, 11.46. Found: C, 46.45; H, 4.49; N, 10.89.</div></div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Evaluation of Potency in Binding to and Activating Dopamine D<sub>2</sub> and D<sub>3</sub> Receptors</h3><div class="NLM_p last">Binding potency was monitored by inhibition of [<sup>3</sup>H]spiroperidol (15.3 Ci/mmol, PerkinElmer) binding to DA rD<sub>2</sub> and rD<sub>3</sub> receptors expressed in HEK-293 cells in a buffer containing 0.9% NaCl. Functional activity of test compounds in activating dopamine hD<sub>2</sub> and hD<sub>3</sub> receptors expressed in CHO cells was measured by stimulation of [<sup>35</sup>S]GTPγS (1250 Ci/mmol, PerkinElmer) binding in comparison to stimulation by the full agonist DA as described by us previously.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> Receptor expression was (pmol/mg of protein): HEK-D2, 2.41; HEK-D3, 1.08; CHO-D2, 0.64; CHO-D3, 6.76. Despite the order of magnitude difference in D<sub>2</sub> and D<sub>3</sub> expressionin CHO cells, the maximal stimulation of [<sup>35</sup>S]GTPγS binding in absolute terms was similar for D<sub>2</sub> and D<sub>3</sub>, likely due to the well- known low efficiency of D<sub>3</sub> receptor-G protein coupling.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Evaluation of Antagonist Property of (−)-<b>34</b></h3><div class="NLM_p last">D<sub>2</sub> antagonist activity was assessed by testing a fixed concentration that by itself had little or no effect on baseline [<sup>35</sup>S]GTPγS binding for its ability to shift the concentration curve of an agonist stimulating [<sup>35</sup>S]GTPγS binding as described for opioid receptors by Sally and co-workers (2010).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The fixed concentration of compound (−)-<b>34</b> was 50 and 300 nM, and that of standard compound (−)-3PPP were studied for comparison, 200 nM and 1 μM. The agonist used was dopamine (0.001–100 μM). <i>K</i><sub>e</sub> is the functional <i>K</i><sub>i</sub> (equilibrium dissociation constant) of an antagonist and is calculated according to the equation: [test compound]/(EC<sub>50–2</sub>/EC<sub>50–1</sub> – 1), where EC<sub>50–2</sub> is the EC<sub>50</sub> value in the presence of the test compound and EC<sub>50–1</sub> is the value in the absence of the test compound.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Animal Experiments: Drugs and Chemicals</h3><div class="NLM_p last">The following commercially available drugs were used in the experiment: reserpine hydrochloride (Alfa Aesar) and ropinirole (Sigma-Aldrich). The TFA salt of (−)-<b>21a</b>, (−)-<b>34</b> and hydrochloride salt of (−)-pramipexole and ropinirole were dissolved in water. Reserpine was dissolved in 20 μL of glacial acetic acid and further diluted with 5.5% glucose solution. The compounds for this study were administered in a volume of 0.1–0.2 mL for subcutaneous administration and 0.5–0.7 mL for intraperitoneal administration into each rat.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Animals</h3><div class="NLM_p last">In rodent studies, animals were male and female Sprague–Dawley rats from Harlan (Indianapolis, IN) weighing 220–225 g unless otherwise specified. Animals were maintained in sawdust-lined cages in a temperature and humidity controlled environment at 22 ± 1 °C and 60 ± 5% humidity, respectively. A 12 h light/dark cycle was maintained, with lights on from 6:00 a.m. to 6:00 p.m. They were group-housed with unrestricted access to food and water. All experiments were performed during the light component. All animal use procedures were in compliance with the Wayne State University Animal Investigation Committee, consistent with AALAC guidelines.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Reversal of Reserpine-Induced Hypolocomotion in Rats</h3><div class="NLM_p last">Administration of reserpine induces catalepsy in rodents primarily by blocking the vesicular monoamine transporter (VMAT) which helps in the internalization of monoamines into vesicles, resulting in metabolism of unprotected monoamines in the cytosol that ultimately causes depletion of monoamines in the synapse of the peripheral sympathetic nerve terminals.<a onclick="showRef(event, 'ref58 ref63'); return false;" href="javascript:void(0);" class="ref ref58 ref63">(58, 63)</a> The ability of compounds (−)-<b>21a</b> and (−)-<b>34</b> to reverse reserpine-induced hypolocomotion was investigated according to a reported procedure.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (−)-Pramipexle and ropinirole were used as standard reference compounds in this study. Reserpine (5.0 mg/kg, sc) was administered to anaesthetized rats 18 h before the injection of drug or vehicle. The rats were placed individually in the chambers for 1 h for acclimatization before administration of the test drug, standard drug, or vehicle. Immediately after administration of drug or vehicle, animals were individually placed in an Opto-Varimex 4 animal activity monitor chamber (Columbus Instruments, Ohio, USA) to start measuring locomotor activity. Locomotion was monitored for 6 h. Consecutive interruption of two infrared beams, situated 50 cm apart and 4 cm above the cage floor in the monitor chamber, recorded movement. The data were presented as horizontal activity (HACTV). The effect of individual doses of drugs on locomotor activity was compared with respect to saline treated controls (mean ± SEM). The data were analyzed by one way analysis of variance (ANOVA) followed by Dunnett’s post hoc test. The effect was considered significant if the difference from control group was observed at <i>p</i> < 0.05.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Cell Culture and Treatments</h3><div class="NLM_p last">PC12 cells (ATCC CRL1721.1, Manassas, VA, USA), a rat adrenal pheochromocytoma cell line, were cultured in T-75 flasks (Greiner Bio One, Frickenhausen, Germany) and maintained in RPMI 1640 medium supplemented with 10% heat-inactivated horse serum, 5% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C in 95% air/5% CO<sub>2</sub>. Stock solutions of (−)-<b>21a</b> and 6-hydroxydopamine (6-OHDA) were prepared in dimethyl sulfoxide (DMSO), and aliquots were stored at −20 °C and −80 °C, respectively. For all experiments assessing neuroprotective effects of the test compound, PC12 cells were pretreated with indicated concentrations of (−)-<b>21a</b> for 24 h and then treated with 75 μM 6-OHDA only for another 24 h. The control cells were treated with above media containing 0.01% DMSO only.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Assessment of Cell Viability</h3><div class="NLM_p last">To determine the neuroprotective effect of (−)-<b>21a</b> on 6-OHDA mediated cell death, a quantitative colorimetric MTT assay was performed. PC12 cells were plated at 17000 cells/well density in 100 μL of media in 96-well plates for 24 h. Cells were treated with varying concentrations of either 6-OHDA or the test compound to determine their direct effect on cell viability and to determine the optimum concentration of 6-OHDA in subsequent neuroprotection experiments. Neuroprotection experiments were conducted by treating cells for 24 h with varying concentrations of (−)-<b>21a</b>. Then the drug containing media was replaced with fresh culture media followed by treatment with 75 μM of 6-OHDA alone for an additional 24 h. After incubation for 24 h, 5 mg/mL MTT solution (prepared in Dulbecco’s phosphate-buffered saline) was added to the cells (to a final concentration of 0.5 mg/mL) and the plates were further incubated at 37 °C in 95% air/5% CO<sub>2</sub> atmosphere for 3–4 h to produce dark-blue formazan crystals. Afterward, the plates were centrifuged at 450<i>g</i> for 10 min and the supernatants were carefully removed. Formazan crystals were dissolved by adding 100 μL of methanol:DMSO (1:1) mixture to each well and shaking gently at 400 rpm for 30 min at room temperature on a Thermomix R shaker (Eppendorf, Hamburg, Germany). The absorbance values were measured on a microplate reader (Biotek Epoch, Winooski, VT, USA) at 570 nm with background correction performed at 690 nm. Data from at least three experiments were analyzed using Graphpad software (version 6, San Diego, CA, USA). Cell viability was defined as percentage reduction in absorbance compared to untreated controls. The data were analyzed by one way analysis of variance (ANOVA) followed by Tukey’s multiple comparison post hoc test.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01031">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81573" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81573" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01031" class="ext-link">10.1021/acs.jmedchem.5b01031</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Details of in vitro antioxidant assay procedures and results; physicochemical properties of the compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_001.pdf">jm5b01031_si_001.pdf (1.44 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_002.csv">jm5b01031_si_002.csv (1.29 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01031" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aloke K. Dutta</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, Wayne State
University, Detroit, Michigan 48202, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#21404554555540615640584f440f444554"><span class="__cf_email__" data-cfemail="7d1c190809091c3d0a1c04131853181908">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Banibrata Das</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, Wayne State
University, Detroit, Michigan 48202, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seenuvasan Vedachalam</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, Wayne State
University, Detroit, Michigan 48202, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Luo</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, Wayne State
University, Detroit, Michigan 48202, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tamara Antonio</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry, New York University, New York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maarten E. A. Reith</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry, New York University, New York, New York 10016, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Pharmacology, New York University, New York, New York 10016, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d406e6748-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work is supported by National Institute of Neurological Disorders and Stroke/National Institute of Health (NS047198, AKD). We are grateful to Dr. K. Neve, Oregon Health and Science University, Portland, OR, for D2L and D3 expressing HEK cells. We are also grateful to Dr. J. Shine, Garvan Institute for Medical Research, Sydney, Australia, for D2L expressing CHO cells.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i78" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i78"> Abbreviations Used</h2><tr><td class="NLM_term">Cs<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">cesium carbonate</p></td></tr><tr><td class="NLM_term">BINAP</td><td class="NLM_def"><p class="first last">2,2′-bis(diphenylphosphino)-1,1′-binaphthyl</p></td></tr><tr><td class="NLM_term">Pd(OAc)<sub>2</sub></td><td class="NLM_def"><p class="first last">palladium(II) acetate</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">SO<sub>3</sub>·py</td><td class="NLM_def"><p class="first last">sulfur trioxide pyridine</p></td></tr><tr><td class="NLM_term">NaBH(OAc)<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium triacetoxyborohydride</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">Trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">GTPγS</td><td class="NLM_def"><p class="first last">guanosine 5′-<i>O</i>-[γ-thio]triphosphate</p></td></tr><tr><td class="NLM_term">5-OH-DPAT</td><td class="NLM_def"><p class="first last">5-hydroxy-2-(dipropylamino)tetralin</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term"><span class="smallcaps smallerCapital">l</span>-DOPA</td><td class="NLM_def"><p class="first last">(<i>S</i>)-(3,4-dihydroxyphenyl) alanine</p></td></tr><tr><td class="NLM_term">(−)-3PPP</td><td class="NLM_def"><p class="first last">(<i>S</i>)-(−)-3-(3-hydroxyphenyl)-<i>N</i>-propylpiperidine</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gelb, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, S.</span><span> </span><span class="NLM_article-title">Diagnostic criteria for Parkinson disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1001/archneur.56.1.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1001%2Farchneur.56.1.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=9923759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A280%3ADyaK1M7itVKgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=33-39&author=D.+J.+Gelbauthor=E.+Oliverauthor=S.+Gilman&title=Diagnostic+criteria+for+Parkinson+disease&doi=10.1001%2Farchneur.56.1.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnostic criteria for Parkinson disease</span></div><div class="casAuthors">Gelb D J; Oliver E; Gilman S</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-9</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">The clinical diagnosis of Parkinson disease (PD) is based on the identification of some combination of the cardinal motor signs of bradykinesia, rigidity, tremor, and postural instability, but few attempts have been made to develop explicit diagnostic criteria.  We propose a clinical diagnostic classification based on a comprehensive review of the literature regarding the sensitivity and specificity of the characteristic clinical features of PD.  Three levels of diagnostic confidence are differentiated: Definite, Probable, and Possible.  The diagnoses of Possible and Probable PD are based on clinical criteria alone.  Neuropathologic confirmation is required for the diagnosis of Definite PD in patients with the clinical diagnosis of Possible or Probable PD.  Criteria for histopathologic confirmation of PD are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzH2Foe5frspNiNltV31zlfW6udTcc2eZ7SDgyEO7DJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7itVKgtg%253D%253D&md5=3ae738e5928989657f49afe4f4d9247c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchneur.56.1.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.56.1.33%26sid%3Dliteratum%253Aachs%26aulast%3DGelb%26aufirst%3DD.%2BJ.%26aulast%3DOliver%26aufirst%3DE.%26aulast%3DGilman%26aufirst%3DS.%26atitle%3DDiagnostic%2520criteria%2520for%2520Parkinson%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1999%26volume%3D56%26spage%3D33%26epage%3D39%26doi%3D10.1001%2Farchneur.56.1.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Schapira, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1001/jama.291.3.358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1001%2Fjama.291.3.358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=14734599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2004&pages=358-364&author=A.+H.+Schapiraauthor=C.+W.+Olanow&title=Neuroprotection+in+Parkinson+disease%3A+mysteries%2C+myths%2C+and+misconceptions&doi=10.1001%2Fjama.291.3.358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection in parkinson disease. Mysteries, myths, and misconceptions</span></div><div class="casAuthors">Schapira, Anthony H. V.; Olanow, C. Warren</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Parkinson disease is an age-related neurodegenerative disease that affects approx. 1 million persons in the United States.  Current therapies provide effective control of symptoms, particularly in the early stages of the disease, but most patients develop motor complications with long-term treatment, and features develop such as postural instability, falling, and dementia that are not adequately controlled with existing medications.  Accordingly, neuroprotective therapy that might slow, stop, or reverse disease progression is urgently needed.  While many agents appear to be promising based on lab. studies, selecting clin. end points for clin. trials that are not confounded by symptomatic effects of the study intervention has been difficult.  More recently, neuroimaging end points have been used as biomarkers of disease progression, but again there are concerns that they may be influenced by regulatory effects of the drugs used.  We review clin. trials aimed at detecting neuroprotection in Parkinson disease and address the controversies surrounding the interpretation of these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRE6EQZrbgtLVg90H21EOLACvtfcHk0lhmTmiO0U5Tyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlelsg%253D%253D&md5=125a2cc3dc326c5877b87cf1b3f3e11a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Fjama.291.3.358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.291.3.358%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DNeuroprotection%2520in%2520Parkinson%2520disease%253A%2520mysteries%252C%2520myths%252C%2520and%2520misconceptions%26jtitle%3DJAMA%26date%3D2004%26volume%3D291%26spage%3D358%26epage%3D364%26doi%3D10.1001%2Fjama.291.3.358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethi, K.</span><span> </span><span class="NLM_article-title">The scientific and clinical basis for the treatment of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">S1</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1212/WNL.0b013e3181a1d44c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1212%2FWNL.0b013e3181a1d44c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=S1-136&author=C.+W.+Olanowauthor=M.+B.+Sternauthor=K.+Sethi&title=The+scientific+and+clinical+basis+for+the+treatment+of+Parkinson+disease&doi=10.1212%2FWNL.0b013e3181a1d44c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1212%2FWNL.0b013e3181a1d44c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0b013e3181a1d44c%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DStern%26aufirst%3DM.%2BB.%26aulast%3DSethi%26aufirst%3DK.%26atitle%3DThe%2520scientific%2520and%2520clinical%2520basis%2520for%2520the%2520treatment%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2009%26volume%3D72%26spage%3DS1%26epage%3D136%26doi%3D10.1212%2FWNL.0b013e3181a1d44c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Siderowf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, M.</span><span> </span><span class="NLM_article-title">Update on Parkinson disease</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span><span class="refDoi"> DOI: 10.7326/0003-4819-138-8-200304150-00013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.7326%2F0003-4819-138-8-200304150-00013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12693888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A280%3ADC%252BD3s7ns1Sjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=651-658&author=A.+Siderowfauthor=M.+Stern&title=Update+on+Parkinson+disease&doi=10.7326%2F0003-4819-138-8-200304150-00013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Parkinson disease</span></div><div class="casAuthors">Siderowf Andrew; Stern Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">651-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This Update reviews developments in the pathophysiology and treatment of Parkinson disease during the past several years.  In the area of pathophysiology, studies have addressed the contribution of environmental factors such as caffeine and pesticides.  Large-scale epidemiologic studies have also expanded the role genetic factors are thought to play.  Detailed studies of kindreds with familial Parkinson disease due to alpha-synuclein and parkin have catalyzed basic science investigations into the pathologic mechanisms of the disease.  These studies have led to the development of a pathophysiologic model of Parkinson disease that emphasizes abnormal protein aggregation.  Studies of treatment have clarified the relative roles of l-dopa and dopamine agonists in early Parkinson disease and shown the potential for surgical interventions, particularly deep-brain stimulation, to relieve the symptoms of advanced, medically refractory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5PWe2QgPGybmQt-ICR3qNfW6udTcc2eaOz52GN8DDaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7ns1Sjsw%253D%253D&md5=808838626323e21298e94fff78d74621</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-138-8-200304150-00013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-138-8-200304150-00013%26sid%3Dliteratum%253Aachs%26aulast%3DSiderowf%26aufirst%3DA.%26aulast%3DStern%26aufirst%3DM.%26atitle%3DUpdate%2520on%2520Parkinson%2520disease%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2003%26volume%3D138%26spage%3D651%26epage%3D658%26doi%3D10.7326%2F0003-4819-138-8-200304150-00013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Molecular pathways of neurodegeneration in Parkinson’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span><span class="refDoi"> DOI: 10.1126/science.1087753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1126%2Fscience.1087753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=14593166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=819-822&author=T.+M.+Dawsonauthor=V.+L.+Dawson&title=Molecular+pathways+of+neurodegeneration+in+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.1087753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pathways of neurodegeneration in Parkinson's disease</span></div><div class="casAuthors">Dawson, Ted M.; Dawson, Valina L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">819-822</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a complex disorder with many different causes, yet they may intersect in common pathways, raising the possibility that neuroprotective agents may have broad applicability in the treatment of PD.  Current evidence suggests that mitochondrial complex I inhibition may be the central cause of sporadic PD and that derangements in complex I cause α-synuclein aggregation, which contributes to the demise of dopamine neurons.  Accumulation and aggregation of α-synuclein may further contribute to the death of dopamine neurons through impairments in protein handling and detoxification.  Dysfunction of parkin (a ubiquitin E3 ligase) and DJ-1 could contribute to these deficits.  Strategies aimed at restoring complex I activity, reducing oxidative stress and α-synuclein aggregation, and enhancing protein degrdn. may hold particular promise as powerful neuroprotective agents in the treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1L96tPhpE7Vg90H21EOLACvtfcHk0lhmTmiO0U5Tyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt7w%253D&md5=3a349d2af4f61c7e514289ed56bf5a29</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087753%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DMolecular%2520pathways%2520of%2520neurodegeneration%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D819%26epage%3D822%26doi%3D10.1126%2Fscience.1087753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Betarbet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Monte, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenamyre, J. T.</span><span> </span><span class="NLM_article-title">Mechanistic approaches to Parkinson’s disease pathogenesis</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">510</span><span class="refDoi"> DOI: 10.1111/j.1750-3639.2002.tb00468.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1111%2Fj.1750-3639.2002.tb00468.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12408237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1GnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=499-510&author=R.+Betarbetauthor=T.+B.+Shererauthor=D.+A.+Di+Monteauthor=J.+T.+Greenamyre&title=Mechanistic+approaches+to+Parkinson%E2%80%99s+disease+pathogenesis&doi=10.1111%2Fj.1750-3639.2002.tb00468.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic approaches to Parkinson's disease pathogenesis</span></div><div class="casAuthors">Betarbet, Ranjita; Sherer, Todd B.; Di Monte, Donato A.; Greenamyre, J. Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-510</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">International Society of Neuropathology</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a progressive neurol. disorder marked by nigrostriatal dopaminergic degeneration and development of cytoplasmic proteinaceous aggregates known as Lewy bodies.  Although the pathogenic mechanisms responsible for PD are not completely understood, many clues have come from biochem., epidemiol., and genetic studies.  Mutations in certain genes found in rare, familial cases of PD, such as α-synuclein and parkin, suggest a role for the ubiquitin-proteosome system and aberrant protein aggregation.  Biochem. analyses have implicated mitochondrial dysfunction in PD.  Epidemiol. and animal model studies point to a role for environmental toxins, some of which are mitochondrial inhibitors.  Mitochondrial dysfunction, resulting from either genetic defects, environmental exposures or an interaction between the two, may cause α-synuclein aggregation or neurodegeneration through oxidative stress or excitotoxicity.  A better understanding of the mechanisms underlying PD should reveal novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs93qK2ac7vrVg90H21EOLACvtfcHk0lhU4yMOr8frzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1GnsL8%253D&md5=6fcb6a524207c401f7e8cee65e8c4be6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.2002.tb00468.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.2002.tb00468.x%26sid%3Dliteratum%253Aachs%26aulast%3DBetarbet%26aufirst%3DR.%26aulast%3DSherer%26aufirst%3DT.%2BB.%26aulast%3DDi%2BMonte%26aufirst%3DD.%2BA.%26aulast%3DGreenamyre%26aufirst%3DJ.%2BT.%26atitle%3DMechanistic%2520approaches%2520to%2520Parkinson%25E2%2580%2599s%2520disease%2520pathogenesis%26jtitle%3DBrain%2520Pathol.%26date%3D2002%26volume%3D12%26spage%3D499%26epage%3D510%26doi%3D10.1111%2Fj.1750-3639.2002.tb00468.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dunnett, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span> </span><span class="NLM_article-title">Prospects for new restorative and neuroprotective treatments in Parkinson’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">A32</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1038/399a032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2F399a032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=A32-39&author=S.+B.+Dunnettauthor=A.+Bjorklund&title=Prospects+for+new+restorative+and+neuroprotective+treatments+in+Parkinson%E2%80%99s+disease&doi=10.1038%2F399a032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F399a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F399a032%26sid%3Dliteratum%253Aachs%26aulast%3DDunnett%26aufirst%3DS.%2BB.%26aulast%3DBjorklund%26aufirst%3DA.%26atitle%3DProspects%2520for%2520new%2520restorative%2520and%2520neuroprotective%2520treatments%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3DA32%26epage%3D39%26doi%3D10.1038%2F399a032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Oxidative stress in Parkinson’s disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S26</span><span class="NLM_x">–</span> <span class="NLM_lpage">S36</span><div class="note"><p class="first last">discussion S36–S38.</p></div><span class="refDoi"> DOI: 10.1002/ana.10483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fana.10483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12666096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFGitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=S26-S36&issue=Suppl+3&author=P.+Jenner&title=Oxidative+stress+in+Parkinson%E2%80%99s+disease&doi=10.1002%2Fana.10483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in Parkinson's disease</span></div><div class="casAuthors">Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S26-S38</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress contributes to the cascade leading to dopamine cell degeneration in Parkinson's disease (PD).  However, oxidative stress is intimately linked to other components of the degenerative process, such as mitochondrial dysfunction, excitotoxicity, nitric oxide toxicity and inflammation.  It is therefore difficult to det. whether oxidative stress leads to, or is a consequence of, these events.  Oxidative damage to lipids, proteins, and DNA occurs in PD, and toxic products of oxidative damage, such as 4-hydroxynonenal (HNE), can react with proteins to impair cell viability.  There is convincing evidence for the involvement of nitric oxide that reacts with superoxide to produce peroxynitrite and ultimately hydroxyl radical prodn.  Recently, altered ubiquitination and degrdn. of proteins have been implicated as key to dopaminergic cell death in PD.  Oxidative stress can impair these processes directly, and products of oxidative damage, such as HNE, can damage the 26S proteasome.  Furthermore, impairment of proteasomal function leads to free radical generation and oxidative stress.  Oxidative stress occurs in idiopathic PD and products of oxidative damage interfere with cellular function, but these form only part of a cascade, and it is not possible to sep. them from other events involved in dopaminergic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4d7dxHYxOD7Vg90H21EOLACvtfcHk0lhU4yMOr8frzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFGitLs%253D&md5=2167a3ecce5168aaacac1dab109700d7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fana.10483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10483%26sid%3Dliteratum%253Aachs%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DOxidative%2520stress%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2003%26volume%3D53%26issue%3DSuppl%25203%26spage%3DS26%26epage%3DS36%26doi%3D10.1002%2Fana.10483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span> </span><span class="NLM_article-title">Alpha-synuclein in Lewy bodies</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1038/42166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2F42166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=9278044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK2sXlslWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1997&pages=839-840&author=M.+G.+Spillantiniauthor=M.+L.+Schmidtauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=R.+Jakesauthor=M.+Goedert&title=Alpha-synuclein+in+Lewy+bodies&doi=10.1038%2F42166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">α-Synuclein in Lewy bodies</span></div><div class="casAuthors">Spillantini, Maria Grazia; Schmidt, Marie Luise; Lee, Virginia M.-Y.; Trojanowski, John Q.; Jakes, Ross; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">6645</span>),
    <span class="NLM_cas:pages">839-840</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The authors report strong staining of Lewy bodies in brain in idiopathic Parkinson's disease and dementia with Lewy bodies with antibodies for α-synuclein.  They conclude that Parkinson's disease and dementia with Lewy bodies may both be α-synuclein diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHyD4IKMqEIrVg90H21EOLACvtfcHk0lhU4yMOr8frzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlslWru7o%253D&md5=ef5d22aaeb6f08828ea33c50e3f7c06d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F42166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F42166%26sid%3Dliteratum%253Aachs%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DSchmidt%26aufirst%3DM.%2BL.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DJakes%26aufirst%3DR.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DAlpha-synuclein%2520in%2520Lewy%2520bodies%26jtitle%3DNature%26date%3D1997%26volume%3D388%26spage%3D839%26epage%3D840%26doi%3D10.1038%2F42166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatton, W. G.</span><span> </span><span class="NLM_article-title">Etiology and pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1146/annurev.neuro.22.1.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1146%2Fannurev.neuro.22.1.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10202534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFemsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=123-144&author=C.+W.+Olanowauthor=W.+G.+Tatton&title=Etiology+and+pathogenesis+of+Parkinson%E2%80%99s+disease&doi=10.1146%2Fannurev.neuro.22.1.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Etiology and pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Olanow, C. W.; Tatton, W. G.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123-144</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with ∼128 refs.  Parkinson's disease (PD) is an age-related neurodegenerative disorder that affects approx. 1 million persons in the United States.  It is characterized by resting tremor, rigidity, bradykinesia or slowness, gait disturbance, and postural instability.  Pathol. features include degeneration of dopaminergic neurons in the substantia nigra pars compacta coupled with intracytoplasmic inclusions known as Lewy bodies.  Neurodegeneration and Lewy bodies can also be found in the locus ceruleus, nucleus basalis, hypothalamus, cerebral cortex, cranial nerve motor nuclei, and central and peripheral components of the autonomic nervous system.  Current treatment consists of a dopamine replacement strategy using primarily the dopamine precursor levodopa.  While levodopa provides benefit to virtually all PD patients, after 5-10 yr of treatment the majority of patients develop adverse events in the form of dyskinesia (involuntary movements) and fluctuations in motor response.  Further, disease progression is assocd. with the development of dementia, autonomic dysfunction, and postural instability, which do not respond to levodopa therapy.  Accordingly, research efforts have been directed toward understanding the etiol. and pathogenesis of PD in the hope of developing a more effective therapy that will slow or halt the natural progression of PD.  This paper reviews recent advances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0mGaU2adIWrVg90H21EOLACvtfcHk0lj-MfIBgTW7Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFemsro%253D&md5=d7823b2fd85fa15ac1d6c7fae5d95174</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.22.1.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.22.1.123%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DTatton%26aufirst%3DW.%2BG.%26atitle%3DEtiology%2520and%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1999%26volume%3D22%26spage%3D123%26epage%3D144%26doi%3D10.1146%2Fannurev.neuro.22.1.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">El-Agnaf, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paleologou, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlossmacher, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span><span class="refDoi"> DOI: 10.1096/fj.03-1449com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1096%2Ffj.03-1449com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=16507759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Wlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=419-425&author=O.+M.+El-Agnafauthor=S.+A.+Salemauthor=K.+E.+Paleologouauthor=M.+D.+Curranauthor=M.+J.+Gibsonauthor=J.+A.+Courtauthor=M.+G.+Schlossmacherauthor=D.+Allsop&title=Detection+of+oligomeric+forms+of+alpha-synuclein+protein+in+human+plasma+as+a+potential+biomarker+for+Parkinson%E2%80%99s+disease&doi=10.1096%2Ffj.03-1449com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease</span></div><div class="casAuthors">El-Agnaf, Omar M. A.; Salem, Sultan A.; Paleologou, Katerina E.; Curran, Martin D.; Gibson, Mark J.; Court, Jennifer A.; Schlossmacher, Michael G.; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">419-425</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">To date there is no accepted clin. diagnostic test for Parkinson's disease (PD) based on biochem. anal. of blood or cerebrospinal fluid (CSF).  α-Synuclein (α-syn) protein has been linked to the pathogenesis of PD with the discovery of mutations in the gene encoding α-syn in familial cases with early-onset PD.  Lewy bodies and Lewy neurites, which constitute the main pathol. features in the brains of patients with sporadic PD and dementia with Lewy bodies, are formed by the conversion of sol. monomers of α-syn into insol. aggregates.  We recently reported the presence of α-syn in normal human blood plasma and in postmortem CSF.  Here, we investigated whether α-syn can be used as a biomarker for PD.  We have developed a novel ELISA method that detects only oligomeric "sol. aggregates" of α-syn.  Using this ELISA, we report the presence of significantly elevated (P = 0.002) levels of oligomeric forms of α-syn in plasma samples obtained from 34 PD patients compared with 27 controls; 52% (95% confidence intervals 0.353-0.687) of the PD patients displayed signals >0.5 OD with our ELISA assay in comparison to only 14.8% (95% confidence intervals 0.014-0.281) for the control cases.  An anal. of the test's diagnostic value revealed a specificity of 0.852 (95% confidence intervals 0.662-0.958), sensitivity of 0.529 (95% confidence intervals 0.351-0.702) and a pos. predictive value of 0.818 (95% confidence intervals 0.597-0.948).  These observations offer new opportunities for developing diagnostic tests for PD and related diseases and for testing therapeutic agents aimed at preventing or reversing the aggregation of α-syn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXsnpiLKP-o7Vg90H21EOLACvtfcHk0lj-MfIBgTW7Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Wlu70%253D&md5=2cefa3cc56ae339db9e9c79f68d24790</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1096%2Ffj.03-1449com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.03-1449com%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Agnaf%26aufirst%3DO.%2BM.%26aulast%3DSalem%26aufirst%3DS.%2BA.%26aulast%3DPaleologou%26aufirst%3DK.%2BE.%26aulast%3DCurran%26aufirst%3DM.%2BD.%26aulast%3DGibson%26aufirst%3DM.%2BJ.%26aulast%3DCourt%26aufirst%3DJ.%2BA.%26aulast%3DSchlossmacher%26aufirst%3DM.%2BG.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DDetection%2520of%2520oligomeric%2520forms%2520of%2520alpha-synuclein%2520protein%2520in%2520human%2520plasma%2520as%2520a%2520potential%2520biomarker%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D419%26epage%3D425%26doi%3D10.1096%2Ffj.03-1449com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lashuel, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petre, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr.</span><span> </span><span class="NLM_article-title">Neurodegenerative disease: amyloid pores from pathogenic mutations</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">418</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="refDoi"> DOI: 10.1038/418291a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2F418291a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12124613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlGmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2002&pages=291&author=H.+A.+Lashuelauthor=D.+Hartleyauthor=B.+M.+Petreauthor=T.+Walzauthor=P.+T.+Lansbury&title=Neurodegenerative+disease%3A+amyloid+pores+from+pathogenic+mutations&doi=10.1038%2F418291a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative disease: Amyloid pores from pathogenic mutations</span></div><div class="casAuthors">Lashuel, Hilal A.; Hartley, Dean; Petre, Benjamin M.; Walz, Thomas; Lansbury, Peter T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">418</span>
        (<span class="NLM_cas:issue">6895</span>),
    <span class="NLM_cas:pages">291</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The structural properties of protofibril formation of A30P and A53T (α-synuclein mutants assocd. with Parkinson's disease) and AβARG (Aβ mutant assocd. with Alzheimer's disease) were examd. for shared structural features that might be related to their toxicity.  Heterogeneous populations of A30P, A53T, and AβARG protofibrils were fractionated by gel-filtration chromatog.  The fraction with the smallest A30P and A53T protofibrils contained β-sheet-rich oligomers comprising 20-25 α-synuclein mols. (relative mol. mass 320-380K; 22-26 monomers).  Anal. of this fraction by electron microscopy revealed annular species (diam. 8-12 nm; inner diam. 2.0-2.5 nm) and coiled species.  Protofibrillar AβARG contained many annular species of similar appearance (7-10 nm; inner diam. 1.5-2.0 nm) and relative mol. mass (150-250K; 40-60 AβARG mols.).  The small annular Aβ and α-synuclein protofibrils resemble the cytolytic β-barrel pore-forming toxins from bacteria such as Clostridium perfringens.  It is concluded that amyloid pores might be wholly or partly responsible for the cyto-toxicity assocd. with the formation of amyloid fibrils in Alzheimer's and Parkinson's diseases and in other age-assocd. degenerative amyloid diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWn7JG2DV4TLVg90H21EOLACvtfcHk0lj-MfIBgTW7Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlGmsrc%253D&md5=d1a4a8e8dbba4b993a9f6814d58b0b03</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F418291a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F418291a%26sid%3Dliteratum%253Aachs%26aulast%3DLashuel%26aufirst%3DH.%2BA.%26aulast%3DHartley%26aufirst%3DD.%26aulast%3DPetre%26aufirst%3DB.%2BM.%26aulast%3DWalz%26aufirst%3DT.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DNeurodegenerative%2520disease%253A%2520amyloid%2520pores%2520from%2520pathogenic%2520mutations%26jtitle%3DNature%26date%3D2002%26volume%3D418%26spage%3D291%26doi%3D10.1038%2F418291a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hashimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundsmo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span> </span><span class="NLM_article-title">Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span><span class="refDoi"> DOI: 10.1097/00001756-199903170-00011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1097%2F00001756-199903170-00011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=717-721&author=M.+Hashimotoauthor=L.+J.+Hsuauthor=Y.+Xiaauthor=A.+Takedaauthor=A.+Siskauthor=M.+Sundsmoauthor=E.+Masliah&title=Oxidative+stress+induces+amyloid-like+aggregate+formation+of+NACP%2Falpha-synuclein+in+vitro&doi=10.1097%2F00001756-199903170-00011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1097%2F00001756-199903170-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199903170-00011%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DHsu%26aufirst%3DL.%2BJ.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DSisk%26aufirst%3DA.%26aulast%3DSundsmo%26aufirst%3DM.%26aulast%3DMasliah%26aufirst%3DE.%26atitle%3DOxidative%2520stress%2520induces%2520amyloid-like%2520aggregate%2520formation%2520of%2520NACP%252Falpha-synuclein%2520in%2520vitro%26jtitle%3DNeuroReport%26date%3D1999%26volume%3D10%26spage%3D717%26epage%3D721%26doi%3D10.1097%2F00001756-199903170-00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. H.</span><span> </span><span class="NLM_article-title">Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span><span class="refDoi"> DOI: 10.1016/S0891-5849(02)00741-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0891-5849%2802%2900741-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=11958955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1ylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=544-550&author=K.+S.+Kimauthor=S.+Y.+Choiauthor=H.+Y.+Kwonauthor=M.+H.+Wonauthor=T.+C.+Kangauthor=J.+H.+Kang&title=Aggregation+of+alpha-synuclein+induced+by+the+Cu%2CZn-superoxide+dismutase+and+hydrogen+peroxide+system&doi=10.1016%2FS0891-5849%2802%2900741-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aggregation of α-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system</span></div><div class="casAuthors">Kim, Kyung Sik; Choi, Soo Young; Kwon, Hyeok Yil; Won, Moo Ho; Kang, Tae-Cheon; Kang, Jung Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">544-550</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Alpha-synuclein is a major component of the abnormal protein aggregation in Lewy bodies of Parkinson's disease (PD) and senile plaques of Alzheimer's disease (AD).  Previous studies have shown that the aggregation of α-synuclein was induced by copper (II) and H2O2 system.  Since copper ions could be released from oxidatively damaged Cu,Zn-superoxide dismutase (SOD), we investigated the role of Cu,Zn-SOD in the aggregation of α-synuclein.  When α-synuclein was incubated with both Cu,Zn-SOD and H2O2, α-synuclein was induced to be aggregated.  This process was inhibited by radical scavengers and spin trapping agents such as 5,5'-dimethyl 1-pyrolline N-oxide and tert-butyl-α-phenylnitrone.  Copper chelators, diethyldithiocarbamate and penicillamine, also inhibited the Cu,Zn-SOD/H2O2 system-induced α-synuclein aggregation.  These results suggest that the aggregation of α-synuclein is mediated by the Cu,Zn-SOD/H2O2 system via the generation of hydroxyl radical by the free radical-generating function of the enzyme.  The Cu,Zn-SOD/H2O2-induced α-synuclein aggregates displayed strong thioflavin-S reactivity, reminiscent of amyloid.  These results suggest that the Cu,Zn-SOD/H2O2 system might be related to abnormal aggregation of α-synuclein, which may be involved in the pathogenesis of PD and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxKJgB_klOjLVg90H21EOLACvtfcHk0lhlvYwvQ4QZyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1ylsL4%253D&md5=fd124a9634f5f65f73b5853de4d10a74</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2900741-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252900741-4%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DChoi%26aufirst%3DS.%2BY.%26aulast%3DKwon%26aufirst%3DH.%2BY.%26aulast%3DWon%26aufirst%3DM.%2BH.%26aulast%3DKang%26aufirst%3DT.%2BC.%26aulast%3DKang%26aufirst%3DJ.%2BH.%26atitle%3DAggregation%2520of%2520alpha-synuclein%2520induced%2520by%2520the%2520Cu%252CZn-superoxide%2520dismutase%2520and%2520hydrogen%2520peroxide%2520system%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2002%26volume%3D32%26spage%3D544%26epage%3D550%26doi%3D10.1016%2FS0891-5849%2802%2900741-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.+M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lhlvYwvQ4QZyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gonnet, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benner, S. A.</span><span> </span><span class="NLM_article-title">Exhaustive matching of the entire protein sequence database</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">–</span> <span class="NLM_lpage">1445</span><span class="refDoi"> DOI: 10.1126/science.1604319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1126%2Fscience.1604319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1604319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK38Xks12hs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=1443-1445&author=G.+H.+Gonnetauthor=M.+A.+Cohenauthor=S.+A.+Benner&title=Exhaustive+matching+of+the+entire+protein+sequence+database&doi=10.1126%2Fscience.1604319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Exhaustive matching of the entire protein sequence database</span></div><div class="casAuthors">Gonnet, Gaston H.; Cohen, Mark A.; Benner, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5062</span>),
    <span class="NLM_cas:pages">1443-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The entire protein sequence database has been exhaustively matched.  Definitive mutation matrixes and models for scoring gaps were obtained for the matching and used to organize the sequence database as sets of evolutionarily connected components.  The methods developed are general and can be used to manage sequence data generated by major genome sequencing projects.  The alignments made possible by the exhaustive matching are the starting point for successful de novo prediction of the folded structures of proteins, for reconstructing sequences of ancient proteins and metabs. in ancient organisms, and for obtaining new perspectives in structural biochem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ATl5B5Q6mLVg90H21EOLACvtfcHk0lhlvYwvQ4QZyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xks12hs7k%253D&md5=89f2045a3221f889fe7aea659eb26956</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.1604319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1604319%26sid%3Dliteratum%253Aachs%26aulast%3DGonnet%26aufirst%3DG.%2BH.%26aulast%3DCohen%26aufirst%3DM.%2BA.%26aulast%3DBenner%26aufirst%3DS.%2BA.%26atitle%3DExhaustive%2520matching%2520of%2520the%2520entire%2520protein%2520sequence%2520database%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D1443%26epage%3D1445%26doi%3D10.1126%2Fscience.1604319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Ligand discovery from a dopamine D3 receptor homology model and crystal structure</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1038/nchembio.662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2Fnchembio.662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=21926995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFylsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=769-778&author=J.+Carlssonauthor=R.+G.+Colemanauthor=V.+Setolaauthor=J.+J.+Irwinauthor=H.+Fanauthor=A.+Schlessingerauthor=A.+Saliauthor=B.+L.+Rothauthor=B.+K.+Shoichet&title=Ligand+discovery+from+a+dopamine+D3+receptor+homology+model+and+crystal+structure&doi=10.1038%2Fnchembio.662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand discovery from a dopamine D3 receptor homology model and crystal structure</span></div><div class="casAuthors">Carlsson, Jens; Coleman, Ryan G.; Setola, Vincent; Irwin, John J.; Fan, Hao; Schlessinger, Avner; Sali, Andrej; Roth, Bryan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">769-778</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are intensely studied as drug targets and for their role in signaling.  With the detn. of the first crystal structures, interest in structure-based ligand discovery increased.  Unfortunately, for most GPCRs no exptl. structures are available.  The detn. of the D3 receptor structure and the challenge to the community to predict it enabled a fully prospective comparison of ligand discovery from a modeled structure vs. that of the subsequently released crystal structure.  Over 3.3 million mols. were docked against a homol. model, and 26 of the highest ranking were tested for binding.  Six had affinities ranging from 0.2 to 3.1 μM.  Subsequently, the crystal structure was released and the docking screen repeated.  Of the 25 compds. selected, five had affinities ranging from 0.3 to 3.0 μM.  One of the new ligands from the homol. model screen was optimized for affinity to 81 nM.  The feasibility of docking screens against modeled GPCRs more generally is considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz6gBx3Olbn7Vg90H21EOLACvtfcHk0ljL7SMgvUueag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFylsLvP&md5=7242aa512079a348678b309d352ecdb9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.662%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DR.%2BG.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DSchlessinger%26aufirst%3DA.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DLigand%2520discovery%2520from%2520a%2520dopamine%2520D3%2520receptor%2520homology%2520model%2520and%2520crystal%2520structure%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D769%26epage%3D778%26doi%3D10.1038%2Fnchembio.662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0ljL7SMgvUueag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Meissner, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frasier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rascol, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tison, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span> </span><span class="NLM_article-title">Priorities in Parkinson’s disease research</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1038/nrd3430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2Fnrd3430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=21532567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVGltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=377-393&author=W.+G.+Meissnerauthor=M.+Frasierauthor=T.+Gasserauthor=C.+G.+Goetzauthor=A.+Lozanoauthor=P.+Picciniauthor=J.+A.+Obesoauthor=O.+Rascolauthor=A.+Schapiraauthor=V.+Voonauthor=D.+M.+Weinerauthor=F.+Tisonauthor=E.+Bezard&title=Priorities+in+Parkinson%E2%80%99s+disease+research&doi=10.1038%2Fnrd3430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Priorities in Parkinson's disease research</span></div><div class="casAuthors">Meissner, Wassilios G.; Frasier, Mark; Gasser, Thomas; Goetz, Christopher G.; Lozano, Andres; Piccini, Paola; Obeso, Jose A.; Rascol, Olivier; Schapira, Anthony; Voon, Valerie; Weiner, David M.; Tison, Francois; Bezard, Erwan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">377-393</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The loss of dopaminergic neurons in the substantia nigra pars compacta leads to the characteristic motor symptoms of Parkinson's disease: bradykinesia, rigidity and resting tremors.  Although these symptoms can be improved using currently available dopamine replacement strategies, there is still a need to improve current strategies of treating these symptoms, together with a need to alleviate non-motor symptoms of the disease.  Moreover, treatments that provide neuroprotection and/or disease-modifying effects remain an urgent unmet clin. need.  This Review describes the most promising biol. targets and therapeutic agents that are currently being assessed to address these treatment goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFgF5KqF7ZzrVg90H21EOLACvtfcHk0ljL7SMgvUueag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVGltr4%253D&md5=d792624cf69d3a56537eb8aa00c5b963</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd3430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3430%26sid%3Dliteratum%253Aachs%26aulast%3DMeissner%26aufirst%3DW.%2BG.%26aulast%3DFrasier%26aufirst%3DM.%26aulast%3DGasser%26aufirst%3DT.%26aulast%3DGoetz%26aufirst%3DC.%2BG.%26aulast%3DLozano%26aufirst%3DA.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DObeso%26aufirst%3DJ.%2BA.%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DSchapira%26aufirst%3DA.%26aulast%3DVoon%26aufirst%3DV.%26aulast%3DWeiner%26aufirst%3DD.%2BM.%26aulast%3DTison%26aufirst%3DF.%26aulast%3DBezard%26aufirst%3DE.%26atitle%3DPriorities%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520research%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D377%26epage%3D393%26doi%3D10.1038%2Fnrd3430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Marsden, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, J. D.</span><span> </span><span class="NLM_article-title">″On-off″ effects in patients with Parkinson’s disease on chronic levodopa therapy</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1016/S0140-6736(76)91416-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0140-6736%2876%2991416-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=1976&pages=292-296&author=C.+D.+Marsdenauthor=J.+D.+Parkes&title=%E2%80%B3On-off%E2%80%B3+effects+in+patients+with+Parkinson%E2%80%99s+disease+on+chronic+levodopa+therapy&doi=10.1016%2FS0140-6736%2876%2991416-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2876%2991416-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252876%252991416-1%26sid%3Dliteratum%253Aachs%26aulast%3DMarsden%26aufirst%3DC.%2BD.%26aulast%3DParkes%26aufirst%3DJ.%2BD.%26atitle%3D%25E2%2580%25B3On-off%25E2%2580%25B3%2520effects%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%2520on%2520chronic%2520levodopa%2520therapy%26jtitle%3DLancet%26date%3D1976%26volume%3D307%26spage%3D292%26epage%3D296%26doi%3D10.1016%2FS0140-6736%2876%2991416-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Basma, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicklas, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geller, H. M.</span><span> </span><span class="NLM_article-title">L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1995.64020825.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1046%2Fj.1471-4159.1995.64020825.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=7830076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK2MXjtFymt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1995&pages=825-832&author=A.+N.+Basmaauthor=E.+J.+Morrisauthor=W.+J.+Nicklasauthor=H.+M.+Geller&title=L-dopa+cytotoxicity+to+PC12+cells+in+culture+is+via+its+autoxidation&doi=10.1046%2Fj.1471-4159.1995.64020825.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation</span></div><div class="casAuthors">Basma, Alie N.; Morris, Erick J.; Nicklas, William J.; Geller, Herbert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">825-32</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">The mechanism of cytotoxicity of L-DOPA was studied in the rat pheochromocytoma PC12 cell line.  The cytotoxicity of L-DOPA to PC12 cells was time and concn. dependent.  Carbidopa, which inhibited the conversion of L-DOPA to dopamine, did not protect against L-DOPA cytotoxicity in PC12 cells.  Furthermore, clorgyline, a selective inhibitor of monoamine oxidase type A, and pargyline, an inhibitor of both monoamine oxidase types A and B, both did not have an effect on L-DOPA toxicity.  These findings suggest that cytotoxicity was not due to dopamine formed from L-DOPA.  Catalase or superoxide dismutase each partially protected against L-DOPA toxicity in PC12 cells.  In combination, the effects were synergistic and provided almost total protection against cytotoxicity.  6-Cyano-7-nitroquinoxaline-2,3-dione, an antagonist of non-NMDA receptors, did not protect against L-DOPA toxicity.  These data suggest that toxicity of L-DOPA is most likely due to the action of free radicals formed as a result of its autoxidn.  Furthermore, these findings suggest that patients on long-term L-DOPA therapy are potentially at risk from the toxic intermediates formed as a result of its autoxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWQJx-LrRiN7Vg90H21EOLACvtfcHk0lgbYGVOmV5TrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtFymt78%253D&md5=7fb5617cc18563f3298d911c50b78f60</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1995.64020825.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1995.64020825.x%26sid%3Dliteratum%253Aachs%26aulast%3DBasma%26aufirst%3DA.%2BN.%26aulast%3DMorris%26aufirst%3DE.%2BJ.%26aulast%3DNicklas%26aufirst%3DW.%2BJ.%26aulast%3DGeller%26aufirst%3DH.%2BM.%26atitle%3DL-dopa%2520cytotoxicity%2520to%2520PC12%2520cells%2520in%2520culture%2520is%2520via%2520its%2520autoxidation%26jtitle%3DJ.%2520Neurochem.%26date%3D1995%26volume%3D64%26spage%3D825%26epage%3D832%26doi%3D10.1046%2Fj.1471-4159.1995.64020825.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fahn, S.</span><span> </span><span class="NLM_article-title">Is levodopa toxic?</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">184S</span><span class="NLM_x">–</span> <span class="NLM_lpage">195S</span><span class="refDoi"> DOI: 10.1212/WNL.47.6_Suppl_3.184S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1212%2FWNL.47.6_Suppl_3.184S" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1996&pages=184S-195S&author=S.+Fahn&title=Is+levodopa+toxic%3F&doi=10.1212%2FWNL.47.6_Suppl_3.184S"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1212%2FWNL.47.6_Suppl_3.184S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.47.6_Suppl_3.184S%26sid%3Dliteratum%253Aachs%26aulast%3DFahn%26aufirst%3DS.%26atitle%3DIs%2520levodopa%2520toxic%253F%26jtitle%3DNeurology%26date%3D1996%26volume%3D47%26spage%3D184S%26epage%3D195S%26doi%3D10.1212%2FWNL.47.6_Suppl_3.184S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Stocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">Neuroprotection in Parkinson’s disease: clinical trials</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S87</span><span class="NLM_x">–</span> <span class="NLM_lpage">S97</span><div class="note"><p class="first last">discussion S97–S99.</p></div><span class="refDoi"> DOI: 10.1002/ana.10488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fana.10488" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=S87-S97&issue=Suppl+3&author=F.+Stocchiauthor=C.+W.+Olanow&title=Neuroprotection+in+Parkinson%E2%80%99s+disease%3A+clinical+trials&doi=10.1002%2Fana.10488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fana.10488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10488%26sid%3Dliteratum%253Aachs%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DNeuroprotection%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520clinical%2520trials%26jtitle%3DAnn.%2520Neurol.%26date%3D2003%26volume%3D53%26issue%3DSuppl%25203%26spage%3DS87%26epage%3DS97%26doi%3D10.1002%2Fana.10488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mandel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunblatt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levites, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Neuroprotective strategies in Parkinson’s disease: an update on progress</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span><span class="refDoi"> DOI: 10.2165/00023210-200317100-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.2165%2F00023210-200317100-00004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=729-762&author=S.+Mandelauthor=E.+Grunblattauthor=P.+Riedererauthor=M.+Gerlachauthor=Y.+Levitesauthor=M.+B.+Youdim&title=Neuroprotective+strategies+in+Parkinson%E2%80%99s+disease%3A+an+update+on+progress&doi=10.2165%2F00023210-200317100-00004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2165%2F00023210-200317100-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200317100-00004%26sid%3Dliteratum%253Aachs%26aulast%3DMandel%26aufirst%3DS.%26aulast%3DGrunblatt%26aufirst%3DE.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DLevites%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DNeuroprotective%2520strategies%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520an%2520update%2520on%2520progress%26jtitle%3DCNS%2520Drugs%26date%3D2003%26volume%3D17%26spage%3D729%26epage%3D762%26doi%3D10.2165%2F00023210-200317100-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span><span class="refDoi"> DOI: 10.1038/nrd1346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2Fnrd1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=15060530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353-359&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia&doi=10.1038%2Fnrd1346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span></div><div class="casAuthors">Roth, Bryan L.; Sheffler, Douglas J.; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-359</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most common central nervous system disorders - such as depression, bipolar disorder, and schizophrenia - seem to be polygenic in origin, and the most effective medications have exceedingly complex pharmacologies.  Attempts to develop more effective treatments for diseases such as schizophrenia and depression by discovering drugs selective for single mol. targets (i.e., 'magic bullets') have, not surprisingly, been largely unsuccessful.  Here the authors propose that designing selectively non-selective drugs (i.e., 'magic shotguns') that interact with several mol. targets will lead to new and more effective medications for a variety of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSsuUXzmbirVg90H21EOLACvtfcHk0lguT9tj0jRopg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D&md5=77196583acccca65457fec7a67218463</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1346%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353%26epage%3D359%26doi%3D10.1038%2Fnrd1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzhikandathil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-o l analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1021/jm070860r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070860r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=101-117&author=S.+Biswasauthor=S.+Zhangauthor=F.+Fernandezauthor=B.+Ghoshauthor=J.+Zhenauthor=E.+Kuzhikandathilauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Further+structure-activity+relationships+study+of+hybrid+7-%7B%5B2-%284-phenylpiperazin-1-yl%29ethyl%5Dpropylamino%7D-5%2C6%2C7%2C8-tetrahydronaphthalen-2-o+l+analogues%3A+identification+of+a+high-affinity+D3-preferring+agonist+with+potent+in+vivo+activity+with+long+duration+of+action&doi=10.1021%2Fjm070860r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm070860r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070860r%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DF.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DKuzhikandathil%26aufirst%3DE.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DFurther%2520structure-activity%2520relationships%2520study%2520of%2520hybrid%25207-%257B%255B2-%25284-phenylpiperazin-1-yl%2529ethyl%255Dpropylamino%257D-5%252C6%252C7%252C8-tetrahydronaphthalen-2-o%2520l%2520analogues%253A%2520identification%2520of%2520a%2520high-affinity%2520D3-preferring%2520agonist%2520with%2520potent%2520in%2520vivo%2520activity%2520with%2520long%2520duration%2520of%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D101%26epage%3D117%26doi%3D10.1021%2Fjm070860r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeldine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrington, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzhikandathil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2- ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3005</span><span class="NLM_x">–</span> <span class="NLM_lpage">3019</span><span class="refDoi"> DOI: 10.1021/jm701524h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701524h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFyksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3005-3019&author=S.+Biswasauthor=S.+Hazeldineauthor=B.+Ghoshauthor=I.+Parringtonauthor=E.+Kuzhikandathilauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Bioisosteric+heterocyclic+versions+of+7-%7B%5B2-%284-phenyl-piperazin-1-yl%29ethyl%5Dpropylamino%7D-5%2C6%2C7%2C8-tetrahydronaphthalen-2-+ol%3A+identification+of+highly+potent+and+selective+agonists+for+dopamine+D3+receptor+with+potent+in+vivo+activity&doi=10.1021%2Fjm701524h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosteric Heterocyclic Versions of 7-{[2-(4-Phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: Identification of Highly Potent and Selective Agonists for Dopamine D3 Receptor with Potent in Vivo Activity</span></div><div class="casAuthors">Biswas, Swati; Hazeldine, Stuart; Ghosh, Balaram; Parrington, Ingrid; Kuzhikandathil, Eldo; Reith, Maarten E. A.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3005-3019</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the current report, the authors extend the SAR study on the hybrid structure 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol further to include heterocyclic bioisosteric analogs.  Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors with tritiated spiperone to evaluate inhibition consts. (Ki).  Functional activity of selected compds. in stimulating GTPγS binding was assessed with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors.  The highest binding affinity and selectivity for D3 receptors were exhibited by compd. (I) (Ki = 0.92 nM and D2/D3=253).  In the functional GTPγS binding assay, I exhibited full agonist activity with picomolar affinity for D3 receptor with high selectivity (EC50 = 0.08 nM and D2/D3=248).  In the in vivo rotational study, I exhibited potent rotational activity in 6-OH-DA unilaterally lesioned rats with long duration of action, which indicates its potential application in neuroprotective treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6yNJ94snDg7Vg90H21EOLACvtfcHk0lguT9tj0jRopg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFyksbk%253D&md5=6c649b6077843039c49dab02128df139</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm701524h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701524h%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DHazeldine%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DParrington%26aufirst%3DI.%26aulast%3DKuzhikandathil%26aufirst%3DE.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DBioisosteric%2520heterocyclic%2520versions%2520of%25207-%257B%255B2-%25284-phenyl-piperazin-1-yl%2529ethyl%255Dpropylamino%257D-5%252C6%252C7%252C8-tetrahydronaphthalen-2-%2520ol%253A%2520identification%2520of%2520highly%2520potent%2520and%2520selective%2520agonists%2520for%2520dopamine%2520D3%2520receptor%2520with%2520potent%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3005%26epage%3D3019%26doi%3D10.1021%2Fjm701524h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydro benzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson’s disease animal models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.1021/jm901184n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901184n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WjsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1023-1037&author=B.+Ghoshauthor=T.+Antonioauthor=J.+Zhenauthor=P.+Kharkarauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Development+of+%28S%29-N6-%282-%284-%28isoquinolin-1-yl%29piperazin-1-yl%29ethyl%29-N6-propyl-4%2C5%2C6%2C7-tetrahydro+benzo%5Bd%5D-thiazole-2%2C6-diamine+and+its+analogue+as+a+D3+receptor+preferring+agonist%3A+potent+in+vivo+activity+in+Parkinson%E2%80%99s+disease+animal+models&doi=10.1021%2Fjm901184n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development of (S)-N6-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: Potent in vivo activity in Parkinson's disease animal models</span></div><div class="casAuthors">Ghosh, Balaram; Antonio, Tamara; Zhen, Juan; Kharkar, Prashant; Reith, Maarten E. A.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1023-1037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here we report structure-activity relationship study of a novel hybrid series of compds. where structural alteration of arom. hydrophobic moieties connected to the piperazine ring and bioisosteric replacement of the arom. tetralin moieties were carried out.  Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors with tritiated spiperone to evaluate inhibition consts. (Ki).  Functional activity of selected compds. in stimulating GTPγS binding was assessed with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors.  SAR results identified compd. (-)-24c (D-301, I) as one of the lead mols. with preferential agonist activity for D3 receptor (EC50 (GTPγS); D3 = 0.52 nM; D2/D3 (EC50): 223).  Compds. (-)-24b and (-)-24c exhibited potent radical scavenging activity.  The two lead compds., (-)-24b and (-)-24c, exhibited high in vivo activity in two Parkinson's disease (PD) animal models, reserpinized rat model and 6-OHDA induced unilaterally lesioned rat model.  Future studies will explore potential use of these compds. in the neuroprotective therapy for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9rYWZ-mha0rVg90H21EOLACvtfcHk0lgA4obifDfWAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WjsLnO&md5=ae4d8fb18fd9607e1508ee936f88b7bd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm901184n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901184n%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DKharkar%26aufirst%3DP.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDevelopment%2520of%2520%2528S%2529-N6-%25282-%25284-%2528isoquinolin-1-yl%2529piperazin-1-yl%2529ethyl%2529-N6-propyl-4%252C5%252C6%252C7-tetrahydro%2520benzo%255Bd%255D-thiazole-2%252C6-diamine%2520and%2520its%2520analogue%2520as%2520a%2520D3%2520receptor%2520preferring%2520agonist%253A%2520potent%2520in%2520vivo%2520activity%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520animal%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1023%26epage%3D1037%26doi%3D10.1021%2Fjm901184n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl) (propyl)amino)ethyl)piperaz in-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2114</span><span class="NLM_x">–</span> <span class="NLM_lpage">2125</span><span class="refDoi"> DOI: 10.1021/jm901618d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901618d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2114-2125&author=B.+Ghoshauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Discovery+of+4-%284-%282-%28%285-Hydroxy-1%2C2%2C3%2C4-tetrahydronaphthalen-2-yl%29+%28propyl%29amino%29ethyl%29piperaz+in-1-yl%29quinolin-8-ol+and+its+analogues+as+highly+potent+dopamine+D2%2FD3+agonists+and+as+iron+chelator%3A+in+vivo+activity+indicates+potential+application+in+symptomatic+and+neuroprotective+therapy+for+Parkinson%E2%80%99s+disease&doi=10.1021%2Fjm901618d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901618d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901618d%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDiscovery%2520of%25204-%25284-%25282-%2528%25285-Hydroxy-1%252C2%252C3%252C4-tetrahydronaphthalen-2-yl%2529%2520%2528propyl%2529amino%2529ethyl%2529piperaz%2520in-1-yl%2529quinolin-8-ol%2520and%2520its%2520analogues%2520as%2520highly%2520potent%2520dopamine%2520D2%252FD3%2520agonists%2520and%2520as%2520iron%2520chelator%253A%2520in%2520vivo%2520activity%2520indicates%2520potential%2520application%2520in%2520symptomatic%2520and%2520neuroprotective%2520therapy%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2114%26epage%3D2125%26doi%3D10.1021%2Fjm901618d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, W.</span><span> </span><span class="NLM_article-title">Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson’s disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">2513</span><span class="NLM_x">–</span> <span class="NLM_lpage">2523</span><span class="refDoi"> DOI: 10.1002/jnr.22405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fjnr.22405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=20623619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1GmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=2513-2523&author=C.+Liauthor=S.+Biswasauthor=X.+Liauthor=A.+K.+Duttaauthor=W.+Le&title=Novel+D3+dopamine+receptor-preferring+agonist+D-264%3A+Evidence+of+neuroprotective+property+in+Parkinson%E2%80%99s+disease+animal+models+induced+by+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+and+lactacystin&doi=10.1002%2Fjnr.22405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel D3 dopamine receptor-preferring agonist D-264: evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin</span></div><div class="casAuthors">Li, Chao; Biswas, S.; Li, Xingang; Dutta, A. K.; Le, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2513-2523</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD), a progressive neurodegenerative movement disorder, is known to be caused by diverse pathol. conditions resulting from dysfunction of the ubiquitin-proteasome system (UPS), mitochondria, and oxidative stress leading to preferential nigral dopamine (DA) neuron degeneration in the substantia nigra.  In the present study, we evaluated the novel D3 receptor-preferring agonist D-264 in a mouse model of PD to evaluate its neuroprotective properties against both the nigrostriatal dopaminergic toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- and the proteasome inhibitor lactacystin-induced dopaminergic degeneration.  C57BL/6 male mice either were given MPTP by i.p. injection twice per day for 2 successive days at a dose 20 mg/kg or were microinjected with lactacystin bilaterally (1.25 μg/side) into the medial forebrain bundle (MFB).  Pretreatment with D-264 (1 mg/kg and 5 mg/kg, i.p., once per day), started 7 days before administration of MPTP or lactacystin.  We found that D-264 significantly improved behavioral performance, attenuated both MPTP- and lactacystin-induced DA neuron loss, and blocked proteasomal inhibition and microglial activation in the substantia nigra (SN).  Furthermore, D-264 treatment was shown to increase the levels of brain-derived neurotrophic factor (BDNF) and glial cell line-derived factor (GDNF) in MPTP- and lactacystin-treated mice, possibly indicating, at least in part, the mechanism of neuroprotection by D-264.  Furthermore, pretreatment with the D3 receptor antagonist U99194 significantly altered the effect of neuroprotection conferred by D-264.  Collectively, our study demonstrates that D-264 can prevent neurodegeneration induced by the selective neurotoxin MPTP and the UPS inhibitor lactacystin.  The results indicate that D-264 could potentially serve as a symptomatic and neuroprotective treatment agent for PD. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5cBGfbUSM67Vg90H21EOLACvtfcHk0lgA4obifDfWAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1GmtLY%253D&md5=32d866170d2ac26eafa98608393881c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22405%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DLe%26aufirst%3DW.%26atitle%3DNovel%2520D3%2520dopamine%2520receptor-preferring%2520agonist%2520D-264%253A%2520Evidence%2520of%2520neuroprotective%2520property%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520animal%2520models%2520induced%2520by%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520and%2520lactacystin%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2010%26volume%3D88%26spage%3D2513%26epage%3D2523%26doi%3D10.1002%2Fjnr.22405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gogoi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Dopamine D(2)/D(3) agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson’s disease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span><span class="refDoi"> DOI: 10.1002/cmdc.201100140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fcmdc.201100140" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=991-995&author=S.+Gogoiauthor=T.+Antonioauthor=S.+Rajagopalanauthor=M.+Reithauthor=J.+Andersenauthor=A.+K.+Dutta&title=Dopamine+D%282%29%2FD%283%29+agonists+with+potent+iron+chelation%2C+antioxidant+and+neuroprotective+properties%3A+potential+implication+in+symptomatic+and+neuroprotective+treatment+of+Parkinson%E2%80%99s+disease&doi=10.1002%2Fcmdc.201100140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100140%26sid%3Dliteratum%253Aachs%26aulast%3DGogoi%26aufirst%3DS.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DRajagopalan%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DJ.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDopamine%2520D%25282%2529%252FD%25283%2529%2520agonists%2520with%2520potent%2520iron%2520chelation%252C%2520antioxidant%2520and%2520neuroprotective%2520properties%253A%2520potential%2520implication%2520in%2520symptomatic%2520and%2520neuroprotective%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D991%26epage%3D995%26doi%3D10.1002%2Fcmdc.201100140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Structure-activity relationship study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydroben zo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5826</span><span class="NLM_x">–</span> <span class="NLM_lpage">5840</span><span class="refDoi"> DOI: 10.1021/jm300268s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300268s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsF2gurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5826-5840&author=M.+Johnsonauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Structure-activity+relationship+study+of+N%286%29-%282-%284-%281H-Indol-5-yl%29piperazin-1-yl%29ethyl%29-N%286%29-propyl-4%2C5%2C6%2C7-tetrahydroben+zo%5Bd%5Dthiazole-2%2C6-diamine+analogues%3A+development+of+highly+selective+D3+dopamine+receptor+agonists+along+with+a+highly+potent+D2%2FD3+agonist+and+their+pharmacological+characterization&doi=10.1021%2Fjm300268s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization</span></div><div class="casAuthors">Johnson, Mark; Antonio, Tamara; Reith, Maarten E. A.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5826-5840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In our effort to develop multifunctional drugs against Parkinson's disease, a structure-activity-relationship study was carried out based on our hybrid mol. template targeting D2/D3 receptors.  Competitive binding with [3H]spiroperidol was used to evaluate affinity (Ki) of test compds.  Functional activity of selected compds. in stimulating [35S]GTPγS binding was assessed in CHO cells expressing either human D2 or D3 receptors.  Our results demonstrated development of highly selective compds. for D3 receptor (for (-)-40 (I) Ki, D3 = 1.84 nM, D2/D3 = 583.2; for (-)-45Ki, D3 = 1.09 nM, D2/D3 = 827.5).  Functional data identified (-)-40 (EC50, D2 = 114 nM, D3 = 0.26 nM, D2/D3 = 438) as one of the highest D3 selective agonists known to date.  In addn., high affinity, nonselective D3 agonist (-)-19 (EC50, D2 = 2.96 nM and D3 = 1.26 nM) was also developed.  Lead compds. with antioxidant activity were evaluated using an in vivo PD animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6RjEg-1KqXbVg90H21EOLACvtfcHk0licCNBm4FWj0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsF2gurk%253D&md5=3b8cfcd3f1e19da405875c342ba3abdc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300268s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300268s%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520N%25286%2529-%25282-%25284-%25281H-Indol-5-yl%2529piperazin-1-yl%2529ethyl%2529-N%25286%2529-propyl-4%252C5%252C6%252C7-tetrahydroben%2520zo%255Bd%255Dthiazole-2%252C6-diamine%2520analogues%253A%2520development%2520of%2520highly%2520selective%2520D3%2520dopamine%2520receptor%2520agonists%2520along%2520with%2520a%2520highly%2520potent%2520D2%252FD3%2520agonist%2520and%2520their%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5826%26epage%3D5840%26doi%3D10.1021%2Fjm300268s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Santra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">D-512 and D-440 as novel multifunctional dopamine agonists: characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson’s disease animal model</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1382</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span><span class="refDoi"> DOI: 10.1021/cn400106n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400106n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SisbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1382-1392&author=S.+Santraauthor=L.+Xuauthor=M.+Shahauthor=M.+Johnsonauthor=A.+Dutta&title=D-512+and+D-440+as+novel+multifunctional+dopamine+agonists%3A+characterization+of+neuroprotection+properties+and+evaluation+of+in+vivo+efficacy+in+a+Parkinson%E2%80%99s+disease+animal+model&doi=10.1021%2Fcn400106n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">D-512 and D-440 as Novel Multifunctional Dopamine Agonists: Characterization of Neuroprotection Properties and Evaluation of In Vivo Efficacy in a Parkinson's Disease Animal Model</span></div><div class="casAuthors">Santra, Soumava; Xu, Liping; Shah, Mrudang; Johnson, Mark; Dutta, Aloke</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1382-1392</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this Article, we have demonstrated the in vivo efficacy of D-512 and D-440 in a 6-OHDA-induced unilaterally lesioned rat model expt., a Parkinson's disease animal model.  D-512 is a novel highly potent D2/D3 agonist, and D-440 is a novel highly selective D3 agonist.  We evaluated the neuroprotective properties of D-512 and D-440 in the dopaminergic MN9D cells.  Cotreatment of these two drugs with 6-OHDA and MPP+ significantly attenuated and reversed 6-OHDA- and MPP+-induced toxicity in a dose-dependent manner in the dopaminergic MN9D cells.  The inhibition of caspase 3/7 and lipid peroxidn. activities along with the restoration of tyrosine hydroxylase levels by D-512 in 6-OHDA-treated cells may partially explain the mechanism of its neuroprotective property.  Furthermore, studies were carried out to elucidate the time-dependent changes in the pERK1/2 and pAkt, two kinases implicated in cell survival and apoptosis, levels upon treatment with 6-OHDA in presence of D-512.  The neuroprotective property exhibited by these drugs was independent of their dopamine-agonist activity, which is consistent with our multifunctional drug-development approach that is focused on the generation of disease-modifying symptomatic-treatment agents for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAHJ2ZjHMCALVg90H21EOLACvtfcHk0licCNBm4FWj0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SisbvL&md5=a50aaf8e29fa94a3257d51ef217a9836</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcn400106n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400106n%26sid%3Dliteratum%253Aachs%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DD-512%2520and%2520D-440%2520as%2520novel%2520multifunctional%2520dopamine%2520agonists%253A%2520characterization%2520of%2520neuroprotection%2520properties%2520and%2520evaluation%2520of%2520in%2520vivo%2520efficacy%2520in%2520a%2520Parkinson%25E2%2580%2599s%2520disease%2520animal%2520model%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1382%26epage%3D1392%26doi%3D10.1021%2Fcn400106n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voshavar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shurubor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1111/jnc.12767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1111%2Fjnc.12767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=24848702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2nu7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2014&pages=74-85&author=M.+Shahauthor=S.+Rajagopalanauthor=L.+Xuauthor=C.+Voshavarauthor=Y.+Shuruborauthor=F.+Bealauthor=J.+K.+Andersenauthor=A.+K.+Dutta&title=The+high-affinity+D2%2FD3+agonist+D512+protects+PC12+cells+from+6-OHDA-induced+apoptotic+cell+death+and+rescues+dopaminergic+neurons+in+the+MPTP+mouse+model+of+Parkinson%E2%80%99s+disease&doi=10.1111%2Fjnc.12767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease</span></div><div class="casAuthors">Shah, Mrudang; Rajagopalan, Subramanian; Xu, Liping; Voshavar, Chandrashekhar; Shurubor, Yevgeniya; Beal, Flint; Andersen, Julie K.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-85</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In this study, in vitro and in vivo expts. were carried out with the high-affinity multifunctional D2/D3 agonist D-512 to explore its potential neuroprotective effects in models of Parkinson's disease and the potential mechanism(s) underlying such properties.  Pre-treatment with D-512 in vitro was found to rescue rat adrenal Pheochromocytoma PC12 cells from toxicity induced by 6-hydroxydopamine administration in a dose-dependent manner.  Neuroprotection was found to coincide with redns. in intracellular reactive oxygen species, lipid peroxidn., and DNA damage.  In vivo, pre-treatment with 0.5 mg/kg D-512 was protective against neurodegenerative phenotypes assocd. with systemic administration of MPTP, including losses in striatal dopamine, redns. in nos. of DAergic neurons in the substantia nigra (SN), and locomotor dysfunction.  These observations strongly suggest that the multifunctional drug D-512 may constitute a novel viable therapy for Parkinson's disease.  Neuroprotective properties of dopamine D2/D3 agonist D-512 was evaluated both in vitro and in vivo models of Parkinson's disease (PD).  D-512 rescued PC12 cells from toxicity induced by 6-hydroxydopamine (6-OHDA).  D-512 reduced intracellular reactive oxygen species and lipid peroxidn. as well as protection of DNA damage from toxicity of 6-OHDA.  D-512 was protective against neurodegenerative phenotypes induced by MPTP in mouse.  Our studies strongly suggest that D-512 with its multifunctional property may constitute a novel viable therapy for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAfJdHZ9ekY7Vg90H21EOLACvtfcHk0licCNBm4FWj0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2nu7%252FN&md5=3219f1a318d7dc556b9441dbd8530091</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12767%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%26aulast%3DRajagopalan%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DVoshavar%26aufirst%3DC.%26aulast%3DShurubor%26aufirst%3DY.%26aulast%3DBeal%26aufirst%3DF.%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DThe%2520high-affinity%2520D2%252FD3%2520agonist%2520D512%2520protects%2520PC12%2520cells%2520from%25206-OHDA-induced%2520apoptotic%2520cell%2520death%2520and%2520rescues%2520dopaminergic%2520neurons%2520in%2520the%2520MPTP%2520mouse%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D131%26spage%3D74%26epage%3D85%26doi%3D10.1111%2Fjnc.12767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Modi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Structural modifications of neuroprotective anti-Parkinsonian (−)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobe nzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1572</span><span class="refDoi"> DOI: 10.1021/jm401883v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401883v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1557-1572&author=G.+Modiauthor=T.+Antonioauthor=M.+Reithauthor=A.+Dutta&title=Structural+modifications+of+neuroprotective+anti-Parkinsonian+%28%E2%88%92%29-N6-%282-%284-%28biphenyl-4-yl%29piperazin-1-yl%29-ethyl%29-N6-propyl-4%2C5%2C6%2C7-tetrahydrobe+nzo%5Bd%5Dthiazole-2%2C6-diamine+%28D-264%29%3A+an+effort+toward+the+improvement+of+in+vivo+efficacy+of+the+parent+molecule&doi=10.1021%2Fjm401883v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm401883v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401883v%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DG.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DStructural%2520modifications%2520of%2520neuroprotective%2520anti-Parkinsonian%2520%2528%25E2%2588%2592%2529-N6-%25282-%25284-%2528biphenyl-4-yl%2529piperazin-1-yl%2529-ethyl%2529-N6-propyl-4%252C5%252C6%252C7-tetrahydrobe%2520nzo%255Bd%255Dthiazole-2%252C6-diamine%2520%2528D-264%2529%253A%2520an%2520effort%2520toward%2520the%2520improvement%2520of%2520in%2520vivo%2520efficacy%2520of%2520the%2520parent%2520molecule%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1557%26epage%3D1572%26doi%3D10.1021%2Fjm401883v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Modi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voshavar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogoi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span><span class="refDoi"> DOI: 10.1021/cn500084x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500084x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVaksrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=700-717&author=G.+Modiauthor=C.+Voshavarauthor=S.+Gogoiauthor=M.+Shahauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Multifunctional+D2%2FD3+agonist+D-520+with+high+in+vivo+efficacy%3A+modulator+of+toxicity+of+alpha-synuclein+aggregates&doi=10.1021%2Fcn500084x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional D2/D3 Agonist D-520 with High in Vivo Efficacy: Modulator of Toxicity of Alpha-Synuclein Aggregates</span></div><div class="casAuthors">Modi, Gyan; Voshavar, Chandrashekhar; Gogoi, Sanjib; Shah, Mrudang; Antonio, Tamara; Reith, Maarten E. A.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">700-717</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed a series of dihydroxy compds. and related analogs based on our hybrid D2/D3 agonist mol. template to develop multifunctional drugs for symptomatic and neuroprotective treatment for Parkinson's disease (PD).  The lead compd. (-)-24b (D-520) exhibited high agonist potency at D2/D3 receptors and produced efficacious activity in the animal models for PD.  The data from thioflavin T (ThT) assay and from transmission electron microscopy (TEM) anal. demonstrate that D-520 is able to modulate aggregation of alpha-synuclein (αSN).  Addnl., coincubation of D-520 with αSN is able to reduce toxicity of preformed aggregates of αSN compared to control αSN alone.  Finally, in a neuroprotection study with dopaminergic MN9D cells, D-520 clearly demonstrated the effect of neuroprotection from toxicity of 6-hydroxydopamine.  Thus, compd. D-520 possesses properties characteristic of multifunctionality conducive to symptomatic and neuroprotective treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn9f2avCxAqbVg90H21EOLACvtfcHk0lh8M1-J6QHiEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVaksrjJ&md5=5660e1b61a029716a21ee7e156a75100</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcn500084x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500084x%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DG.%26aulast%3DVoshavar%26aufirst%3DC.%26aulast%3DGogoi%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DMultifunctional%2520D2%252FD3%2520agonist%2520D-520%2520with%2520high%2520in%2520vivo%2520efficacy%253A%2520modulator%2520of%2520toxicity%2520of%2520alpha-synuclein%2520aggregates%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D700%26epage%3D717%26doi%3D10.1021%2Fcn500084x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments: binding activity at D2 and D3 receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.1016/S0960-894X(01)00820-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0960-894X%2801%2900820-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=619-622&author=A.+K.+Duttaauthor=X.+S.+Feiauthor=M.+E.+Reith&title=A+novel+series+of+hybrid+compounds+derived+by+combining+2-aminotetralin+and+piperazine+fragments%3A+binding+activity+at+D2+and+D3+receptors&doi=10.1016%2FS0960-894X%2801%2900820-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900820-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900820-4%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DFei%26aufirst%3DX.%2BS.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DA%2520novel%2520series%2520of%2520hybrid%2520compounds%2520derived%2520by%2520combining%25202-aminotetralin%2520and%2520piperazine%2520fragments%253A%2520binding%2520activity%2520at%2520D2%2520and%2520D3%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D619%26epage%3D622%26doi%3D10.1016%2FS0960-894X%2801%2900820-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolhatkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4361</span><span class="NLM_x">–</span> <span class="NLM_lpage">4373</span><span class="refDoi"> DOI: 10.1016/j.bmc.2004.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.bmc.2004.06.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4361-4373&author=A.+K.+Duttaauthor=S.+K.+Venkataramanauthor=X.+S.+Feiauthor=R.+Kolhatkarauthor=S.+Zhangauthor=M.+E.+Reith&title=Synthesis+and+biological+characterization+of+novel+hybrid+7-%5B%5B2-%284-phenyl-piperazin-1-yl%29-ethyl%5D-propyl-amino%5D-5%2C6%2C7%2C8-tetrahydro-naphthalen-2-ol+and+their+heterocyclic+bioisosteric+analogues+for+dopamine+D2+and+D3+receptors&doi=10.1016%2Fj.bmc.2004.06.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DVenkataraman%26aufirst%3DS.%2BK.%26aulast%3DFei%26aufirst%3DX.%2BS.%26aulast%3DKolhatkar%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DSynthesis%2520and%2520biological%2520characterization%2520of%2520novel%2520hybrid%25207-%255B%255B2-%25284-phenyl-piperazin-1-yl%2529-ethyl%255D-propyl-amino%255D-5%252C6%252C7%252C8-tetrahydro-naphthalen-2-ol%2520and%2520their%2520heterocyclic%2520bioisosteric%2520analogues%2520for%2520dopamine%2520D2%2520and%2520D3%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4361%26epage%3D4373%26doi%3D10.1016%2Fj.bmc.2004.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Markey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, C. J.</span><span> </span><span class="NLM_article-title">A new route to alpha-carbolines based on 6pi-electrocyclization of indole-3-alkenyl oximes</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6306</span><span class="NLM_x">–</span> <span class="NLM_lpage">6308</span><span class="refDoi"> DOI: 10.1021/ol403191k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol403191k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=6306-6308&author=S.+J.+Markeyauthor=W.+Lewisauthor=C.+J.+Moody&title=A+new+route+to+alpha-carbolines+based+on+6pi-electrocyclization+of+indole-3-alkenyl+oximes&doi=10.1021%2Fol403191k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fol403191k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol403191k%26sid%3Dliteratum%253Aachs%26aulast%3DMarkey%26aufirst%3DS.%2BJ.%26aulast%3DLewis%26aufirst%3DW.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DA%2520new%2520route%2520to%2520alpha-carbolines%2520based%2520on%25206pi-electrocyclization%2520of%2520indole-3-alkenyl%2520oximes%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D6306%26epage%3D6308%26doi%3D10.1021%2Fol403191k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Practical, asymmetric synthesis of aromatic-substituted bulky and hydrophobic tryptophan derivatives</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">7717</span><span class="NLM_x">–</span> <span class="NLM_lpage">7719</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)01626-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0040-4039%2801%2901626-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsV2ku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=7717-7719&author=W.+Wangauthor=C.+Xiongauthor=J.+Yangauthor=V.+J.+Hruby&title=Practical%2C+asymmetric+synthesis+of+aromatic-substituted+bulky+and+hydrophobic+tryptophan+derivatives&doi=10.1016%2FS0040-4039%2801%2901626-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Practical, asymmetric synthesis of aromatic-substituted bulky and hydrophobic tryptophan derivatives</span></div><div class="casAuthors">Wang, Wei; Xiong, Chiyi; Yang, Jianqing; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">7717-7719</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An efficient method for the synthesis of novel arom. substituted, bulky and hydrophobic tryptophan derivs. has been developed.  Asym. hydrogenations of α-enamide (I) using Burk's DuPHOS-based catalysts generated high enantiomerically pure D- and L-α-amino acid derivs., which subsequently underwent Suzuki cross couplings with boronic acid derivs. to afford arom. substituted D- and L-tryptophan derivs. (II; Ar = Ph, MeO-4-C6H4-, 1-naphthyl) in high yields.  The method can allow for the prepn. of such amino acids in large-scales for extensive structure-activity studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYQXdd5_07Vg90H21EOLACvtfcHk0lhFxwDqaelX-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsV2ku7w%253D&md5=792e44d5a38c3d4ed735aab2f08c7b4a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2901626-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252901626-4%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DPractical%252C%2520asymmetric%2520synthesis%2520of%2520aromatic-substituted%2520bulky%2520and%2520hydrophobic%2520tryptophan%2520derivatives%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D7717%26epage%3D7719%26doi%3D10.1016%2FS0040-4039%2801%2901626-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Parikh, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doering, W. v. E.</span><span> </span><span class="NLM_article-title">Sulfur trioxide in the oxidation of alcohols by dimethyl sulfoxide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5507</span><span class="refDoi"> DOI: 10.1021/ja00997a067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00997a067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaF1cXjtV2q" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1967&pages=5505-5507&author=J.+R.+Parikhauthor=W.+v.+E.+Doering&title=Sulfur+trioxide+in+the+oxidation+of+alcohols+by+dimethyl+sulfoxide&doi=10.1021%2Fja00997a067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfur trioxide in the oxidation of alcohols by dimethyl sulfoxide</span></div><div class="casAuthors">Parikh, Jekishan R.; Doering, William v. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5505-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A soln. of pyridine-SO3 complex in Me2SO is used to oxidize p-nitrobenzyl alc., l-menthol, and many steroidal alcs. to the corresponding aldehydes and ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ2qbwXRJMT7Vg90H21EOLACvtfcHk0lhFxwDqaelX-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXjtV2q&md5=fa83f740ef49cb695547ae90c1ae291a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja00997a067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00997a067%26sid%3Dliteratum%253Aachs%26aulast%3DParikh%26aufirst%3DJ.%2BR.%26aulast%3DDoering%26aufirst%3DW.%2Bv.%2BE.%26atitle%3DSulfur%2520trioxide%2520in%2520the%2520oxidation%2520of%2520alcohols%2520by%2520dimethyl%2520sulfoxide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1967%26volume%3D89%26spage%3D5505%26epage%3D5507%26doi%3D10.1021%2Fja00997a067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Schneider, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierau, J.</span><span> </span><span class="NLM_article-title">Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.1021/jm00386a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00386a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=494-498&author=C.+S.+Schneiderauthor=J.+Mierau&title=Dopamine+autoreceptor+agonists%3A+resolution+and+pharmacological+activity+of+2%2C6-diaminotetrahydrobenzothiazole+and+an+aminothiazole+analogue+of+apomorphine&doi=10.1021%2Fjm00386a009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00386a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00386a009%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DC.%2BS.%26aulast%3DMierau%26aufirst%3DJ.%26atitle%3DDopamine%2520autoreceptor%2520agonists%253A%2520resolution%2520and%2520pharmacological%2520activity%2520of%25202%252C6-diaminotetrahydrobenzothiazole%2520and%2520an%2520aminothiazole%2520analogue%2520of%2520apomorphine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D494%26epage%3D498%26doi%3D10.1021%2Fjm00386a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Mancuso, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swern, D.</span><span> </span><span class="NLM_article-title">Oxidation of long-chain and related alcohols to carbonyls by dimethyl sulfoxide ″activated″ by oxalyl chloride</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2480</span><span class="NLM_x">–</span> <span class="NLM_lpage">2482</span><span class="refDoi"> DOI: 10.1021/jo00406a041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00406a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaE1cXkt1elu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=2480-2482&author=A.+J.+Mancusoauthor=S.-L.+Huangauthor=D.+Swern&title=Oxidation+of+long-chain+and+related+alcohols+to+carbonyls+by+dimethyl+sulfoxide+%E2%80%B3activated%E2%80%B3+by+oxalyl+chloride&doi=10.1021%2Fjo00406a041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of long-chain and related alcohols to carbonyls by dimethyl sulfoxide "activated" by oxalyl chloride</span></div><div class="casAuthors">Mancuso, Anthony J.; Huang, Shui-Lung; Swern, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2480-2</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Higher alkanols and alkenols, farnesol, lower alkynols, and cholesterol were oxidized to the resp. carbonyl compds. by Me2SO-(COCl)2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPghc3oGz-GrVg90H21EOLACvtfcHk0lhFxwDqaelX-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXkt1elu74%253D&md5=346ac457db6d8a6ff8d5b3c1e826701a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo00406a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00406a041%26sid%3Dliteratum%253Aachs%26aulast%3DMancuso%26aufirst%3DA.%2BJ.%26aulast%3DHuang%26aufirst%3DS.-L.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DOxidation%2520of%2520long-chain%2520and%2520related%2520alcohols%2520to%2520carbonyls%2520by%2520dimethyl%2520sulfoxide%2520%25E2%2580%25B3activated%25E2%2580%25B3%2520by%2520oxalyl%2520chloride%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D2480%26epage%3D2482%26doi%3D10.1021%2Fjo00406a041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Correction to structure-activity relationship study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydroben zo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1021/jm301634c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301634c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=589-590&author=M.+Johnsonauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Correction+to+structure-activity+relationship+study+of+N%286%29-%282-%284-%281H-Indol-5-yl%29piperazin-1-yl%29ethyl%29-N%286%29-propyl-4%2C5%2C6%2C7-tetrahydroben+zo%5Bd%5Dthiazole-2%2C6-diamine+analogues%3A+development+of+highly+selective+D3+dopamine+receptor+agonists+along+with+a+highly+potent+D2%2FD3+agonist+and+their+pharmacological+characterization&doi=10.1021%2Fjm301634c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm301634c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301634c%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DCorrection%2520to%2520structure-activity%2520relationship%2520study%2520of%2520N%25286%2529-%25282-%25284-%25281H-Indol-5-yl%2529piperazin-1-yl%2529ethyl%2529-N%25286%2529-propyl-4%252C5%252C6%252C7-tetrahydroben%2520zo%255Bd%255Dthiazole-2%252C6-diamine%2520analogues%253A%2520development%2520of%2520highly%2520selective%2520D3%2520dopamine%2520receptor%2520agonists%2520along%2520with%2520a%2520highly%2520potent%2520D2%252FD3%2520agonist%2520and%2520their%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D589%26epage%3D590%26doi%3D10.1021%2Fjm301634c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Langlois, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouilhès, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Génin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andriamialisoa, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, N.</span><span> </span><span class="NLM_article-title">New approaches to the synthesis of eburnane alkaloids</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3755</span><span class="NLM_x">–</span> <span class="NLM_lpage">3761</span><span class="refDoi"> DOI: 10.1016/S0040-4020(01)88616-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0040-4020%2801%2988616-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1983&pages=3755-3761&author=Y.+Langloisauthor=A.+Pouilh%C3%A8sauthor=D.+G%C3%A9ninauthor=R.+Z.+Andriamialisoaauthor=N.+Langlois&title=New+approaches+to+the+synthesis+of+eburnane+alkaloids&doi=10.1016%2FS0040-4020%2801%2988616-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2988616-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252988616-6%26sid%3Dliteratum%253Aachs%26aulast%3DLanglois%26aufirst%3DY.%26aulast%3DPouilh%25C3%25A8s%26aufirst%3DA.%26aulast%3DG%25C3%25A9nin%26aufirst%3DD.%26aulast%3DAndriamialisoa%26aufirst%3DR.%2BZ.%26aulast%3DLanglois%26aufirst%3DN.%26atitle%3DNew%2520approaches%2520to%2520the%2520synthesis%2520of%2520eburnane%2520alkaloids%26jtitle%3DTetrahedron%26date%3D1983%26volume%3D39%26spage%3D3755%26epage%3D3761%26doi%3D10.1016%2FS0040-4020%2801%2988616-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallis, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisholm, J. D.</span><span> </span><span class="NLM_article-title">Tandem oxidation/halogenation of aryl allylic alcohols under Moffatt–Swern conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">7054</span><span class="NLM_x">–</span> <span class="NLM_lpage">7057</span><span class="refDoi"> DOI: 10.1021/jo0711992</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0711992" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=7054-7057&author=J.+Yinauthor=C.+E.+Gallisauthor=J.+D.+Chisholm&title=Tandem+oxidation%2Fhalogenation+of+aryl+allylic+alcohols+under+Moffatt%E2%80%93Swern+conditions&doi=10.1021%2Fjo0711992"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo0711992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0711992%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DGallis%26aufirst%3DC.%2BE.%26aulast%3DChisholm%26aufirst%3DJ.%2BD.%26atitle%3DTandem%2520oxidation%252Fhalogenation%2520of%2520aryl%2520allylic%2520alcohols%2520under%2520Moffatt%25E2%2580%2593Swern%2520conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D7054%26epage%3D7057%26doi%3D10.1021%2Fjo0711992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Živec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anžič, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">A novel scalable synthesis of pramipexole</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1129</span><span class="refDoi"> DOI: 10.1021/op1000989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op1000989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=1125-1129&author=M.+%C5%BDivecauthor=B.+An%C5%BEi%C4%8Dauthor=S.+Gobec&title=A+novel+scalable+synthesis+of+pramipexole&doi=10.1021%2Fop1000989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fop1000989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop1000989%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25BDivec%26aufirst%3DM.%26aulast%3DAn%25C5%25BEi%25C4%258D%26aufirst%3DB.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DA%2520novel%2520scalable%2520synthesis%2520of%2520pramipexole%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2010%26volume%3D14%26spage%3D1125%26epage%3D1129%26doi%3D10.1021%2Fop1000989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Brown, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrington, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthale n-2-ol: effect on affinity and selectivity for dopamine D3 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3933</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.04.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.bmc.2009.04.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3923-3933&author=D.+A.+Brownauthor=M.+Mishraauthor=S.+Zhangauthor=S.+Biswasauthor=I.+Parringtonauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Investigation+of+various+N-heterocyclic+substituted+piperazine+versions+of+5%2F7-%7B%5B2-%284-aryl-piperazin-1-yl%29-ethyl%5D-propyl-amino%7D-5%2C6%2C7%2C8-tetrahydro-naphthale+n-2-ol%3A+effect+on+affinity+and+selectivity+for+dopamine+D3+receptor&doi=10.1016%2Fj.bmc.2009.04.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BA.%26aulast%3DMishra%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DParrington%26aufirst%3DI.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DInvestigation%2520of%2520various%2520N-heterocyclic%2520substituted%2520piperazine%2520versions%2520of%25205%252F7-%257B%255B2-%25284-aryl-piperazin-1-yl%2529-ethyl%255D-propyl-amino%257D-5%252C6%252C7%252C8-tetrahydro-naphthale%2520n-2-ol%253A%2520effect%2520on%2520affinity%2520and%2520selectivity%2520for%2520dopamine%2520D3%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3923%26epage%3D3933%26doi%3D10.1016%2Fj.bmc.2009.04.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: comparison with functional GTPgammaS assays</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2015.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.jneumeth.2015.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=25840364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtFSjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2015&pages=7-15&author=J.+Zhenauthor=T.+Antonioauthor=S.+Aliauthor=K.+A.+Neveauthor=A.+K.+Duttaauthor=M.+E.+Reith&title=Use+of+radiolabeled+antagonist+assays+for+assessing+agonism+at+D2+and+D3+dopamine+receptors%3A+comparison+with+functional+GTPgammaS+assays&doi=10.1016%2Fj.jneumeth.2015.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: Comparison with functional GTPγS assays</span></div><div class="casAuthors">Zhen, Juan; Antonio, Tamara; Ali, Solav; Neve, Kim A.; Dutta, Aloke K.; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-15</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cell-based drug screening assays are essential tools for drug discovery and development targeting G protein-coupled receptors, which include dopamine D3 receptors.  D3 is notorious for its poor coupling to G protein in most heterologous cell lines, and therefore D3 agonist-stimulated binding of [35S]GTPγS to G protein cannot be obsd. in many "non-functional" D3 expressing cell lines.  The present work explores the use of an alternate method for assessing agonist activity, consisting of measuring the difference in agonist competition between [3H]spiperone bound to low-affinity states of the receptor and that with radioligand bound to high-affinity states (GTP shift assay).  The current study describes the detn. of GTP shifts in [3H]spiperone binding assays for the assessment of agonists' potencies (at D2 and D3) and efficacies (at D3).  Compared with GTP35γS binding assays, the new method removes the cumbersome need of functional D3 cell lines and limited project duration due to short half-life of isotope 35S.  The new method allows the estn. of potency (D2 and D3) and efficacy (D3) at the level of receptor and G protein activation in a simple fashion from shifts in monophasic-inhibition curves.  Moreover, it does not require [35S]GTPγS binding assays with functional D3 cells.  This method will have wide applicability for D3-selective agonist screening.  It may also be useful for other GPCRs circumventing the need for functional assays and offering the ability to detect agonist activity regardless of the particular signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCV3v1p95VarVg90H21EOLACvtfcHk0lhV4jDitTqwFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtFSjtb0%253D&md5=5810dda72377ec553967c99dc8dc1a65</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2015.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2015.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DUse%2520of%2520radiolabeled%2520antagonist%2520assays%2520for%2520assessing%2520agonism%2520at%2520D2%2520and%2520D3%2520dopamine%2520receptors%253A%2520comparison%2520with%2520functional%2520GTPgammaS%2520assays%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2015%26volume%3D248%26spage%3D7%26epage%3D15%26doi%3D10.1016%2Fj.jneumeth.2015.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Giros, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martres, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Gene cloning of human dopaminergic D3 receptor and identification of its chromosome</span> <span class="citation_source-journal">C. R. Acad. Sci. III</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=2129115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK38XhsVym" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=1990&pages=501-508&author=B.+Girosauthor=M.+P.+Martresauthor=P.+Sokoloffauthor=J.+C.+Schwartz&title=Gene+cloning+of+human+dopaminergic+D3+receptor+and+identification+of+its+chromosome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the human dopaminergic D3 receptor gene and its chromosome identification</span></div><div class="casAuthors">Giros, Bruno; Martres, Marie Pascale; Sokoloff, Pierre; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Comptes Rendus de l'Academie des Sciences, Serie III:  Sciences de la Vie</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">501-8</span>CODEN:
                <span class="NLM_cas:coden">CRASEV</span>;
        ISSN:<span class="NLM_cas:issn">0764-4469</span>.
    </div><div class="casAbstract">The coding region of the human dopaminergic D3 receptor gene was cloned and sequenced.  The deduced amino acid sequence displays a global homol. of 78% with rat D3 receptor with a deletion of 46 residues within the third intracytoplasmic loop.  Southern anal. assigned the human gene to chromosome 3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt_FAWtR59PLVg90H21EOLACvtfcHk0ljkt7uiXIbywg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVym&md5=1167dbd5978fd1eb528ad7f097fc5204</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DMartres%26aufirst%3DM.%2BP.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DGene%2520cloning%2520of%2520human%2520dopaminergic%2520D3%2520receptor%2520and%2520identification%2520of%2520its%2520chromosome%26jtitle%3DC.%2520R.%2520Acad.%2520Sci.%2520III%26date%3D1990%26volume%3D311%26spage%3D501%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stofko, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frothingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke-Howie, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Server, A. C.</span><span> </span><span class="NLM_article-title">Cloning of the cDNA and gene for a human D2 dopamine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">9762</span><span class="NLM_x">–</span> <span class="NLM_lpage">9766</span><span class="refDoi"> DOI: 10.1073/pnas.86.24.9762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1073%2Fpnas.86.24.9762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=2532362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK3cXksFegtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=9762-9766&author=D.+K.+Grandyauthor=M.+A.+Marchionniauthor=H.+Makamauthor=R.+E.+Stofkoauthor=M.+Alfanoauthor=L.+Frothinghamauthor=J.+B.+Fischerauthor=K.+J.+Burke-Howieauthor=J.+R.+Bunzowauthor=A.+C.+Server&title=Cloning+of+the+cDNA+and+gene+for+a+human+D2+dopamine+receptor&doi=10.1073%2Fpnas.86.24.9762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the cDNA and gene for a human D2 dopamine receptor</span></div><div class="casAuthors">Grandy, David K.; Marchionni, Mark A.; Makam, Haripriya; Stofko, Renata E.; Alfano, Mario; Frothingham, Leslie; Fischer, James B.; Burke-Howie, Kathleen J.; Bunzow, James R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9762-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A clone encoding a human D2 dopamine receptor was isolated from a pituitary cDNA library and sequenced.  The deduced protein sequence is 96% identical with that of the cloned rat receptor with one major difference: the human receptor contains an addnl. 29 amino acids in its putative third cytoplasmic loop.  Southern blotting demonstrated the presence of only 1 human D2 receptor gene.  Two overlapping phage contg. the gene were isolated and characterized.  DNA sequence anal. of these clones showed that the coding sequence is interrupted by 6 introns and that the addnl. amino acids present in the human pituitary receptor are encoded by a single exon of 87 base pairs.  The involvement of this sequence in alternative splicing and its biol. significance are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8flaLZHH5TrVg90H21EOLACvtfcHk0ljkt7uiXIbywg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFegtb8%253D&md5=08f829fb8ae6ab0d4e522525e94858a5</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.86.24.9762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.86.24.9762%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DMarchionni%26aufirst%3DM.%2BA.%26aulast%3DMakam%26aufirst%3DH.%26aulast%3DStofko%26aufirst%3DR.%2BE.%26aulast%3DAlfano%26aufirst%3DM.%26aulast%3DFrothingham%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DBurke-Howie%26aufirst%3DK.%2BJ.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DServer%26aufirst%3DA.%2BC.%26atitle%3DCloning%2520of%2520the%2520cDNA%2520and%2520gene%2520for%2520a%2520human%2520D2%2520dopamine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1989%26volume%3D86%26spage%3D9762%26epage%3D9766%26doi%3D10.1073%2Fpnas.86.24.9762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2010.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.jneumeth.2010.01.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=20122961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2010&pages=32-38&author=J.+Zhenauthor=T.+Antonioauthor=A.+K.+Duttaauthor=M.+E.+Reith&title=Concentration+of+receptor+and+ligand+revisited+in+a+modified+receptor+binding+protocol+for+high-affinity+radioligands%3A+%5B3H%5DSpiperone+binding+to+D2+and+D3+dopamine+receptors&doi=10.1016%2Fj.jneumeth.2010.01.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors</span></div><div class="casAuthors">Zhen, Juan; Antonio, Tamara; Dutta, Aloke K.; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-38</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In receptor binding assays with ultra-high-affinity radioligands, it is difficult, in practice, to adhere the golden rule that the receptor concn. in the assay should be substantially (at least 10-fold) lower than the dissocn. const. (K d) of the radioligand and inhibition const. (K i) of compd.  Esp. for low specific activity radioligands (usually tritiated ligands of a couple of TBq/mmol), routinely applied in concns. at around or below the K d, the use of extremely small amts. of receptor protein per assay will result in low levels of bound radioactivity; the alternative use of larger assay vols. will make it difficult to apply 96-well filtration devices.  For assessing the inhibition const. (K i) of competitive inhibitors under conditions violating the above golden rule, equations are available incorporating both [receptor] and [ligand] vs. K d; however, their application requires precise knowledge of [receptor] or initial bound/free [radioligand] ratio.  In this study, we present the theor. basis for detg. the K i for a competitive inhibitor in a new protocol at high [protein] and high [radioligand] with the simple Cheng-Prusoff correction without the need to correct for [receptor] or initial bound/free [radioligand] ratio.  In addn., we present results on the binding of the ultra-high-affinity ligand [3H]spiperone to dopamine D2 and D3 receptors validating the K i values calcd. with the new protocol for competitive inhibitors as compared with those calcd. with the most comprehensive equation available to date, that of .  Binding was measured at varying [radioligand] and [receptor], test compds. (including (-)5-OH-DPAT, (±)7-OH-DPAT, and ropinirole) were run with varying [receptor], and simulations were done at vastly varying [radioligand] for inhibitors with vastly different K is.  The modified high [radioligand] protocol presented here removes a major hindrance in the proper execution of binding assays with ultra-high-affinity tritiated ligands with K d values in the sub-nanomolar range, allowing the use of 96-well plates with small vols. of 100-200 μl per binding assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2qiImQ-s3ErVg90H21EOLACvtfcHk0ljkt7uiXIbywg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKlu7c%253D&md5=ba058c5367570106bc335eddc32bc8ab</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2010.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2010.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DConcentration%2520of%2520receptor%2520and%2520ligand%2520revisited%2520in%2520a%2520modified%2520receptor%2520binding%2520protocol%2520for%2520high-affinity%2520radioligands%253A%2520%255B3H%255DSpiperone%2520binding%2520to%2520D2%2520and%2520D3%2520dopamine%2520receptors%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2010%26volume%3D188%26spage%3D32%26epage%3D38%26doi%3D10.1016%2Fj.jneumeth.2010.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopishetty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Further delineation of hydrophobic binding sites in dopamine D(2)/D(3) receptors for N-4 substituents on the piperazine ring of the hybrid template 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthale n-2-ol</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5661</span><span class="NLM_x">–</span> <span class="NLM_lpage">5674</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.bmc.2010.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5661-5674&author=B.+Ghoshauthor=T.+Antonioauthor=B.+Gopishettyauthor=M.+Reithauthor=A.+Dutta&title=Further+delineation+of+hydrophobic+binding+sites+in+dopamine+D%282%29%2FD%283%29+receptors+for+N-4+substituents+on+the+piperazine+ring+of+the+hybrid+template+5%2F7-%7B%5B2-%284-aryl-piperazin-1-yl%29-ethyl%5D-propyl-amino%7D-5%2C6%2C7%2C8-tetrahydro-naphthale+n-2-ol&doi=10.1016%2Fj.bmc.2010.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DGopishetty%26aufirst%3DB.%26aulast%3DReith%26aufirst%3DM.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DFurther%2520delineation%2520of%2520hydrophobic%2520binding%2520sites%2520in%2520dopamine%2520D%25282%2529%252FD%25283%2529%2520receptors%2520for%2520N-4%2520substituents%2520on%2520the%2520piperazine%2520ring%2520of%2520the%2520hybrid%2520template%25205%252F7-%257B%255B2-%25284-aryl-piperazin-1-yl%2529-ethyl%255D-propyl-amino%257D-5%252C6%252C7%252C8-tetrahydro-naphthale%2520n-2-ol%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5661%26epage%3D5674%26doi%3D10.1016%2Fj.bmc.2010.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Das, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Dopamine d3 agonists in the treatment of Parkinson’s disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">926</span><span class="refDoi"> DOI: 10.2174/156802661510150328223428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.2174%2F156802661510150328223428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=25832718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1akt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=908-926&author=B.+Dasauthor=G.+Modiauthor=A.+Dutta&title=Dopamine+d3+agonists+in+the+treatment+of+Parkinson%E2%80%99s+disease&doi=10.2174%2F156802661510150328223428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 Agonists in the Treatment of Parkinson's Disease</span></div><div class="casAuthors">Das, Banibrata; Modi, Gyan; Dutta, Aloke</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">908-926</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is t he second most common form of neurodegenerative disorders that results from the progressive loss of dopaminergic neurons in the midbrain substantia nigra pars compacta (SNpc) triggering profound motor perturbation, as well as cognitive, sensory and mood deficits.  Although these symptoms can be improved using currently available dopamine replacement strategies, they are not able to slow the neurodegenerative process that underlies PD progression.  Following the discovery of the D3 receptor from mol. cloning, it has gained much attention as a potential therapeutic target for the treatment of PD due to their localization in the limbic regions of the brain as well as pharmacol. similarity to the D2 receptor subtype.  Of particular interest, D3 receptor- selective agonists appear to have neuroprotective effects apart from their ability to relieve PD symptoms.  Owing to the distinct significance of D3 receptor in mediating diverse neurol. effects, it represents a unique target for therapeutic intervention in PD with much less undesirable side effects.  Herein, we review progress in the development of D3 receptor selective agonist mols. having a broad spectrum of affinities, selectivities as well as unique pharmacol. properties directed at slowing the neurodegeneration process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vO7t50SK9rVg90H21EOLACvtfcHk0ljdguGG3skDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1akt7w%253D&md5=46885592d050d099cbad73ba7ef8e61b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F156802661510150328223428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802661510150328223428%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DB.%26aulast%3DModi%26aufirst%3DG.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DDopamine%2520d3%2520agonists%2520in%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D908%26epage%3D926%26doi%3D10.2174%2F156802661510150328223428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Tadori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuade, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span> </span><span class="NLM_article-title">Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">607</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2009.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.ejphar.2009.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=19217900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=607&publication_year=2009&pages=35-40&author=Y.+Tadoriauthor=R.+A.+Forbesauthor=R.+D.+McQuadeauthor=T.+Kikuchi&title=Receptor+reserve-dependent+properties+of+antipsychotics+at+human+dopamine+D2+receptors&doi=10.1016%2Fj.ejphar.2009.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors</span></div><div class="casAuthors">Tadori, Yoshihiro; Forbes, Robert A.; McQuade, Robert D.; Kikuchi, Tetsuro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">607</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">35-40</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aripiprazole is the first dopamine D2/D3 receptor partial agonist approved for use in the treatment of psychiatric disorders including schizophrenia, bipolar disorder, and unipolar depression in the US.  Aripiprazole has demonstrated a relatively favorable side effect profile compared to other commonly prescribed antipsychotics, including a low propensity for treatment-limiting extrapyramidal symptoms, hyperprolactinemia, and body wt. gain.  In an effort to elucidate aripiprazole's pharmacol. activity in relation to clin. relevant fluctuation of dopamine D2 receptor reserves, we compared the properties of aripiprazole to other antipsychotics, quetiapine, clozapine, olanzapine, ziprasidone, risperidone and haloperidol, a dopamine D2 receptor partial agonist, bifeprunox, dopamine D3 receptor modulators, BP897 (N-[4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl]naphthalene-2-carboxamide) and GR103691 (4'-Acetyl-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]biphenyl-4-carboxamide), and a 5-HT1A partial agonist, buspirone using forskolin-stimulated cAMP accumulation in clonal Chinese hamster ovary cell lines expressing low and high densities of human dopamine D2S receptors (hD2S-Low and hD2S-High, resp.).  In hD2S-Low cells lacking receptor reserves for dopamine, all drugs antagonized dopamine responses, and their potencies correlated well with resp. affinities.  In hD2S-High cells possessing receptor reserves, all antipsychotics except aripiprazole antagonized dopamine responses, and their antagonist potencies were less than those in hD2S-Low cells treated with the equal dopamine concn.  In contrast, aripiprazole and bifeprunox acted as full agonists.  BP897, GR103691 and buspirone acted as partial agonists.  These data suggest that the level of receptor reserves influences antagonist potencies and side effects assocd. with antipsychotics.  Aripiprazole's unique receptor reserve dependent properties may account for its favorable tolerability in the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofSL8HTaf5hrVg90H21EOLACvtfcHk0ljdguGG3skDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFWltr4%253D&md5=e1f85ac39e7fad2e3ab36e9ae33feebb</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DTadori%26aufirst%3DY.%26aulast%3DForbes%26aufirst%3DR.%2BA.%26aulast%3DMcQuade%26aufirst%3DR.%2BD.%26aulast%3DKikuchi%26aufirst%3DT.%26atitle%3DReceptor%2520reserve-dependent%2520properties%2520of%2520antipsychotics%2520at%2520human%2520dopamine%2520D2%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D607%26spage%3D35%26epage%3D40%26doi%3D10.1016%2Fj.ejphar.2009.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Reith, M. E. A.; Zhen, J.; Antonio, T.; Jacob, J. C.; Grandy, D.; Dutta, A. K.; Selley, D. E.</span><span> </span><span class="NLM_article-title">Influence of aromatic moieties linked to piperazine ring of tetrahydrobenzo[<i>d</i>]-thiazole based hybrid compounds impacts efficacy of dopamine D2/D3 agonists at D3 receptors</span>. <span class="NLM_conf-name">Society for Neuroscience Meeting</span>, <span class="NLM_conf-loc">Chicago</span>, <span class="NLM_conf-date">October 17–21, 2015</span>; in: abstract viewer and itinerary planner, Society for Neuroscience, online, no. 678.04.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Reith%2C+M.+E.+A.%3B+Zhen%2C+J.%3B+Antonio%2C+T.%3B+Jacob%2C+J.+C.%3B+Grandy%2C+D.%3B+Dutta%2C+A.+K.%3B+Selley%2C+D.+E.+Influence+of+aromatic+moieties+linked+to+piperazine+ring+of+tetrahydrobenzo%5Bd%5D-thiazole+based+hybrid+compounds+impacts+efficacy+of+dopamine+D2%2FD3+agonists+at+D3+receptors.+Society+for+Neuroscience+Meeting%2C+Chicago%2C+October+17%E2%80%9321%2C+2015%3B+in%3A+abstract+viewer+and+itinerary+planner%2C+Society+for+Neuroscience%2C+online%2C+no.+678.04."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26atitle%3DInfluence%2520of%2520aromatic%2520moieties%2520linked%2520to%2520piperazine%2520ring%2520of%2520tetrahydrobenzo%255Bd%255D-thiazole%2520based%2520hybrid%2520compounds%2520impacts%2520efficacy%2520of%2520dopamine%2520D2%252FD3%2520agonists%2520at%2520D3%2520receptors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Sally, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsin, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuvelis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span> </span><span class="NLM_article-title">Identification of a novel ″almost neutral″ micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1002/syn.20723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fsyn.20723" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2010&pages=280-288&author=E.+J.+Sallyauthor=H.+Xuauthor=C.+M.+Derschauthor=L.+W.+Hsinauthor=L.+T.+Changauthor=T.+E.+Prisinzanoauthor=D.+S.+Simpsonauthor=D.+Giuvelisauthor=K.+C.+Riceauthor=A.+E.+Jacobsonauthor=K.+Chengauthor=E.+J.+Bilskyauthor=R.+B.+Rothman&title=Identification+of+a+novel+%E2%80%B3almost+neutral%E2%80%B3+micro-opioid+receptor+antagonist+in+CHO+cells+expressing+the+cloned+human+mu-opioid+receptor&doi=10.1002%2Fsyn.20723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20723%26sid%3Dliteratum%253Aachs%26aulast%3DSally%26aufirst%3DE.%2BJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26aulast%3DChang%26aufirst%3DL.%2BT.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DSimpson%26aufirst%3DD.%2BS.%26aulast%3DGiuvelis%26aufirst%3DD.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DJacobson%26aufirst%3DA.%2BE.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DBilsky%26aufirst%3DE.%2BJ.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26atitle%3DIdentification%2520of%2520a%2520novel%2520%25E2%2580%25B3almost%2520neutral%25E2%2580%25B3%2520micro-opioid%2520receptor%2520antagonist%2520in%2520CHO%2520cells%2520expressing%2520the%2520cloned%2520human%2520mu-opioid%2520receptor%26jtitle%3DSynapse%26date%3D2010%26volume%3D64%26spage%3D280%26epage%3D288%26doi%3D10.1002%2Fsyn.20723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindqvist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, T.</span><span> </span><span class="NLM_article-title">3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="refDoi"> DOI: 10.1038/1801200a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2F1801200a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=13483658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaG1cXis1Kjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=1957&pages=1200&author=A.+Carlssonauthor=M.+Lindqvistauthor=T.+Magnusson&title=3%2C4-Dihydroxyphenylalanine+and+5-hydroxytryptophan+as+reserpine+antagonists&doi=10.1038%2F1801200a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists</span></div><div class="casAuthors">Carlsson, Arvid; Lindqvist, Margit; Magnusson, Tor</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1200</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Male mice, 16 hrs. after reserpine injection, markedly tranquillized and showing complete ptosis of the eyelid, were intraperitoneally injected with 5-hydroxytryptophan (I), 3,4-dihydroxyphenylalanine (II), or a mixt. of both amino acids (DL-form).  In doses up to 1000 mg./kg. I was unable to antagonize the tranquillizing action of reserpine.  Response to an injection of 500-1000 mg./kg. of II was dramatic.  The animals resumed normal behavior and ptosis disappeared within 15-30 min.  The effect lasted approx. 1 hr. followed by return to the former tranquillized condition.  Equal amts., 250-500 mg./kg., of I and II injected at the same time produced a more complete and longer-lasting effect than did II alone.  Intravenous injection of II (200 mg./kg.) in rabbits was very effective in overcoming the effect of reserpine injection.  Tranquillization as well as ptosis and meiosis disappeared within 10-15 min. after injection of II.  Injection of iproniazid (100 mg./kg.) 2 hrs. prior to injection of II markedly reduced the amt. of II needed to overcome the effects of reserpine, however, it had no effect without II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5al1bdzjz_LVg90H21EOLACvtfcHk0lj6Wa5hC9KMzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXis1Kjuw%253D%253D&md5=72d0b819b514e9db1e2707b5d230fb2e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2F1801200a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1801200a0%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindqvist%26aufirst%3DM.%26aulast%3DMagnusson%26aufirst%3DT.%26atitle%3D3%252C4-Dihydroxyphenylalanine%2520and%25205-hydroxytryptophan%2520as%2520reserpine%2520antagonists%26jtitle%3DNature%26date%3D1957%26volume%3D180%26spage%3D1200%26doi%3D10.1038%2F1801200a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Skalisz, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijamini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joca, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vital, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Cunha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreatini, R.</span><span> </span><span class="NLM_article-title">Evaluation of the face validity of reserpine administration as an animal model of depression--Parkinson’s disease association</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">883</span><span class="refDoi"> DOI: 10.1016/S0278-5846(01)00333-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0278-5846%2801%2900333-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12369260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVCitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2002&pages=879-883&author=L.+L.+Skaliszauthor=V.+Beijaminiauthor=S.+L.+Jocaauthor=M.+A.+Vitalauthor=C.+Da+Cunhaauthor=R.+Andreatini&title=Evaluation+of+the+face+validity+of+reserpine+administration+as+an+animal+model+of+depression%2D%2DParkinson%E2%80%99s+disease+association&doi=10.1016%2FS0278-5846%2801%2900333-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the face validity of reserpine administration as an animal model of depression-Parkinson's disease association</span></div><div class="casAuthors">Skalisz, Luana L.; Beijamini, Vanessa; Joca, Samia L.; Vital, Maria A. B. F.; Da Cunha, Claudio; Andreatini, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">879-883</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aim of the present study was to develop an animal model for the study of depressive symptoms assocd. with Parkinson's disease (PD).  Mice treated i.p. with reserpine (RES), 2.0 and 1.0 mg/kg, or its vehicle (VEHIC) were submitted to the sucrose soln. (2%) consumption test (a model employed to mimic the depressive symptoms found in PD) and to the spontaneous locomotor activity test (a model employed to mimic the motor impairment found in PD).  All animals were submitted to both tests.  Twenty-four hours after treatment, only RES 2.0-treated animals showed a significantly decreased preference for the sucrose soln. (mean ± S.E.M. RES 2.0=54.4±4.1%, RES 1.0=68.5±2.5%, VEHIC=62.3±4.1%).  There was no significant difference among groups in water, sucrose or total fluid consumption.  Locomotor activity was significantly decreased by both RES doses (no. of beam interruptions: RES 2.0=59.9±11.4, RES 1.0=82.2±9.7, VEHIC=116.8±8.2).  Thus, RES 2.0 administration to mice induced depressive (anhedonia) and motor (decreased locomotor activity) symptoms of depression-PD assocn.  This suggests that the RES model shows an important aspect of face validity for the depressive state assocd. with PD, i.e., phenomenol. similarities between the model and the situation being modeled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx-zmSPZjpsrVg90H21EOLACvtfcHk0lj6Wa5hC9KMzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVCitb4%253D&md5=4e91964eed89eeab89a6ddb82cdd17db</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0278-5846%2801%2900333-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0278-5846%252801%252900333-5%26sid%3Dliteratum%253Aachs%26aulast%3DSkalisz%26aufirst%3DL.%2BL.%26aulast%3DBeijamini%26aufirst%3DV.%26aulast%3DJoca%26aufirst%3DS.%2BL.%26aulast%3DVital%26aufirst%3DM.%2BA.%26aulast%3DDa%2BCunha%26aufirst%3DC.%26aulast%3DAndreatini%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520the%2520face%2520validity%2520of%2520reserpine%2520administration%2520as%2520an%2520animal%2520model%2520of%2520depression--Parkinson%25E2%2580%2599s%2520disease%2520association%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2002%26volume%3D26%26spage%3D879%26epage%3D883%26doi%3D10.1016%2FS0278-5846%2801%2900333-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissou, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benabid, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verna, J. M.</span><span> </span><span class="NLM_article-title">Extracellular toxicity of 6-hydroxydopamine on PC12 cells</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1016/S0304-3940(00)00948-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0304-3940%2800%2900948-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2000&pages=193-196&author=D.+Blumauthor=S.+Torchauthor=M.+F.+Nissouauthor=A.+L.+Benabidauthor=J.+M.+Verna&title=Extracellular+toxicity+of+6-hydroxydopamine+on+PC12+cells&doi=10.1016%2FS0304-3940%2800%2900948-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2800%2900948-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252800%252900948-4%26sid%3Dliteratum%253Aachs%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DTorch%26aufirst%3DS.%26aulast%3DNissou%26aufirst%3DM.%2BF.%26aulast%3DBenabid%26aufirst%3DA.%2BL.%26aulast%3DVerna%26aufirst%3DJ.%2BM.%26atitle%3DExtracellular%2520toxicity%2520of%25206-hydroxydopamine%2520on%2520PC12%2520cells%26jtitle%3DNeurosci.%2520Lett.%26date%3D2000%26volume%3D283%26spage%3D193%26epage%3D196%26doi%3D10.1016%2FS0304-3940%2800%2900948-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermida-Ameijeiras, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Patino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labandeira-Garcia, J. L.</span><span> </span><span class="NLM_article-title">Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0741605.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1046%2Fj.1471-4159.2000.0741605.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10737618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVegtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=1605-1612&author=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Hermida-Ameijeirasauthor=A.+M.+Munoz-Patinoauthor=J.+L.+Labandeira-Garcia&title=Autoxidation+and+neurotoxicity+of+6-hydroxydopamine+in+the+presence+of+some+antioxidants%3A+potential+implication+in+relation+to+the+pathogenesis+of+Parkinson%E2%80%99s+disease&doi=10.1046%2Fj.1471-4159.2000.0741605.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Hermida-Ameijeiras, Alvaro; Munoz-Patino, Ana Maria; Labandeira-Garcia, Jose Luis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">6-Hydroxydopamine (6-OHDA) is a dopaminergic neurotoxin putatively involved in the pathogenesis of Parkinson's disease (PD).  Its neurotoxicity has been related to the prodn. of reactive oxygen species.  In this study, the authors examine the effects of the antioxidants ascorbic acid (AA), glutathione (GSH), cysteine (CySH), and N-acetyl-CySH (NAC) on the autoxidn. and neurotoxicity of 6-OHDA.  In vitro, the autoxidn. of 6-OHDA proceeds rapidly with the formation of H2O2 and with the participation of the H2O2 produced in the reaction.  The presence of AA induced a redn. in the consumption of O2 during the autoxidn. of 6-OHDA and a negligible presence of the p-quinone, which demonstrates the efficiency of AA to act as a redox cycling agent.  The presence of GSH, CySH, and NAC produced a significant redn. in the autoxidn. of 6-OHDA.  In vivo, the presence of sulfhydryl antioxidants protected against neuronal degeneration in the striatum, which was particularly remarkable in the case of CySH and was attributed to its capacity to remove the H2O2 produced in the autoxidn. of 6-OHDA.  These results corroborate the involvement of oxidative stress as the major mechanism in the neurotoxicity of 6-OHDA and the putative role of CySH as a scavenger in relation to PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWrhSqHMH12bVg90H21EOLACvtfcHk0lj6Wa5hC9KMzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVegtbc%253D&md5=a2466276b0c39d97aa728c7f1beb5fc1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0741605.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0741605.x%26sid%3Dliteratum%253Aachs%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DHermida-Ameijeiras%26aufirst%3DA.%26aulast%3DMunoz-Patino%26aufirst%3DA.%2BM.%26aulast%3DLabandeira-Garcia%26aufirst%3DJ.%2BL.%26atitle%3DAutoxidation%2520and%2520neurotoxicity%2520of%25206-hydroxydopamine%2520in%2520the%2520presence%2520of%2520some%2520antioxidants%253A%2520potential%2520implication%2520in%2520relation%2520to%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D1605%26epage%3D1612%26doi%3D10.1046%2Fj.1471-4159.2000.0741605.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Bardiot, D.; Carlens, G.; Dallmeier, K.; Kaptein, S.; McNaughton, M.; Marchand, A.; Neyts, J.; Smets, W.</span><span> </span><span class="NLM_article-title">1,2-Amino-1-(indolyl)ethanone derivatives as viral replication inhibitors and their preparation of Flaviviridae infections</span>. PCT Int. Appl. WO2013045516,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+Bardiot&author=G.+Carlens&author=K.+Dallmeier&author=S.+Kaptein&author=M.+McNaughton&author=A.+Marchand&author=J.+Neyts&author=W.+Smets&title=1%2C2-Amino-1-%28indolyl%29ethanone+derivatives+as+viral+replication+inhibitors+and+their+preparation+of+Flaviviridae+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBardiot%26aufirst%3DD.%26atitle%3D1%252C2-Amino-1-%2528indolyl%2529ethanone%2520derivatives%2520as%2520viral%2520replication%2520inhibitors%2520and%2520their%2520preparation%2520of%2520Flaviviridae%2520infections%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crossman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocco, M.</span><span> </span><span class="NLM_article-title">S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1124/jpet.103.062414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1124%2Fjpet.103.062414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=14978195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=921-935&author=M.+J.+Millanauthor=B.+Di+Caraauthor=M.+Hillauthor=M.+Jacksonauthor=J.+N.+Joyceauthor=J.+Brotchieauthor=S.+McGuireauthor=A.+Crossmanauthor=L.+Smithauthor=P.+Jennerauthor=A.+Gobertauthor=J.+L.+Peglionauthor=M.+Brocco&title=S32504%2C+a+novel+naphtoxazine+agonist+at+dopamine+D3%2FD2+receptors%3A+II.+Actions+in+rodent%2C+primate%2C+and+cellular+models+of+antiparkinsonian+activity+in+comparison+to+ropinirole&doi=10.1124%2Fjpet.103.062414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">S32504, a novel naphthoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole</span></div><div class="casAuthors">Millan, Mark J.; Di Cara, Benjamin; Hill, Michael; Jackson, Michael; Joyce, Jeffrey N.; Brotchie, Jonathan; McGuire, Steve; Crossman, Alan; Smith, Lance; Jenner, Peter; Gobert, Alain; Peglion, Jean-Louis; Brocco, Mauricette</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">921-935</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">These studies evaluated the potential antiparkinsonian properties of the novel dopamine D3/D2 receptor agonist S32504 [(+)-trans-3,4,4a,5,6,10b-hexahydro-9-carbamoyl-4-propyl-2H-naphth[1,2-b]-1,4-oxazine] in comparison with those of the clin. employed agonist ropinirole.  In rats with a unilateral, 6-hydroxydopamine lesion of the substantia nigra, S32504 (0.0025-0.04 mg/kg, s.c.) more potently elicited contralateral rotation than S32601 [(-)-trans-3,4,4a,5,6,10b-hexahydro-9-carbamoyl-4-propyl-2H-naphth-[1,2-b]-1,4-oxazine (its less active enantiomer)], ropinirole, and L-3,4-dihydroxyphenylalanine (L-DOPA).  Rotation elicited by S32504 was blocked by the D2/D3 receptor antagonists haloperidol and raclopride and by the D2 antagonist L741,626 [4-(4-chlorophenyl)-1-(1H-indol-3-yl-methyl)piperidin-4-ol], but not by the D3 antagonist S33084 [(3aR,9bS)-N-[4-(8-cyano-1,3a,4,9b-tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2-yl)-butyl]-(4-phenyl)benzamide].  As assessed by dialysis in both lesioned and nonlesioned animals, S32504 (0.04-2.5 mg/kg, s.c.) reduced striatal levels of acetylcholine.  This effect was blocked by raclopride, haloperidol, and L741,626 but not S33084.  In rats treated with reserpine, hypolocomotion was reversed by S32504 and, less potently, by ropinirole.  In "unprimed" marmosets treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, both s.c. (0.01-0.04 mg/kg) and p.o. (0.04-1.25 mg/kg) administration of S32504 dose-dependently and rapidly (within 10 min) increased locomotor activity and reduced disability.  Furthermore, S32504 dose-dependently reversed bradykinesia and improved posture in "L-DOPA-primed" animals, whereas eliciting less pronounced dyskinesia than L-DOPA.  Finally, in terminally differentiated SHSY5Y cells presenting a dopaminergic phenotype, S32504, but not S32601, abrogated the neurotoxic effects of 1-methyl-4-phenylpyridinium, an action inhibited by raclopride and S33084 but not L741,626.  Ropinirole was weakly neuroprotective in this model.  In conclusion, S32504 displays potent and stereospecific activity in rodent, primate, and cellular models of antiparkinsonian properties.  Although activation of D2 receptors is crucial to the motor actions of S32504, engagement of D3 receptors contributes to its neuroprotective properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMwGUJPMC4erVg90H21EOLACvtfcHk0ligk95wHvmHiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCnsbw%253D&md5=5854c162ece5869dfc437b6c54e70a95</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062414%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BCara%26aufirst%3DB.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DM.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26aulast%3DBrotchie%26aufirst%3DJ.%26aulast%3DMcGuire%26aufirst%3DS.%26aulast%3DCrossman%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DPeglion%26aufirst%3DJ.%2BL.%26aulast%3DBrocco%26aufirst%3DM.%26atitle%3DS32504%252C%2520a%2520novel%2520naphtoxazine%2520agonist%2520at%2520dopamine%2520D3%252FD2%2520receptors%253A%2520II.%2520Actions%2520in%2520rodent%252C%2520primate%252C%2520and%2520cellular%2520models%2520of%2520antiparkinsonian%2520activity%2520in%2520comparison%2520to%2520ropinirole%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D921%26epage%3D935%26doi%3D10.1124%2Fjpet.103.062414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">McCall, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lookingland, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, R. M.</span><span> </span><span class="NLM_article-title">Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson’s disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">1248</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span><span class="refDoi"> DOI: 10.1124/jpet.105.084202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1124%2Fjpet.105.084202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=15980060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1248-1256&author=R.+B.+McCallauthor=K.+J.+Lookinglandauthor=P.+J.+Bedardauthor=R.+M.+Huff&title=Sumanirole%2C+a+highly+dopamine+D2-selective+receptor+agonist%3A+in+vitro+and+in+vivo+pharmacological+characterization+and+efficacy+in+animal+models+of+Parkinson%E2%80%99s+disease&doi=10.1124%2Fjpet.105.084202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Sumanirole, a highly dopamine D2-selective receptor agonist: In vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease</span></div><div class="casAuthors">McCall, Robert B.; Lookingland, Keith J.; Bedard, Paul J.; Huff, Rita M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1248-1256</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The purpose of this study is to demonstrate that sumanirole is a novel dopamine receptor agonist with high in vitro and in vivo selectivity for the D2 receptor subtype.  Sumanirole, (R)-5,6-dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Z)-2-butenedioate (1:1), is unique; it has greater than 200-fold selectivity for the D2 receptor subtype vs. the other dopamine receptor subtypes in radioligand binding assays.  In cell-based assays, sumanirole is a fully efficacious agonist, with EC50 values between 17 and 75 nM.  In animals, sumanirole elicits many physiol. responses attributed to D2-like receptor function.  In rats, sumanirole is a full agonist for elevation of striatal acetylcholine levels (ED50 = 12.1 μmol/kg i.p.).  Sumanirole s.c. dose dependently decreased plasma prolactin levels and depressed dopamine neuron firing rates in the substantia nigra pars compacta with an ED50 of 2.3 μmol/kg i.v.  This high selectivity for D2 receptors translates into excellent locomotor stimulant activity in animal models of Parkinson's disease.  In reserpinized, α-methyl-para-tyrosine-treated rats, sumanirole caused a significant and sustained increase in horizontal activity at doses ≥12.5 μmol/kg s.c.  In unilateral 6-hydroxydopamine-lesioned rats, sumanirole caused profound, sustained rotational behavior and was substantially more efficacious than any other agonist tested.  Sumanirole-stimulated rotational behavior was blocked by the dopamine receptor antagonist haloperidol.  Sumanirole dose dependently improved disability scores and locomotor activities of two of three 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned monkeys.  In summary, sumanirole is the first published selective D2 receptor agonist.  The compd. has activity in animal models of dopamine hypofunction and has a high level of efficacy in animal models of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxa0W5oALaLbVg90H21EOLACvtfcHk0ligk95wHvmHiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLc%253D&md5=792585b571abe46c833a2238ab9213ae</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.084202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.084202%26sid%3Dliteratum%253Aachs%26aulast%3DMcCall%26aufirst%3DR.%2BB.%26aulast%3DLookingland%26aufirst%3DK.%2BJ.%26aulast%3DBedard%26aufirst%3DP.%2BJ.%26aulast%3DHuff%26aufirst%3DR.%2BM.%26atitle%3DSumanirole%252C%2520a%2520highly%2520dopamine%2520D2-selective%2520receptor%2520agonist%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%2520and%2520efficacy%2520in%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1248%26epage%3D1256%26doi%3D10.1124%2Fjpet.105.084202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylene Group, Friend or Foe in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5625-5663. <a href="https://doi.org/10.1021/acs.jmedchem.9b01617" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01617%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcetylene%252BGroup%25252C%252BFriend%252Bor%252BFoe%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29092019%26date%3D19022020%26date%3D07022020%26volume%3D63%26issue%3D11%26spage%3D5625%26epage%3D5663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabio Del Bello, Dario Ambrosini, Alessandro Bonifazi, Amy H. Newman, Thomas M. Keck, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Loredana Cappellacci, Antonio Cilia, Silvia Franchini, <span class="NLM_string-name hlFld-ContribAuthor">Wilma Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson’s Disease or Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 2222-2228. <a href="https://doi.org/10.1021/acschemneuro.8b00677" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00677</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00677%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMultitarget%252B1%25252C4-Dioxane%252BCompounds%252BCombining%252BFavorable%252BD2-like%252Band%252B5-HT1A%252BReceptor%252BInteractions%252Bwith%252BPotential%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%252Bor%252BSchizophrenia%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D06122018%26date%3D04012019%26date%3D09012019%26date%3D04012019%26volume%3D10%26issue%3D5%26spage%3D2222%26epage%3D2228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Asma Elmabruk, Banibrata Das, Deepthi Yedlapudi, Liping Xu, Tamara Antonio, Maarten E. A. Reith, <span class="NLM_string-name hlFld-ContribAuthor">Aloke K. Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 396-411. <a href="https://doi.org/10.1021/acschemneuro.8b00291" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00291%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BCharacterization%252Bof%252BCarbazole%252BBased%252BDopamine%252BAgonists%252Bas%252BPotential%252BSymptomatic%252Band%252BNeuroprotective%252BTherapeutic%252BAgents%252Bfor%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DElmabruk%26aufirst%3DAsma%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18062018%26date%3D09102018%26date%3D24102018%26date%3D09102018%26volume%3D10%26issue%3D1%26spage%3D396%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Banibrata  Das</span>, <span class="hlFld-ContribAuthor ">Ashoka  Kandegedara</span>, <span class="hlFld-ContribAuthor ">Liping  Xu</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Timothy  Stemmler</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, and <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 723-730. <a href="https://doi.org/10.1021/acschemneuro.6b00356" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00356%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BNovel%252BIron%252528II%252529%252BPreferring%252BDopamine%252BAgonist%252BChelator%252Bas%252BPotential%252BSymptomatic%252Band%252BNeuroprotective%252BTherapeutic%252BAgent%252Bfor%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DDas%26aufirst%3DBanibrata%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D19102016%26date%3D20012017%26date%3D27012017%26date%3D19042017%26date%3D20012017%26volume%3D8%26issue%3D4%26spage%3D723%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaozhao  Wang</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Tocker</span>, <span class="hlFld-ContribAuthor ">Peng  Huang</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Lee-Yuan  Liu-Chen</span>, <span class="hlFld-ContribAuthor ">Amos B.  Smith, III</span>, and <span class="hlFld-ContribAuthor ">Sandhya  Kortagere</span>  . </span><span class="cited-content_cbyCitation_article-title">Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 486-500. <a href="https://doi.org/10.1021/acschemneuro.6b00221" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00221%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DFunctional%252BCharacterization%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BBiased%252BSignaling%252BDopamine%252BD3%252BReceptor%252BAgonists%26aulast%3DXu%26aufirst%3DWei%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29072016%26date%3D01112016%26date%3D23112016%26date%3D15032017%26date%3D01112016%26volume%3D8%26issue%3D3%26spage%3D486%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Jin</span>, <span class="hlFld-ContribAuthor ">Dongbo  Guo</span>, <span class="hlFld-ContribAuthor ">Gangsheng  Tong</span>, and <span class="hlFld-ContribAuthor ">Xinyuan  Zhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Iron Chelation Nanoparticles with Delayed Saturation as an Effective Therapy for Parkinson Disease. </span><span class="cited-content_cbyCitation_journal-name">Biomacromolecules</span><span> <strong>2017,</strong> <em>18 </em>
                                    (2)
                                     , 461-474. <a href="https://doi.org/10.1021/acs.biomac.6b01547" title="DOI URL">https://doi.org/10.1021/acs.biomac.6b01547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biomac.6b01547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biomac.6b01547%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomacromolecules%26atitle%3DIron%252BChelation%252BNanoparticles%252Bwith%252BDelayed%252BSaturation%252Bas%252Ban%252BEffective%252BTherapy%252Bfor%252BParkinson%252BDisease%26aulast%3DWang%26aufirst%3DNan%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D20102016%26date%3D11122016%26date%3D29122016%26date%3D13022017%26date%3D19122016%26volume%3D18%26issue%3D2%26spage%3D461%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyan  Sheng</span>, <span class="hlFld-ContribAuthor ">Shuiyuan  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Wen</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongfeng  Ye</span>, <span class="hlFld-ContribAuthor ">Peng  Zhao</span>, <span class="hlFld-ContribAuthor ">Limin  Zang</span>, <span class="hlFld-ContribAuthor ">Kang  Peng</span>, <span class="hlFld-ContribAuthor ">Enming  Du</span>, <span class="hlFld-ContribAuthor ">Sai  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model. </span><span class="cited-content_cbyCitation_journal-name">Chinese Medicine</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13020-021-00429-y" title="DOI URL">https://doi.org/10.1186/s13020-021-00429-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13020-021-00429-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13020-021-00429-y%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Medicine%26atitle%3DNeuroprotective%252Beffects%252Bof%252BShende%2525E2%252580%252599an%252Btablet%252Bin%252Bthe%252BParkinson%2525E2%252580%252599s%252Bdisease%252Bmodel%26aulast%3DSheng%26aufirst%3DXiaoyan%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Cerri</span>, <span class="hlFld-ContribAuthor ">Fabio  Blandini</span>. </span><span class="cited-content_cbyCitation_article-title">An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2020,</strong> <em>21 </em>
                                    (18)
                                     , 2279-2291. <a href="https://doi.org/10.1080/14656566.2020.1805432" title="DOI URL">https://doi.org/10.1080/14656566.2020.1805432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2020.1805432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2020.1805432%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DAn%252Bupdate%252Bon%252Bthe%252Buse%252Bof%252Bnon-ergot%252Bdopamine%252Bagonists%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DCerri%26aufirst%3DSilvia%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D18%26spage%3D2279%26epage%3D2291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paweł  Sobczuk</span>, <span class="hlFld-ContribAuthor ">Michał  Łomiak</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Cudnoch-Jędrzejewska</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D1 Receptor in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (11)
                                     , 3232. <a href="https://doi.org/10.3390/cancers12113232" title="DOI URL">https://doi.org/10.3390/cancers12113232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12113232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12113232%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DDopamine%252BD1%252BReceptor%252Bin%252BCancer%26aulast%3DSobczuk%26aufirst%3DPawe%25C5%2582%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D11%26spage%3D3232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Mao</span>, <span class="hlFld-ContribAuthor ">Wang-zhi  Qin</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>, <span class="hlFld-ContribAuthor ">Na  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (4)
                                     , 471-482. <a href="https://doi.org/10.1038/s41401-020-0365-y" title="DOI URL">https://doi.org/10.1038/s41401-020-0365-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-0365-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-0365-y%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DRecent%252Badvances%252Bin%252Bdopaminergic%252Bstrategies%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DMao%26aufirst%3DQi%26date%3D2020%26date%3D2020%26volume%3D41%26issue%3D4%26spage%3D471%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Su</span>, <span class="hlFld-ContribAuthor ">Zixi  Xue</span>, <span class="hlFld-ContribAuthor ">Yaoyao  Feng</span>, <span class="hlFld-ContribAuthor ">Ying  Xie</span>, <span class="hlFld-ContribAuthor ">Bo  Deng</span>, <span class="hlFld-ContribAuthor ">Ye  Yao</span>, <span class="hlFld-ContribAuthor ">Xiuyun  Tian</span>, <span class="hlFld-ContribAuthor ">Qiming  An</span>, <span class="hlFld-ContribAuthor ">Liang  Yang</span>, <span class="hlFld-ContribAuthor ">Qingyu  Yao</span>, <span class="hlFld-ContribAuthor ">Junsheng  Xue</span>, <span class="hlFld-ContribAuthor ">Guoshu  Chen</span>, <span class="hlFld-ContribAuthor ">Chunyi  Hao</span>, <span class="hlFld-ContribAuthor ">Tianyan  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1DR activation. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2019,</strong> <em>384 </em>, 114789. <a href="https://doi.org/10.1016/j.taap.2019.114789" title="DOI URL">https://doi.org/10.1016/j.taap.2019.114789</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2019.114789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2019.114789%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DN-arylpiperazine-containing%252Bcompound%252B%252528C2%252529%25253A%252BAn%252Benhancer%252Bof%252Bsunitinib%252Bin%252Bthe%252Btreatment%252Bof%252Bpancreatic%252Bcancer%25252C%252Binvolving%252BD1DR%252Bactivation%26aulast%3DSu%26aufirst%3DHong%26date%3D2019%26volume%3D384%26spage%3D114789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marlene  Jacobson</span>, <span class="hlFld-ContribAuthor ">Wayne  Childers</span>, <span class="hlFld-ContribAuthor ">Magid  Abou‐Gharbia</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D
              2
              Partial Agonists – Discovery, Evolution, and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 83-130. <a href="https://doi.org/10.1002/9783527814695.ch4" title="DOI URL">https://doi.org/10.1002/9783527814695.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527814695.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527814695.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DDopamine%252BD%252B2%252BPartial%252BAgonists%252B%2525E2%252580%252593%252BDiscovery%25252C%252BEvolution%25252C%252Band%252BTherapeutic%252BPotential%26aulast%3DJacobson%26aufirst%3DMarlene%26date%3D2019%26date%3D2019%26spage%3D83%26epage%3D130%26pub%3DWiley%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2019%26date%3D2019%26volume%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqian  Niu</span>, <span class="hlFld-ContribAuthor ">Jiejian  Chen</span>, <span class="hlFld-ContribAuthor ">Jianqing  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Pharmaceutical Sciences</span><span> <strong>2019,</strong> <em>14 </em>
                                    (5)
                                     , 480-496. <a href="https://doi.org/10.1016/j.ajps.2018.09.005" title="DOI URL">https://doi.org/10.1016/j.ajps.2018.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ajps.2018.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ajps.2018.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DNanocarriers%252Bas%252Ba%252Bpowerful%252Bvehicle%252Bto%252Bovercome%252Bblood-brain%252Bbarrier%252Bin%252Btreating%252Bneurodegenerative%252Bdiseases%25253A%252BFocus%252Bon%252Brecent%252Badvances%26aulast%3DNiu%26aufirst%3DXiaoqian%26date%3D2019%26volume%3D14%26issue%3D5%26spage%3D480%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marianna  Tosato</span>, <span class="hlFld-ContribAuthor ">Valerio  Di Marco</span>. </span><span class="cited-content_cbyCitation_article-title">Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (7)
                                     , 269. <a href="https://doi.org/10.3390/biom9070269" title="DOI URL">https://doi.org/10.3390/biom9070269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9070269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9070269%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DMetal%252BChelation%252BTherapy%252Band%252BParkinson%2525E2%252580%252599s%252BDisease%25253A%252BA%252BCritical%252BReview%252Bon%252Bthe%252BThermodynamics%252Bof%252BComplex%252BFormation%252Bbetween%252BRelevant%252BMetal%252BIons%252Band%252BPromising%252Bor%252BEstablished%252BDrugs%26aulast%3DTosato%26aufirst%3DMarianna%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D7%26spage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Metehan  Ilter</span>, <span class="hlFld-ContribAuthor ">Samman  Mansoor</span>, <span class="hlFld-ContribAuthor ">Ozge  Sensoy</span>. </span><span class="cited-content_cbyCitation_article-title">Utilization of Biased G Protein-Coupled Receptor Signaling towards Development of Safer and Personalized Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (11)
                                     , 2052. <a href="https://doi.org/10.3390/molecules24112052" title="DOI URL">https://doi.org/10.3390/molecules24112052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24112052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24112052%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DUtilization%252Bof%252BBiased%252BG%252BProtein-Coupled%252BReceptor%252BSignaling%252Btowards%252BDevelopment%252Bof%252BSafer%252Band%252BPersonalized%252BTherapeutics%26aulast%3DIlter%26aufirst%3DMetehan%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D11%26spage%3D2052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benhua  Zhou</span>, <span class="hlFld-ContribAuthor ">Kwon Ho  Hong</span>, <span class="hlFld-ContribAuthor ">Min  Ji</span>, <span class="hlFld-ContribAuthor ">Jin  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>92 </em>
                                    (3)
                                     , 1597-1609. <a href="https://doi.org/10.1111/cbdd.13324" title="DOI URL">https://doi.org/10.1111/cbdd.13324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13324%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bstructurally%252Bconstrained%252Bhybrid%252Banalogues%252Bcontaining%252Bropinirole%252Bmoiety%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252Band%252Bselective%252Bdopamine%252BD3%252Breceptor%252Bligands%26aulast%3DZhou%26aufirst%3DBenhua%26date%3D2018%26date%3D2018%26volume%3D92%26issue%3D3%26spage%3D1597%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anahid  Omran</span>, <span class="hlFld-ContribAuthor ">Shakiba  Eslamimehr</span>, <span class="hlFld-ContribAuthor ">A. Michael  Crider</span>, <span class="hlFld-ContribAuthor ">William L.  Neumann</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-(3-hydroxyphenyl)pyrrolidine dopamine D3 receptor ligands with extended functionality for probing the secondary binding pocket. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1897-1902. <a href="https://doi.org/10.1016/j.bmcl.2018.03.084" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252B3-%2525283-hydroxyphenyl%252529pyrrolidine%252Bdopamine%252BD3%252Breceptor%252Bligands%252Bwith%252Bextended%252Bfunctionality%252Bfor%252Bprobing%252Bthe%252Bsecondary%252Bbinding%252Bpocket%26aulast%3DOmran%26aufirst%3DAnahid%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1897%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benhua  Zhou</span>, <span class="hlFld-ContribAuthor ">Min  Ji</span>, <span class="hlFld-ContribAuthor ">Jin  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>77 </em>, 125-135. <a href="https://doi.org/10.1016/j.bioorg.2017.12.026" title="DOI URL">https://doi.org/10.1016/j.bioorg.2017.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2017.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2017.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbitopic%252Barylpiperazine-hexahydro-pyrazinoquinolines%252Bas%252Bpreferential%252Bdopamine%252BD3%252Breceptor%252Bligands%26aulast%3DZhou%26aufirst%3DBenhua%26date%3D2018%26volume%3D77%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy E.  Moritz</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2018,</strong> <em>41 </em>, 75-81. <a href="https://doi.org/10.1016/j.cellsig.2017.07.003" title="DOI URL">https://doi.org/10.1016/j.cellsig.2017.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2017.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2017.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DAdvances%252Band%252Bchallenges%252Bin%252Bthe%252Bsearch%252Bfor%252BD2%252Band%252BD3%252Bdopamine%252Breceptor-selective%252Bcompounds%26aulast%3DMoritz%26aufirst%3DAmy%2BE.%26date%3D2018%26volume%3D41%26spage%3D75%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Ligands in Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 477-508. <a href="https://doi.org/10.1002/9783527674381.ch16" title="DOI URL">https://doi.org/10.1002/9783527674381.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DMultiple%252BLigands%252Bin%252BNeurodegenerative%252BDiseases%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2017%26date%3D2017%26spage%3D477%26epage%3D508%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Valdman</span>, <span class="hlFld-ContribAuthor ">Inga  Kapitsa</span>, <span class="hlFld-ContribAuthor ">Еlena  Ivanova</span>, <span class="hlFld-ContribAuthor ">Tat`iana  Voronina</span>, <span class="hlFld-ContribAuthor ">Oleg  Ardashov</span>, <span class="hlFld-ContribAuthor ">Konstantin  Volcho</span>, <span class="hlFld-ContribAuthor ">Veniamin  Khazanov</span>, <span class="hlFld-ContribAuthor ">Nariman  Salakhutdinov</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of anti-parkinsonian activity of monoterpenoid (1 R ,2 R ,6 S )-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>815 </em>, 351-363. <a href="https://doi.org/10.1016/j.ejphar.2017.09.022" title="DOI URL">https://doi.org/10.1016/j.ejphar.2017.09.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2017.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2017.09.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DEvolution%252Bof%252Banti-parkinsonian%252Bactivity%252Bof%252Bmonoterpenoid%252B%2525281%252BR%252B%25252C2%252BR%252B%25252C6%252BS%252B%252529-3-methyl-6-%252528prop-1-en-2-yl%252529cyclohex-3-ene-1%25252C2-diol%252Bin%252Bvarious%252Bin%252Bvivo%252Bmodels%26aulast%3DValdman%26aufirst%3DElena%26date%3D2017%26volume%3D815%26spage%3D351%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Banibrata  Das</span>, <span class="hlFld-ContribAuthor ">Subramanian  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Gnanada S.  Joshi</span>, <span class="hlFld-ContribAuthor ">Liping  Xu</span>, <span class="hlFld-ContribAuthor ">Dan  Luo</span>, <span class="hlFld-ContribAuthor ">Julie K.  Andersen</span>, <span class="hlFld-ContribAuthor ">Sokol V.  Todi</span>, <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>123 </em>, 88-99. <a href="https://doi.org/10.1016/j.neuropharm.2017.05.019" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DA%252Bnovel%252Biron%252B%252528II%252529%252Bpreferring%252Bdopamine%252Bagonist%252Bchelator%252BD-607%252Bsignificantly%252Bsuppresses%252B%2525CE%2525B1-syn-%252Band%252BMPTP-induced%252Btoxicities%252Bin%2525C2%2525A0vivo%26aulast%3DDas%26aufirst%3DBanibrata%26date%3D2017%26volume%3D123%26spage%3D88%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudharshan  Madapa</span>, <span class="hlFld-ContribAuthor ">Satishkumar  Gadhiya</span>, <span class="hlFld-ContribAuthor ">Thomas  Kurtzman</span>, <span class="hlFld-ContribAuthor ">Ian L.  Alberts</span>, <span class="hlFld-ContribAuthor ">Steven  Ramsey</span>, <span class="hlFld-ContribAuthor ">Maarten  Reith</span>, <span class="hlFld-ContribAuthor ">Wayne W.  Harding</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 255-268. <a href="https://doi.org/10.1016/j.ejmech.2016.09.036" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.036%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252BC9%252Balkoxy%252Banalogues%252Bof%252B%252528-%252529-stepholidine%252Bas%252Bdopamine%252Breceptor%252Bligands%26aulast%3DMadapa%26aufirst%3DSudharshan%26date%3D2017%26volume%3D125%26spage%3D255%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Luo</span>, <span class="hlFld-ContribAuthor ">Horrick  Sharma</span>, <span class="hlFld-ContribAuthor ">Deepthi  Yedlapudi</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten E.A.  Reith</span>, <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">Novel multifunctional dopamine D 2 /D 3 receptors agonists with potential neuroprotection and anti-alpha synuclein protein aggregation properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (21)
                                     , 5088-5102. <a href="https://doi.org/10.1016/j.bmc.2016.08.021" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.08.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.08.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bmultifunctional%252Bdopamine%252BD%252B2%252B%25252FD%252B3%252Breceptors%252Bagonists%252Bwith%252Bpotential%252Bneuroprotection%252Band%252Banti-alpha%252Bsynuclein%252Bprotein%252Baggregation%252Bproperties%26aulast%3DLuo%26aufirst%3DDan%26date%3D2016%26volume%3D24%26issue%3D21%26spage%3D5088%26epage%3D5102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 317-339. <a href="https://doi.org/10.1016/B978-0-08-100755-6.00009-0" title="DOI URL">https://doi.org/10.1016/B978-0-08-100755-6.00009-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100755-6.00009-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100755-6.00009-0%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2016%26spage%3D317%26epage%3D339%26pub%3DElsevier%26date%3D2016%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structures of D<sub>2</sub>/D<sub>3</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, 4-DMAP, THF, rt, overnight; (b) NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h; (c) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, overnight; (b) (i) POCl<sub>3</sub>, DMF, 0–40 °C, 1.5 h, (ii) ice, 2 M NaOH, (iii) reflux, 5 min; (c) (Boc)<sub>2</sub>O, 4-DMAP, THF, rt, overnight; (d) <b>6</b>, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h; (e) <i>n</i>-Bu<sub>4</sub>NF, THF, 0 °C to rt, 2 h; (f) SO<sub>3</sub>·py, CH<sub>2</sub>Cl<sub>2</sub>:DMSO (2:1), Et<sub>3</sub>N, 0 °C to rt, 1.5 h; (g) (±)-pramipexole, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h;( h) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 3 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, 4-DMAP, THF, rt, overnight; (b) <b>6</b>, Pd(OAc)<sub>2</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, reflux, 15 h; (c) <i>n</i>-Bu<sub>4</sub>NF, THF, 0 °C to rt, 2 h; (d) oxalyl chloride, DMSO, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 2 h; (e) (−)-pramipexole, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h; (f) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 3 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, 4-DMAP, THF, rt, overnight; (b) <b>6</b>, Pd(OAc)<sub>2</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, reflux, 15 h; (c) <i>n</i>-Bu<sub>4</sub>NF, THF, 0 °C to rt, 2 h; (d) SO<sub>3</sub>·py, CH<sub>2</sub>Cl<sub>2</sub>:DMSO (2:1), Et<sub>3</sub>N, 0 °C to rt, 1.5 h; (e) (−)-pramipexole, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h; (f) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 3 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-nitrobenzenesulfonyl chloride, Et<sub>3</sub>N, THF, −10 °C to rt, 1.5 h; (b) propargyl bromide, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 50 °C, overnight; (c) thioglycolic acid, K<sub>2</sub>CO<sub>3</sub>, DMF, 0 °C to rt to 50 °C, 16 h; (d) NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 40 h; (e) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rightward shift in dopamine curves for stimulation of [<sup>35</sup>S]GTPγS binding in CHO-hD<sub>2</sub> cells by 50 nM and 300 nM (−)-<b>34</b> (A), or 200 nM and 1 μM (−)-3PPP (B). The indicated fixed concentrations of test compound were copresent with increasing concentrations of dopamine (colored curves). The two test compounds and vehicle with dopamine were tested in 4–7 independent experiments (carried out in triplicate); in order to show the shifts without clutter, the drugs are shown in separate panels (A,B) along with the same dopamine curve (averaged from all DA data obtained in two sets of experiments). The EC<sub>50</sub> values calculated from the right-shifted curves were significantly larger than the EC<sub>50</sub> of dopamine observed in the same set of experiments (<i>P</i> < 0.05, one-tailed Student’s <i>t</i> test). For <i>K</i><sub>e</sub> values calculated from these shifts, see text. Data points are mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of different drugs upon reserpine (5.0 mg/kg, sc, 18 h pretreatment) induced hypolocomotion in rats. Each point represents the mean ± SEM for three rats. Horizontal activity was measured as described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Representation of horizontal locomotor activity is at discrete 30 min intervals after the administration of (−)-<b>21a</b> (10 μMol/kg), (−)-<b>34</b> (10 μMol/kg), (−)-Pramipexole (10 μMol/kg), and Ropinirole (10 μMol/kg) compared to control rats, 18 h after reserpine treatment. Differences among treatments were significant by one-way ANOVA analysis (<i>F</i> (4, 60) = 31.62 (<i>P</i> < 0.0001)): (****) <i>P</i> < 0.001 ((−)-<b>21a</b>), (**) <i>P</i> < 0.05 ((−)-<b>34</b>) or (****) <i>P</i> < 0.001 Pramipexole compared to reserpine control (Dunnett’s multiple comparison test after one-way ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/medium/jm-2015-010317_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose-dependent effect on the viability of PC12 cells by the  pretreatment of the cells with different concentrations of (−)-<b>21a</b> followed by treatment with 75 μM 6-OHDA. (a) PC12 cells were treated with different concentrations of 6-OHDA (25–100 μM). (b) Dose-dependent effect of (−)-<b>21a</b> on cell viability. (c) PC12 cells were pretreated with varying concentrations of (−)-<b>21a</b> for 24 h and then the media was replaced with fresh culture media followed by treatment with 75 μM 6-OHDA for another 24 h. The values shown are the mean ± SD of at least three independent experiments performed in four to six replicates. One way ANOVA analysis <i>F</i> (4, 30) = 313.6, <i>p</i> < 0.0001 for <b>4a</b>, <i>F</i> (3, 24) = 18.23, <i>p</i> < 0.0001 for <b>4b</b>, and <i>F</i> (3, 18) = 118.7, <i>p</i> < 0.0001 for <b>4c</b>. ANOVA was followed by Tukey’s multiple comparison post hoc test (****<i>p</i> < 0.0001, ***<i>p</i> < 0.001, **<i>p</i> < 0.01 compared to control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01031/20151204/images/large/jm-2015-010317_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01031&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gelb, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, S.</span><span> </span><span class="NLM_article-title">Diagnostic criteria for Parkinson disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1001/archneur.56.1.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1001%2Farchneur.56.1.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=9923759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A280%3ADyaK1M7itVKgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=33-39&author=D.+J.+Gelbauthor=E.+Oliverauthor=S.+Gilman&title=Diagnostic+criteria+for+Parkinson+disease&doi=10.1001%2Farchneur.56.1.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnostic criteria for Parkinson disease</span></div><div class="casAuthors">Gelb D J; Oliver E; Gilman S</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-9</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">The clinical diagnosis of Parkinson disease (PD) is based on the identification of some combination of the cardinal motor signs of bradykinesia, rigidity, tremor, and postural instability, but few attempts have been made to develop explicit diagnostic criteria.  We propose a clinical diagnostic classification based on a comprehensive review of the literature regarding the sensitivity and specificity of the characteristic clinical features of PD.  Three levels of diagnostic confidence are differentiated: Definite, Probable, and Possible.  The diagnoses of Possible and Probable PD are based on clinical criteria alone.  Neuropathologic confirmation is required for the diagnosis of Definite PD in patients with the clinical diagnosis of Possible or Probable PD.  Criteria for histopathologic confirmation of PD are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzH2Foe5frspNiNltV31zlfW6udTcc2eb8b_Z8PJ8ZJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7itVKgtg%253D%253D&md5=3ae738e5928989657f49afe4f4d9247c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchneur.56.1.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.56.1.33%26sid%3Dliteratum%253Aachs%26aulast%3DGelb%26aufirst%3DD.%2BJ.%26aulast%3DOliver%26aufirst%3DE.%26aulast%3DGilman%26aufirst%3DS.%26atitle%3DDiagnostic%2520criteria%2520for%2520Parkinson%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1999%26volume%3D56%26spage%3D33%26epage%3D39%26doi%3D10.1001%2Farchneur.56.1.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Schapira, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1001/jama.291.3.358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1001%2Fjama.291.3.358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=14734599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2004&pages=358-364&author=A.+H.+Schapiraauthor=C.+W.+Olanow&title=Neuroprotection+in+Parkinson+disease%3A+mysteries%2C+myths%2C+and+misconceptions&doi=10.1001%2Fjama.291.3.358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection in parkinson disease. Mysteries, myths, and misconceptions</span></div><div class="casAuthors">Schapira, Anthony H. V.; Olanow, C. Warren</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Parkinson disease is an age-related neurodegenerative disease that affects approx. 1 million persons in the United States.  Current therapies provide effective control of symptoms, particularly in the early stages of the disease, but most patients develop motor complications with long-term treatment, and features develop such as postural instability, falling, and dementia that are not adequately controlled with existing medications.  Accordingly, neuroprotective therapy that might slow, stop, or reverse disease progression is urgently needed.  While many agents appear to be promising based on lab. studies, selecting clin. end points for clin. trials that are not confounded by symptomatic effects of the study intervention has been difficult.  More recently, neuroimaging end points have been used as biomarkers of disease progression, but again there are concerns that they may be influenced by regulatory effects of the drugs used.  We review clin. trials aimed at detecting neuroprotection in Parkinson disease and address the controversies surrounding the interpretation of these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRE6EQZrbgtLVg90H21EOLACvtfcHk0li2QDLBniS-uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlelsg%253D%253D&md5=125a2cc3dc326c5877b87cf1b3f3e11a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Fjama.291.3.358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.291.3.358%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DNeuroprotection%2520in%2520Parkinson%2520disease%253A%2520mysteries%252C%2520myths%252C%2520and%2520misconceptions%26jtitle%3DJAMA%26date%3D2004%26volume%3D291%26spage%3D358%26epage%3D364%26doi%3D10.1001%2Fjama.291.3.358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethi, K.</span><span> </span><span class="NLM_article-title">The scientific and clinical basis for the treatment of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">S1</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1212/WNL.0b013e3181a1d44c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1212%2FWNL.0b013e3181a1d44c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=S1-136&author=C.+W.+Olanowauthor=M.+B.+Sternauthor=K.+Sethi&title=The+scientific+and+clinical+basis+for+the+treatment+of+Parkinson+disease&doi=10.1212%2FWNL.0b013e3181a1d44c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1212%2FWNL.0b013e3181a1d44c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0b013e3181a1d44c%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DStern%26aufirst%3DM.%2BB.%26aulast%3DSethi%26aufirst%3DK.%26atitle%3DThe%2520scientific%2520and%2520clinical%2520basis%2520for%2520the%2520treatment%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2009%26volume%3D72%26spage%3DS1%26epage%3D136%26doi%3D10.1212%2FWNL.0b013e3181a1d44c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Siderowf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, M.</span><span> </span><span class="NLM_article-title">Update on Parkinson disease</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span><span class="refDoi"> DOI: 10.7326/0003-4819-138-8-200304150-00013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.7326%2F0003-4819-138-8-200304150-00013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12693888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A280%3ADC%252BD3s7ns1Sjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=651-658&author=A.+Siderowfauthor=M.+Stern&title=Update+on+Parkinson+disease&doi=10.7326%2F0003-4819-138-8-200304150-00013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Parkinson disease</span></div><div class="casAuthors">Siderowf Andrew; Stern Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">651-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This Update reviews developments in the pathophysiology and treatment of Parkinson disease during the past several years.  In the area of pathophysiology, studies have addressed the contribution of environmental factors such as caffeine and pesticides.  Large-scale epidemiologic studies have also expanded the role genetic factors are thought to play.  Detailed studies of kindreds with familial Parkinson disease due to alpha-synuclein and parkin have catalyzed basic science investigations into the pathologic mechanisms of the disease.  These studies have led to the development of a pathophysiologic model of Parkinson disease that emphasizes abnormal protein aggregation.  Studies of treatment have clarified the relative roles of l-dopa and dopamine agonists in early Parkinson disease and shown the potential for surgical interventions, particularly deep-brain stimulation, to relieve the symptoms of advanced, medically refractory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5PWe2QgPGybmQt-ICR3qNfW6udTcc2eZ0Tl4f8jDZ3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7ns1Sjsw%253D%253D&md5=808838626323e21298e94fff78d74621</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-138-8-200304150-00013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-138-8-200304150-00013%26sid%3Dliteratum%253Aachs%26aulast%3DSiderowf%26aufirst%3DA.%26aulast%3DStern%26aufirst%3DM.%26atitle%3DUpdate%2520on%2520Parkinson%2520disease%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2003%26volume%3D138%26spage%3D651%26epage%3D658%26doi%3D10.7326%2F0003-4819-138-8-200304150-00013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Molecular pathways of neurodegeneration in Parkinson’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span><span class="refDoi"> DOI: 10.1126/science.1087753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1126%2Fscience.1087753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=14593166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=819-822&author=T.+M.+Dawsonauthor=V.+L.+Dawson&title=Molecular+pathways+of+neurodegeneration+in+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.1087753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pathways of neurodegeneration in Parkinson's disease</span></div><div class="casAuthors">Dawson, Ted M.; Dawson, Valina L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">819-822</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a complex disorder with many different causes, yet they may intersect in common pathways, raising the possibility that neuroprotective agents may have broad applicability in the treatment of PD.  Current evidence suggests that mitochondrial complex I inhibition may be the central cause of sporadic PD and that derangements in complex I cause α-synuclein aggregation, which contributes to the demise of dopamine neurons.  Accumulation and aggregation of α-synuclein may further contribute to the death of dopamine neurons through impairments in protein handling and detoxification.  Dysfunction of parkin (a ubiquitin E3 ligase) and DJ-1 could contribute to these deficits.  Strategies aimed at restoring complex I activity, reducing oxidative stress and α-synuclein aggregation, and enhancing protein degrdn. may hold particular promise as powerful neuroprotective agents in the treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1L96tPhpE7Vg90H21EOLACvtfcHk0liRpzS8kHCibQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt7w%253D&md5=3a349d2af4f61c7e514289ed56bf5a29</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087753%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DMolecular%2520pathways%2520of%2520neurodegeneration%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D819%26epage%3D822%26doi%3D10.1126%2Fscience.1087753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Betarbet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Monte, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenamyre, J. T.</span><span> </span><span class="NLM_article-title">Mechanistic approaches to Parkinson’s disease pathogenesis</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">510</span><span class="refDoi"> DOI: 10.1111/j.1750-3639.2002.tb00468.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1111%2Fj.1750-3639.2002.tb00468.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12408237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1GnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=499-510&author=R.+Betarbetauthor=T.+B.+Shererauthor=D.+A.+Di+Monteauthor=J.+T.+Greenamyre&title=Mechanistic+approaches+to+Parkinson%E2%80%99s+disease+pathogenesis&doi=10.1111%2Fj.1750-3639.2002.tb00468.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic approaches to Parkinson's disease pathogenesis</span></div><div class="casAuthors">Betarbet, Ranjita; Sherer, Todd B.; Di Monte, Donato A.; Greenamyre, J. Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-510</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">International Society of Neuropathology</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a progressive neurol. disorder marked by nigrostriatal dopaminergic degeneration and development of cytoplasmic proteinaceous aggregates known as Lewy bodies.  Although the pathogenic mechanisms responsible for PD are not completely understood, many clues have come from biochem., epidemiol., and genetic studies.  Mutations in certain genes found in rare, familial cases of PD, such as α-synuclein and parkin, suggest a role for the ubiquitin-proteosome system and aberrant protein aggregation.  Biochem. analyses have implicated mitochondrial dysfunction in PD.  Epidemiol. and animal model studies point to a role for environmental toxins, some of which are mitochondrial inhibitors.  Mitochondrial dysfunction, resulting from either genetic defects, environmental exposures or an interaction between the two, may cause α-synuclein aggregation or neurodegeneration through oxidative stress or excitotoxicity.  A better understanding of the mechanisms underlying PD should reveal novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs93qK2ac7vrVg90H21EOLACvtfcHk0liRpzS8kHCibQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1GnsL8%253D&md5=6fcb6a524207c401f7e8cee65e8c4be6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.2002.tb00468.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.2002.tb00468.x%26sid%3Dliteratum%253Aachs%26aulast%3DBetarbet%26aufirst%3DR.%26aulast%3DSherer%26aufirst%3DT.%2BB.%26aulast%3DDi%2BMonte%26aufirst%3DD.%2BA.%26aulast%3DGreenamyre%26aufirst%3DJ.%2BT.%26atitle%3DMechanistic%2520approaches%2520to%2520Parkinson%25E2%2580%2599s%2520disease%2520pathogenesis%26jtitle%3DBrain%2520Pathol.%26date%3D2002%26volume%3D12%26spage%3D499%26epage%3D510%26doi%3D10.1111%2Fj.1750-3639.2002.tb00468.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dunnett, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span> </span><span class="NLM_article-title">Prospects for new restorative and neuroprotective treatments in Parkinson’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">A32</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1038/399a032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2F399a032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=A32-39&author=S.+B.+Dunnettauthor=A.+Bjorklund&title=Prospects+for+new+restorative+and+neuroprotective+treatments+in+Parkinson%E2%80%99s+disease&doi=10.1038%2F399a032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F399a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F399a032%26sid%3Dliteratum%253Aachs%26aulast%3DDunnett%26aufirst%3DS.%2BB.%26aulast%3DBjorklund%26aufirst%3DA.%26atitle%3DProspects%2520for%2520new%2520restorative%2520and%2520neuroprotective%2520treatments%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3DA32%26epage%3D39%26doi%3D10.1038%2F399a032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Oxidative stress in Parkinson’s disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S26</span><span class="NLM_x">–</span> <span class="NLM_lpage">S36</span><div class="note"><p class="first last">discussion S36–S38.</p></div><span class="refDoi"> DOI: 10.1002/ana.10483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fana.10483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12666096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFGitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=S26-S36&issue=Suppl+3&author=P.+Jenner&title=Oxidative+stress+in+Parkinson%E2%80%99s+disease&doi=10.1002%2Fana.10483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in Parkinson's disease</span></div><div class="casAuthors">Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S26-S38</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress contributes to the cascade leading to dopamine cell degeneration in Parkinson's disease (PD).  However, oxidative stress is intimately linked to other components of the degenerative process, such as mitochondrial dysfunction, excitotoxicity, nitric oxide toxicity and inflammation.  It is therefore difficult to det. whether oxidative stress leads to, or is a consequence of, these events.  Oxidative damage to lipids, proteins, and DNA occurs in PD, and toxic products of oxidative damage, such as 4-hydroxynonenal (HNE), can react with proteins to impair cell viability.  There is convincing evidence for the involvement of nitric oxide that reacts with superoxide to produce peroxynitrite and ultimately hydroxyl radical prodn.  Recently, altered ubiquitination and degrdn. of proteins have been implicated as key to dopaminergic cell death in PD.  Oxidative stress can impair these processes directly, and products of oxidative damage, such as HNE, can damage the 26S proteasome.  Furthermore, impairment of proteasomal function leads to free radical generation and oxidative stress.  Oxidative stress occurs in idiopathic PD and products of oxidative damage interfere with cellular function, but these form only part of a cascade, and it is not possible to sep. them from other events involved in dopaminergic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4d7dxHYxOD7Vg90H21EOLACvtfcHk0lhUiz8gMIRrcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFGitLs%253D&md5=2167a3ecce5168aaacac1dab109700d7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fana.10483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10483%26sid%3Dliteratum%253Aachs%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DOxidative%2520stress%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2003%26volume%3D53%26issue%3DSuppl%25203%26spage%3DS26%26epage%3DS36%26doi%3D10.1002%2Fana.10483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span> </span><span class="NLM_article-title">Alpha-synuclein in Lewy bodies</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1038/42166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2F42166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=9278044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK2sXlslWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1997&pages=839-840&author=M.+G.+Spillantiniauthor=M.+L.+Schmidtauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=R.+Jakesauthor=M.+Goedert&title=Alpha-synuclein+in+Lewy+bodies&doi=10.1038%2F42166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">α-Synuclein in Lewy bodies</span></div><div class="casAuthors">Spillantini, Maria Grazia; Schmidt, Marie Luise; Lee, Virginia M.-Y.; Trojanowski, John Q.; Jakes, Ross; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">6645</span>),
    <span class="NLM_cas:pages">839-840</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The authors report strong staining of Lewy bodies in brain in idiopathic Parkinson's disease and dementia with Lewy bodies with antibodies for α-synuclein.  They conclude that Parkinson's disease and dementia with Lewy bodies may both be α-synuclein diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHyD4IKMqEIrVg90H21EOLACvtfcHk0lhUiz8gMIRrcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlslWru7o%253D&md5=ef5d22aaeb6f08828ea33c50e3f7c06d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F42166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F42166%26sid%3Dliteratum%253Aachs%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DSchmidt%26aufirst%3DM.%2BL.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DJakes%26aufirst%3DR.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DAlpha-synuclein%2520in%2520Lewy%2520bodies%26jtitle%3DNature%26date%3D1997%26volume%3D388%26spage%3D839%26epage%3D840%26doi%3D10.1038%2F42166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatton, W. G.</span><span> </span><span class="NLM_article-title">Etiology and pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1146/annurev.neuro.22.1.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1146%2Fannurev.neuro.22.1.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10202534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFemsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=123-144&author=C.+W.+Olanowauthor=W.+G.+Tatton&title=Etiology+and+pathogenesis+of+Parkinson%E2%80%99s+disease&doi=10.1146%2Fannurev.neuro.22.1.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Etiology and pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Olanow, C. W.; Tatton, W. G.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123-144</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with ∼128 refs.  Parkinson's disease (PD) is an age-related neurodegenerative disorder that affects approx. 1 million persons in the United States.  It is characterized by resting tremor, rigidity, bradykinesia or slowness, gait disturbance, and postural instability.  Pathol. features include degeneration of dopaminergic neurons in the substantia nigra pars compacta coupled with intracytoplasmic inclusions known as Lewy bodies.  Neurodegeneration and Lewy bodies can also be found in the locus ceruleus, nucleus basalis, hypothalamus, cerebral cortex, cranial nerve motor nuclei, and central and peripheral components of the autonomic nervous system.  Current treatment consists of a dopamine replacement strategy using primarily the dopamine precursor levodopa.  While levodopa provides benefit to virtually all PD patients, after 5-10 yr of treatment the majority of patients develop adverse events in the form of dyskinesia (involuntary movements) and fluctuations in motor response.  Further, disease progression is assocd. with the development of dementia, autonomic dysfunction, and postural instability, which do not respond to levodopa therapy.  Accordingly, research efforts have been directed toward understanding the etiol. and pathogenesis of PD in the hope of developing a more effective therapy that will slow or halt the natural progression of PD.  This paper reviews recent advances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0mGaU2adIWrVg90H21EOLACvtfcHk0lhUiz8gMIRrcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFemsro%253D&md5=d7823b2fd85fa15ac1d6c7fae5d95174</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.22.1.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.22.1.123%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DTatton%26aufirst%3DW.%2BG.%26atitle%3DEtiology%2520and%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1999%26volume%3D22%26spage%3D123%26epage%3D144%26doi%3D10.1146%2Fannurev.neuro.22.1.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">El-Agnaf, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paleologou, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlossmacher, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span><span class="refDoi"> DOI: 10.1096/fj.03-1449com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1096%2Ffj.03-1449com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=16507759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Wlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=419-425&author=O.+M.+El-Agnafauthor=S.+A.+Salemauthor=K.+E.+Paleologouauthor=M.+D.+Curranauthor=M.+J.+Gibsonauthor=J.+A.+Courtauthor=M.+G.+Schlossmacherauthor=D.+Allsop&title=Detection+of+oligomeric+forms+of+alpha-synuclein+protein+in+human+plasma+as+a+potential+biomarker+for+Parkinson%E2%80%99s+disease&doi=10.1096%2Ffj.03-1449com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease</span></div><div class="casAuthors">El-Agnaf, Omar M. A.; Salem, Sultan A.; Paleologou, Katerina E.; Curran, Martin D.; Gibson, Mark J.; Court, Jennifer A.; Schlossmacher, Michael G.; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">419-425</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">To date there is no accepted clin. diagnostic test for Parkinson's disease (PD) based on biochem. anal. of blood or cerebrospinal fluid (CSF).  α-Synuclein (α-syn) protein has been linked to the pathogenesis of PD with the discovery of mutations in the gene encoding α-syn in familial cases with early-onset PD.  Lewy bodies and Lewy neurites, which constitute the main pathol. features in the brains of patients with sporadic PD and dementia with Lewy bodies, are formed by the conversion of sol. monomers of α-syn into insol. aggregates.  We recently reported the presence of α-syn in normal human blood plasma and in postmortem CSF.  Here, we investigated whether α-syn can be used as a biomarker for PD.  We have developed a novel ELISA method that detects only oligomeric "sol. aggregates" of α-syn.  Using this ELISA, we report the presence of significantly elevated (P = 0.002) levels of oligomeric forms of α-syn in plasma samples obtained from 34 PD patients compared with 27 controls; 52% (95% confidence intervals 0.353-0.687) of the PD patients displayed signals >0.5 OD with our ELISA assay in comparison to only 14.8% (95% confidence intervals 0.014-0.281) for the control cases.  An anal. of the test's diagnostic value revealed a specificity of 0.852 (95% confidence intervals 0.662-0.958), sensitivity of 0.529 (95% confidence intervals 0.351-0.702) and a pos. predictive value of 0.818 (95% confidence intervals 0.597-0.948).  These observations offer new opportunities for developing diagnostic tests for PD and related diseases and for testing therapeutic agents aimed at preventing or reversing the aggregation of α-syn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXsnpiLKP-o7Vg90H21EOLACvtfcHk0ljxIcFMyIXdRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Wlu70%253D&md5=2cefa3cc56ae339db9e9c79f68d24790</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1096%2Ffj.03-1449com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.03-1449com%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Agnaf%26aufirst%3DO.%2BM.%26aulast%3DSalem%26aufirst%3DS.%2BA.%26aulast%3DPaleologou%26aufirst%3DK.%2BE.%26aulast%3DCurran%26aufirst%3DM.%2BD.%26aulast%3DGibson%26aufirst%3DM.%2BJ.%26aulast%3DCourt%26aufirst%3DJ.%2BA.%26aulast%3DSchlossmacher%26aufirst%3DM.%2BG.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DDetection%2520of%2520oligomeric%2520forms%2520of%2520alpha-synuclein%2520protein%2520in%2520human%2520plasma%2520as%2520a%2520potential%2520biomarker%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D419%26epage%3D425%26doi%3D10.1096%2Ffj.03-1449com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lashuel, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petre, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr.</span><span> </span><span class="NLM_article-title">Neurodegenerative disease: amyloid pores from pathogenic mutations</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">418</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="refDoi"> DOI: 10.1038/418291a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2F418291a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12124613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlGmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2002&pages=291&author=H.+A.+Lashuelauthor=D.+Hartleyauthor=B.+M.+Petreauthor=T.+Walzauthor=P.+T.+Lansbury&title=Neurodegenerative+disease%3A+amyloid+pores+from+pathogenic+mutations&doi=10.1038%2F418291a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative disease: Amyloid pores from pathogenic mutations</span></div><div class="casAuthors">Lashuel, Hilal A.; Hartley, Dean; Petre, Benjamin M.; Walz, Thomas; Lansbury, Peter T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">418</span>
        (<span class="NLM_cas:issue">6895</span>),
    <span class="NLM_cas:pages">291</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The structural properties of protofibril formation of A30P and A53T (α-synuclein mutants assocd. with Parkinson's disease) and AβARG (Aβ mutant assocd. with Alzheimer's disease) were examd. for shared structural features that might be related to their toxicity.  Heterogeneous populations of A30P, A53T, and AβARG protofibrils were fractionated by gel-filtration chromatog.  The fraction with the smallest A30P and A53T protofibrils contained β-sheet-rich oligomers comprising 20-25 α-synuclein mols. (relative mol. mass 320-380K; 22-26 monomers).  Anal. of this fraction by electron microscopy revealed annular species (diam. 8-12 nm; inner diam. 2.0-2.5 nm) and coiled species.  Protofibrillar AβARG contained many annular species of similar appearance (7-10 nm; inner diam. 1.5-2.0 nm) and relative mol. mass (150-250K; 40-60 AβARG mols.).  The small annular Aβ and α-synuclein protofibrils resemble the cytolytic β-barrel pore-forming toxins from bacteria such as Clostridium perfringens.  It is concluded that amyloid pores might be wholly or partly responsible for the cyto-toxicity assocd. with the formation of amyloid fibrils in Alzheimer's and Parkinson's diseases and in other age-assocd. degenerative amyloid diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWn7JG2DV4TLVg90H21EOLACvtfcHk0ljxIcFMyIXdRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlGmsrc%253D&md5=d1a4a8e8dbba4b993a9f6814d58b0b03</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F418291a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F418291a%26sid%3Dliteratum%253Aachs%26aulast%3DLashuel%26aufirst%3DH.%2BA.%26aulast%3DHartley%26aufirst%3DD.%26aulast%3DPetre%26aufirst%3DB.%2BM.%26aulast%3DWalz%26aufirst%3DT.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DNeurodegenerative%2520disease%253A%2520amyloid%2520pores%2520from%2520pathogenic%2520mutations%26jtitle%3DNature%26date%3D2002%26volume%3D418%26spage%3D291%26doi%3D10.1038%2F418291a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hashimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundsmo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span> </span><span class="NLM_article-title">Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span><span class="refDoi"> DOI: 10.1097/00001756-199903170-00011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1097%2F00001756-199903170-00011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=717-721&author=M.+Hashimotoauthor=L.+J.+Hsuauthor=Y.+Xiaauthor=A.+Takedaauthor=A.+Siskauthor=M.+Sundsmoauthor=E.+Masliah&title=Oxidative+stress+induces+amyloid-like+aggregate+formation+of+NACP%2Falpha-synuclein+in+vitro&doi=10.1097%2F00001756-199903170-00011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1097%2F00001756-199903170-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199903170-00011%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DHsu%26aufirst%3DL.%2BJ.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DSisk%26aufirst%3DA.%26aulast%3DSundsmo%26aufirst%3DM.%26aulast%3DMasliah%26aufirst%3DE.%26atitle%3DOxidative%2520stress%2520induces%2520amyloid-like%2520aggregate%2520formation%2520of%2520NACP%252Falpha-synuclein%2520in%2520vitro%26jtitle%3DNeuroReport%26date%3D1999%26volume%3D10%26spage%3D717%26epage%3D721%26doi%3D10.1097%2F00001756-199903170-00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. H.</span><span> </span><span class="NLM_article-title">Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span><span class="refDoi"> DOI: 10.1016/S0891-5849(02)00741-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0891-5849%2802%2900741-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=11958955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1ylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=544-550&author=K.+S.+Kimauthor=S.+Y.+Choiauthor=H.+Y.+Kwonauthor=M.+H.+Wonauthor=T.+C.+Kangauthor=J.+H.+Kang&title=Aggregation+of+alpha-synuclein+induced+by+the+Cu%2CZn-superoxide+dismutase+and+hydrogen+peroxide+system&doi=10.1016%2FS0891-5849%2802%2900741-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aggregation of α-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system</span></div><div class="casAuthors">Kim, Kyung Sik; Choi, Soo Young; Kwon, Hyeok Yil; Won, Moo Ho; Kang, Tae-Cheon; Kang, Jung Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">544-550</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Alpha-synuclein is a major component of the abnormal protein aggregation in Lewy bodies of Parkinson's disease (PD) and senile plaques of Alzheimer's disease (AD).  Previous studies have shown that the aggregation of α-synuclein was induced by copper (II) and H2O2 system.  Since copper ions could be released from oxidatively damaged Cu,Zn-superoxide dismutase (SOD), we investigated the role of Cu,Zn-SOD in the aggregation of α-synuclein.  When α-synuclein was incubated with both Cu,Zn-SOD and H2O2, α-synuclein was induced to be aggregated.  This process was inhibited by radical scavengers and spin trapping agents such as 5,5'-dimethyl 1-pyrolline N-oxide and tert-butyl-α-phenylnitrone.  Copper chelators, diethyldithiocarbamate and penicillamine, also inhibited the Cu,Zn-SOD/H2O2 system-induced α-synuclein aggregation.  These results suggest that the aggregation of α-synuclein is mediated by the Cu,Zn-SOD/H2O2 system via the generation of hydroxyl radical by the free radical-generating function of the enzyme.  The Cu,Zn-SOD/H2O2-induced α-synuclein aggregates displayed strong thioflavin-S reactivity, reminiscent of amyloid.  These results suggest that the Cu,Zn-SOD/H2O2 system might be related to abnormal aggregation of α-synuclein, which may be involved in the pathogenesis of PD and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxKJgB_klOjLVg90H21EOLACvtfcHk0ljxIcFMyIXdRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1ylsL4%253D&md5=fd124a9634f5f65f73b5853de4d10a74</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2900741-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252900741-4%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DChoi%26aufirst%3DS.%2BY.%26aulast%3DKwon%26aufirst%3DH.%2BY.%26aulast%3DWon%26aufirst%3DM.%2BH.%26aulast%3DKang%26aufirst%3DT.%2BC.%26aulast%3DKang%26aufirst%3DJ.%2BH.%26atitle%3DAggregation%2520of%2520alpha-synuclein%2520induced%2520by%2520the%2520Cu%252CZn-superoxide%2520dismutase%2520and%2520hydrogen%2520peroxide%2520system%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2002%26volume%3D32%26spage%3D544%26epage%3D550%26doi%3D10.1016%2FS0891-5849%2802%2900741-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.+M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lj6w1amDPb-Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gonnet, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benner, S. A.</span><span> </span><span class="NLM_article-title">Exhaustive matching of the entire protein sequence database</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">–</span> <span class="NLM_lpage">1445</span><span class="refDoi"> DOI: 10.1126/science.1604319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1126%2Fscience.1604319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1604319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK38Xks12hs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=1443-1445&author=G.+H.+Gonnetauthor=M.+A.+Cohenauthor=S.+A.+Benner&title=Exhaustive+matching+of+the+entire+protein+sequence+database&doi=10.1126%2Fscience.1604319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Exhaustive matching of the entire protein sequence database</span></div><div class="casAuthors">Gonnet, Gaston H.; Cohen, Mark A.; Benner, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5062</span>),
    <span class="NLM_cas:pages">1443-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The entire protein sequence database has been exhaustively matched.  Definitive mutation matrixes and models for scoring gaps were obtained for the matching and used to organize the sequence database as sets of evolutionarily connected components.  The methods developed are general and can be used to manage sequence data generated by major genome sequencing projects.  The alignments made possible by the exhaustive matching are the starting point for successful de novo prediction of the folded structures of proteins, for reconstructing sequences of ancient proteins and metabs. in ancient organisms, and for obtaining new perspectives in structural biochem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ATl5B5Q6mLVg90H21EOLACvtfcHk0lj6w1amDPb-Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xks12hs7k%253D&md5=89f2045a3221f889fe7aea659eb26956</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.1604319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1604319%26sid%3Dliteratum%253Aachs%26aulast%3DGonnet%26aufirst%3DG.%2BH.%26aulast%3DCohen%26aufirst%3DM.%2BA.%26aulast%3DBenner%26aufirst%3DS.%2BA.%26atitle%3DExhaustive%2520matching%2520of%2520the%2520entire%2520protein%2520sequence%2520database%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D1443%26epage%3D1445%26doi%3D10.1126%2Fscience.1604319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Ligand discovery from a dopamine D3 receptor homology model and crystal structure</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1038/nchembio.662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2Fnchembio.662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=21926995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFylsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=769-778&author=J.+Carlssonauthor=R.+G.+Colemanauthor=V.+Setolaauthor=J.+J.+Irwinauthor=H.+Fanauthor=A.+Schlessingerauthor=A.+Saliauthor=B.+L.+Rothauthor=B.+K.+Shoichet&title=Ligand+discovery+from+a+dopamine+D3+receptor+homology+model+and+crystal+structure&doi=10.1038%2Fnchembio.662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand discovery from a dopamine D3 receptor homology model and crystal structure</span></div><div class="casAuthors">Carlsson, Jens; Coleman, Ryan G.; Setola, Vincent; Irwin, John J.; Fan, Hao; Schlessinger, Avner; Sali, Andrej; Roth, Bryan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">769-778</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are intensely studied as drug targets and for their role in signaling.  With the detn. of the first crystal structures, interest in structure-based ligand discovery increased.  Unfortunately, for most GPCRs no exptl. structures are available.  The detn. of the D3 receptor structure and the challenge to the community to predict it enabled a fully prospective comparison of ligand discovery from a modeled structure vs. that of the subsequently released crystal structure.  Over 3.3 million mols. were docked against a homol. model, and 26 of the highest ranking were tested for binding.  Six had affinities ranging from 0.2 to 3.1 μM.  Subsequently, the crystal structure was released and the docking screen repeated.  Of the 25 compds. selected, five had affinities ranging from 0.3 to 3.0 μM.  One of the new ligands from the homol. model screen was optimized for affinity to 81 nM.  The feasibility of docking screens against modeled GPCRs more generally is considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz6gBx3Olbn7Vg90H21EOLACvtfcHk0lg_NVUh6qjhbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFylsLvP&md5=7242aa512079a348678b309d352ecdb9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.662%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DR.%2BG.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DSchlessinger%26aufirst%3DA.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DLigand%2520discovery%2520from%2520a%2520dopamine%2520D3%2520receptor%2520homology%2520model%2520and%2520crystal%2520structure%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D769%26epage%3D778%26doi%3D10.1038%2Fnchembio.662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lg_NVUh6qjhbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Meissner, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frasier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rascol, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tison, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span> </span><span class="NLM_article-title">Priorities in Parkinson’s disease research</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1038/nrd3430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2Fnrd3430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=21532567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVGltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=377-393&author=W.+G.+Meissnerauthor=M.+Frasierauthor=T.+Gasserauthor=C.+G.+Goetzauthor=A.+Lozanoauthor=P.+Picciniauthor=J.+A.+Obesoauthor=O.+Rascolauthor=A.+Schapiraauthor=V.+Voonauthor=D.+M.+Weinerauthor=F.+Tisonauthor=E.+Bezard&title=Priorities+in+Parkinson%E2%80%99s+disease+research&doi=10.1038%2Fnrd3430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Priorities in Parkinson's disease research</span></div><div class="casAuthors">Meissner, Wassilios G.; Frasier, Mark; Gasser, Thomas; Goetz, Christopher G.; Lozano, Andres; Piccini, Paola; Obeso, Jose A.; Rascol, Olivier; Schapira, Anthony; Voon, Valerie; Weiner, David M.; Tison, Francois; Bezard, Erwan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">377-393</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The loss of dopaminergic neurons in the substantia nigra pars compacta leads to the characteristic motor symptoms of Parkinson's disease: bradykinesia, rigidity and resting tremors.  Although these symptoms can be improved using currently available dopamine replacement strategies, there is still a need to improve current strategies of treating these symptoms, together with a need to alleviate non-motor symptoms of the disease.  Moreover, treatments that provide neuroprotection and/or disease-modifying effects remain an urgent unmet clin. need.  This Review describes the most promising biol. targets and therapeutic agents that are currently being assessed to address these treatment goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFgF5KqF7ZzrVg90H21EOLACvtfcHk0lg_NVUh6qjhbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVGltr4%253D&md5=d792624cf69d3a56537eb8aa00c5b963</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd3430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3430%26sid%3Dliteratum%253Aachs%26aulast%3DMeissner%26aufirst%3DW.%2BG.%26aulast%3DFrasier%26aufirst%3DM.%26aulast%3DGasser%26aufirst%3DT.%26aulast%3DGoetz%26aufirst%3DC.%2BG.%26aulast%3DLozano%26aufirst%3DA.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DObeso%26aufirst%3DJ.%2BA.%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DSchapira%26aufirst%3DA.%26aulast%3DVoon%26aufirst%3DV.%26aulast%3DWeiner%26aufirst%3DD.%2BM.%26aulast%3DTison%26aufirst%3DF.%26aulast%3DBezard%26aufirst%3DE.%26atitle%3DPriorities%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520research%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D377%26epage%3D393%26doi%3D10.1038%2Fnrd3430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Marsden, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, J. D.</span><span> </span><span class="NLM_article-title">″On-off″ effects in patients with Parkinson’s disease on chronic levodopa therapy</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1016/S0140-6736(76)91416-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0140-6736%2876%2991416-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=1976&pages=292-296&author=C.+D.+Marsdenauthor=J.+D.+Parkes&title=%E2%80%B3On-off%E2%80%B3+effects+in+patients+with+Parkinson%E2%80%99s+disease+on+chronic+levodopa+therapy&doi=10.1016%2FS0140-6736%2876%2991416-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2876%2991416-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252876%252991416-1%26sid%3Dliteratum%253Aachs%26aulast%3DMarsden%26aufirst%3DC.%2BD.%26aulast%3DParkes%26aufirst%3DJ.%2BD.%26atitle%3D%25E2%2580%25B3On-off%25E2%2580%25B3%2520effects%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%2520on%2520chronic%2520levodopa%2520therapy%26jtitle%3DLancet%26date%3D1976%26volume%3D307%26spage%3D292%26epage%3D296%26doi%3D10.1016%2FS0140-6736%2876%2991416-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Basma, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicklas, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geller, H. M.</span><span> </span><span class="NLM_article-title">L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1995.64020825.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1046%2Fj.1471-4159.1995.64020825.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=7830076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK2MXjtFymt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1995&pages=825-832&author=A.+N.+Basmaauthor=E.+J.+Morrisauthor=W.+J.+Nicklasauthor=H.+M.+Geller&title=L-dopa+cytotoxicity+to+PC12+cells+in+culture+is+via+its+autoxidation&doi=10.1046%2Fj.1471-4159.1995.64020825.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation</span></div><div class="casAuthors">Basma, Alie N.; Morris, Erick J.; Nicklas, William J.; Geller, Herbert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">825-32</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">The mechanism of cytotoxicity of L-DOPA was studied in the rat pheochromocytoma PC12 cell line.  The cytotoxicity of L-DOPA to PC12 cells was time and concn. dependent.  Carbidopa, which inhibited the conversion of L-DOPA to dopamine, did not protect against L-DOPA cytotoxicity in PC12 cells.  Furthermore, clorgyline, a selective inhibitor of monoamine oxidase type A, and pargyline, an inhibitor of both monoamine oxidase types A and B, both did not have an effect on L-DOPA toxicity.  These findings suggest that cytotoxicity was not due to dopamine formed from L-DOPA.  Catalase or superoxide dismutase each partially protected against L-DOPA toxicity in PC12 cells.  In combination, the effects were synergistic and provided almost total protection against cytotoxicity.  6-Cyano-7-nitroquinoxaline-2,3-dione, an antagonist of non-NMDA receptors, did not protect against L-DOPA toxicity.  These data suggest that toxicity of L-DOPA is most likely due to the action of free radicals formed as a result of its autoxidn.  Furthermore, these findings suggest that patients on long-term L-DOPA therapy are potentially at risk from the toxic intermediates formed as a result of its autoxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWQJx-LrRiN7Vg90H21EOLACvtfcHk0ljv-5Puyjsitg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtFymt78%253D&md5=7fb5617cc18563f3298d911c50b78f60</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1995.64020825.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1995.64020825.x%26sid%3Dliteratum%253Aachs%26aulast%3DBasma%26aufirst%3DA.%2BN.%26aulast%3DMorris%26aufirst%3DE.%2BJ.%26aulast%3DNicklas%26aufirst%3DW.%2BJ.%26aulast%3DGeller%26aufirst%3DH.%2BM.%26atitle%3DL-dopa%2520cytotoxicity%2520to%2520PC12%2520cells%2520in%2520culture%2520is%2520via%2520its%2520autoxidation%26jtitle%3DJ.%2520Neurochem.%26date%3D1995%26volume%3D64%26spage%3D825%26epage%3D832%26doi%3D10.1046%2Fj.1471-4159.1995.64020825.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fahn, S.</span><span> </span><span class="NLM_article-title">Is levodopa toxic?</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">184S</span><span class="NLM_x">–</span> <span class="NLM_lpage">195S</span><span class="refDoi"> DOI: 10.1212/WNL.47.6_Suppl_3.184S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1212%2FWNL.47.6_Suppl_3.184S" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1996&pages=184S-195S&author=S.+Fahn&title=Is+levodopa+toxic%3F&doi=10.1212%2FWNL.47.6_Suppl_3.184S"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1212%2FWNL.47.6_Suppl_3.184S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.47.6_Suppl_3.184S%26sid%3Dliteratum%253Aachs%26aulast%3DFahn%26aufirst%3DS.%26atitle%3DIs%2520levodopa%2520toxic%253F%26jtitle%3DNeurology%26date%3D1996%26volume%3D47%26spage%3D184S%26epage%3D195S%26doi%3D10.1212%2FWNL.47.6_Suppl_3.184S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Stocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">Neuroprotection in Parkinson’s disease: clinical trials</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S87</span><span class="NLM_x">–</span> <span class="NLM_lpage">S97</span><div class="note"><p class="first last">discussion S97–S99.</p></div><span class="refDoi"> DOI: 10.1002/ana.10488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fana.10488" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=S87-S97&issue=Suppl+3&author=F.+Stocchiauthor=C.+W.+Olanow&title=Neuroprotection+in+Parkinson%E2%80%99s+disease%3A+clinical+trials&doi=10.1002%2Fana.10488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fana.10488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10488%26sid%3Dliteratum%253Aachs%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DNeuroprotection%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520clinical%2520trials%26jtitle%3DAnn.%2520Neurol.%26date%3D2003%26volume%3D53%26issue%3DSuppl%25203%26spage%3DS87%26epage%3DS97%26doi%3D10.1002%2Fana.10488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mandel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunblatt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levites, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Neuroprotective strategies in Parkinson’s disease: an update on progress</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span><span class="refDoi"> DOI: 10.2165/00023210-200317100-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.2165%2F00023210-200317100-00004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=729-762&author=S.+Mandelauthor=E.+Grunblattauthor=P.+Riedererauthor=M.+Gerlachauthor=Y.+Levitesauthor=M.+B.+Youdim&title=Neuroprotective+strategies+in+Parkinson%E2%80%99s+disease%3A+an+update+on+progress&doi=10.2165%2F00023210-200317100-00004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2165%2F00023210-200317100-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200317100-00004%26sid%3Dliteratum%253Aachs%26aulast%3DMandel%26aufirst%3DS.%26aulast%3DGrunblatt%26aufirst%3DE.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DLevites%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DNeuroprotective%2520strategies%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520an%2520update%2520on%2520progress%26jtitle%3DCNS%2520Drugs%26date%3D2003%26volume%3D17%26spage%3D729%26epage%3D762%26doi%3D10.2165%2F00023210-200317100-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span><span class="refDoi"> DOI: 10.1038/nrd1346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2Fnrd1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=15060530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353-359&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia&doi=10.1038%2Fnrd1346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span></div><div class="casAuthors">Roth, Bryan L.; Sheffler, Douglas J.; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-359</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most common central nervous system disorders - such as depression, bipolar disorder, and schizophrenia - seem to be polygenic in origin, and the most effective medications have exceedingly complex pharmacologies.  Attempts to develop more effective treatments for diseases such as schizophrenia and depression by discovering drugs selective for single mol. targets (i.e., 'magic bullets') have, not surprisingly, been largely unsuccessful.  Here the authors propose that designing selectively non-selective drugs (i.e., 'magic shotguns') that interact with several mol. targets will lead to new and more effective medications for a variety of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSsuUXzmbirVg90H21EOLACvtfcHk0ljv-5Puyjsitg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D&md5=77196583acccca65457fec7a67218463</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1346%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353%26epage%3D359%26doi%3D10.1038%2Fnrd1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzhikandathil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-o l analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1021/jm070860r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070860r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=101-117&author=S.+Biswasauthor=S.+Zhangauthor=F.+Fernandezauthor=B.+Ghoshauthor=J.+Zhenauthor=E.+Kuzhikandathilauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Further+structure-activity+relationships+study+of+hybrid+7-%7B%5B2-%284-phenylpiperazin-1-yl%29ethyl%5Dpropylamino%7D-5%2C6%2C7%2C8-tetrahydronaphthalen-2-o+l+analogues%3A+identification+of+a+high-affinity+D3-preferring+agonist+with+potent+in+vivo+activity+with+long+duration+of+action&doi=10.1021%2Fjm070860r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm070860r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070860r%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DF.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DKuzhikandathil%26aufirst%3DE.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DFurther%2520structure-activity%2520relationships%2520study%2520of%2520hybrid%25207-%257B%255B2-%25284-phenylpiperazin-1-yl%2529ethyl%255Dpropylamino%257D-5%252C6%252C7%252C8-tetrahydronaphthalen-2-o%2520l%2520analogues%253A%2520identification%2520of%2520a%2520high-affinity%2520D3-preferring%2520agonist%2520with%2520potent%2520in%2520vivo%2520activity%2520with%2520long%2520duration%2520of%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D101%26epage%3D117%26doi%3D10.1021%2Fjm070860r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeldine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrington, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzhikandathil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2- ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3005</span><span class="NLM_x">–</span> <span class="NLM_lpage">3019</span><span class="refDoi"> DOI: 10.1021/jm701524h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701524h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFyksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3005-3019&author=S.+Biswasauthor=S.+Hazeldineauthor=B.+Ghoshauthor=I.+Parringtonauthor=E.+Kuzhikandathilauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Bioisosteric+heterocyclic+versions+of+7-%7B%5B2-%284-phenyl-piperazin-1-yl%29ethyl%5Dpropylamino%7D-5%2C6%2C7%2C8-tetrahydronaphthalen-2-+ol%3A+identification+of+highly+potent+and+selective+agonists+for+dopamine+D3+receptor+with+potent+in+vivo+activity&doi=10.1021%2Fjm701524h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosteric Heterocyclic Versions of 7-{[2-(4-Phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: Identification of Highly Potent and Selective Agonists for Dopamine D3 Receptor with Potent in Vivo Activity</span></div><div class="casAuthors">Biswas, Swati; Hazeldine, Stuart; Ghosh, Balaram; Parrington, Ingrid; Kuzhikandathil, Eldo; Reith, Maarten E. A.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3005-3019</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the current report, the authors extend the SAR study on the hybrid structure 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol further to include heterocyclic bioisosteric analogs.  Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors with tritiated spiperone to evaluate inhibition consts. (Ki).  Functional activity of selected compds. in stimulating GTPγS binding was assessed with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors.  The highest binding affinity and selectivity for D3 receptors were exhibited by compd. (I) (Ki = 0.92 nM and D2/D3=253).  In the functional GTPγS binding assay, I exhibited full agonist activity with picomolar affinity for D3 receptor with high selectivity (EC50 = 0.08 nM and D2/D3=248).  In the in vivo rotational study, I exhibited potent rotational activity in 6-OH-DA unilaterally lesioned rats with long duration of action, which indicates its potential application in neuroprotective treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6yNJ94snDg7Vg90H21EOLACvtfcHk0lglpa0uJAqwaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFyksbk%253D&md5=6c649b6077843039c49dab02128df139</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm701524h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701524h%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DHazeldine%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DParrington%26aufirst%3DI.%26aulast%3DKuzhikandathil%26aufirst%3DE.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DBioisosteric%2520heterocyclic%2520versions%2520of%25207-%257B%255B2-%25284-phenyl-piperazin-1-yl%2529ethyl%255Dpropylamino%257D-5%252C6%252C7%252C8-tetrahydronaphthalen-2-%2520ol%253A%2520identification%2520of%2520highly%2520potent%2520and%2520selective%2520agonists%2520for%2520dopamine%2520D3%2520receptor%2520with%2520potent%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3005%26epage%3D3019%26doi%3D10.1021%2Fjm701524h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydro benzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson’s disease animal models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.1021/jm901184n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901184n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WjsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1023-1037&author=B.+Ghoshauthor=T.+Antonioauthor=J.+Zhenauthor=P.+Kharkarauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Development+of+%28S%29-N6-%282-%284-%28isoquinolin-1-yl%29piperazin-1-yl%29ethyl%29-N6-propyl-4%2C5%2C6%2C7-tetrahydro+benzo%5Bd%5D-thiazole-2%2C6-diamine+and+its+analogue+as+a+D3+receptor+preferring+agonist%3A+potent+in+vivo+activity+in+Parkinson%E2%80%99s+disease+animal+models&doi=10.1021%2Fjm901184n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development of (S)-N6-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: Potent in vivo activity in Parkinson's disease animal models</span></div><div class="casAuthors">Ghosh, Balaram; Antonio, Tamara; Zhen, Juan; Kharkar, Prashant; Reith, Maarten E. A.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1023-1037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here we report structure-activity relationship study of a novel hybrid series of compds. where structural alteration of arom. hydrophobic moieties connected to the piperazine ring and bioisosteric replacement of the arom. tetralin moieties were carried out.  Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors with tritiated spiperone to evaluate inhibition consts. (Ki).  Functional activity of selected compds. in stimulating GTPγS binding was assessed with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors.  SAR results identified compd. (-)-24c (D-301, I) as one of the lead mols. with preferential agonist activity for D3 receptor (EC50 (GTPγS); D3 = 0.52 nM; D2/D3 (EC50): 223).  Compds. (-)-24b and (-)-24c exhibited potent radical scavenging activity.  The two lead compds., (-)-24b and (-)-24c, exhibited high in vivo activity in two Parkinson's disease (PD) animal models, reserpinized rat model and 6-OHDA induced unilaterally lesioned rat model.  Future studies will explore potential use of these compds. in the neuroprotective therapy for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9rYWZ-mha0rVg90H21EOLACvtfcHk0lglpa0uJAqwaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WjsLnO&md5=ae4d8fb18fd9607e1508ee936f88b7bd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm901184n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901184n%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DKharkar%26aufirst%3DP.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDevelopment%2520of%2520%2528S%2529-N6-%25282-%25284-%2528isoquinolin-1-yl%2529piperazin-1-yl%2529ethyl%2529-N6-propyl-4%252C5%252C6%252C7-tetrahydro%2520benzo%255Bd%255D-thiazole-2%252C6-diamine%2520and%2520its%2520analogue%2520as%2520a%2520D3%2520receptor%2520preferring%2520agonist%253A%2520potent%2520in%2520vivo%2520activity%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520animal%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1023%26epage%3D1037%26doi%3D10.1021%2Fjm901184n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl) (propyl)amino)ethyl)piperaz in-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2114</span><span class="NLM_x">–</span> <span class="NLM_lpage">2125</span><span class="refDoi"> DOI: 10.1021/jm901618d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901618d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2114-2125&author=B.+Ghoshauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Discovery+of+4-%284-%282-%28%285-Hydroxy-1%2C2%2C3%2C4-tetrahydronaphthalen-2-yl%29+%28propyl%29amino%29ethyl%29piperaz+in-1-yl%29quinolin-8-ol+and+its+analogues+as+highly+potent+dopamine+D2%2FD3+agonists+and+as+iron+chelator%3A+in+vivo+activity+indicates+potential+application+in+symptomatic+and+neuroprotective+therapy+for+Parkinson%E2%80%99s+disease&doi=10.1021%2Fjm901618d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901618d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901618d%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDiscovery%2520of%25204-%25284-%25282-%2528%25285-Hydroxy-1%252C2%252C3%252C4-tetrahydronaphthalen-2-yl%2529%2520%2528propyl%2529amino%2529ethyl%2529piperaz%2520in-1-yl%2529quinolin-8-ol%2520and%2520its%2520analogues%2520as%2520highly%2520potent%2520dopamine%2520D2%252FD3%2520agonists%2520and%2520as%2520iron%2520chelator%253A%2520in%2520vivo%2520activity%2520indicates%2520potential%2520application%2520in%2520symptomatic%2520and%2520neuroprotective%2520therapy%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2114%26epage%3D2125%26doi%3D10.1021%2Fjm901618d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, W.</span><span> </span><span class="NLM_article-title">Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson’s disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">2513</span><span class="NLM_x">–</span> <span class="NLM_lpage">2523</span><span class="refDoi"> DOI: 10.1002/jnr.22405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fjnr.22405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=20623619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1GmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=2513-2523&author=C.+Liauthor=S.+Biswasauthor=X.+Liauthor=A.+K.+Duttaauthor=W.+Le&title=Novel+D3+dopamine+receptor-preferring+agonist+D-264%3A+Evidence+of+neuroprotective+property+in+Parkinson%E2%80%99s+disease+animal+models+induced+by+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+and+lactacystin&doi=10.1002%2Fjnr.22405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel D3 dopamine receptor-preferring agonist D-264: evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin</span></div><div class="casAuthors">Li, Chao; Biswas, S.; Li, Xingang; Dutta, A. K.; Le, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2513-2523</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD), a progressive neurodegenerative movement disorder, is known to be caused by diverse pathol. conditions resulting from dysfunction of the ubiquitin-proteasome system (UPS), mitochondria, and oxidative stress leading to preferential nigral dopamine (DA) neuron degeneration in the substantia nigra.  In the present study, we evaluated the novel D3 receptor-preferring agonist D-264 in a mouse model of PD to evaluate its neuroprotective properties against both the nigrostriatal dopaminergic toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- and the proteasome inhibitor lactacystin-induced dopaminergic degeneration.  C57BL/6 male mice either were given MPTP by i.p. injection twice per day for 2 successive days at a dose 20 mg/kg or were microinjected with lactacystin bilaterally (1.25 μg/side) into the medial forebrain bundle (MFB).  Pretreatment with D-264 (1 mg/kg and 5 mg/kg, i.p., once per day), started 7 days before administration of MPTP or lactacystin.  We found that D-264 significantly improved behavioral performance, attenuated both MPTP- and lactacystin-induced DA neuron loss, and blocked proteasomal inhibition and microglial activation in the substantia nigra (SN).  Furthermore, D-264 treatment was shown to increase the levels of brain-derived neurotrophic factor (BDNF) and glial cell line-derived factor (GDNF) in MPTP- and lactacystin-treated mice, possibly indicating, at least in part, the mechanism of neuroprotection by D-264.  Furthermore, pretreatment with the D3 receptor antagonist U99194 significantly altered the effect of neuroprotection conferred by D-264.  Collectively, our study demonstrates that D-264 can prevent neurodegeneration induced by the selective neurotoxin MPTP and the UPS inhibitor lactacystin.  The results indicate that D-264 could potentially serve as a symptomatic and neuroprotective treatment agent for PD. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5cBGfbUSM67Vg90H21EOLACvtfcHk0lj_WRXUyHfaDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1GmtLY%253D&md5=32d866170d2ac26eafa98608393881c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22405%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DLe%26aufirst%3DW.%26atitle%3DNovel%2520D3%2520dopamine%2520receptor-preferring%2520agonist%2520D-264%253A%2520Evidence%2520of%2520neuroprotective%2520property%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520animal%2520models%2520induced%2520by%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520and%2520lactacystin%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2010%26volume%3D88%26spage%3D2513%26epage%3D2523%26doi%3D10.1002%2Fjnr.22405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gogoi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Dopamine D(2)/D(3) agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson’s disease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span><span class="refDoi"> DOI: 10.1002/cmdc.201100140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fcmdc.201100140" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=991-995&author=S.+Gogoiauthor=T.+Antonioauthor=S.+Rajagopalanauthor=M.+Reithauthor=J.+Andersenauthor=A.+K.+Dutta&title=Dopamine+D%282%29%2FD%283%29+agonists+with+potent+iron+chelation%2C+antioxidant+and+neuroprotective+properties%3A+potential+implication+in+symptomatic+and+neuroprotective+treatment+of+Parkinson%E2%80%99s+disease&doi=10.1002%2Fcmdc.201100140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100140%26sid%3Dliteratum%253Aachs%26aulast%3DGogoi%26aufirst%3DS.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DRajagopalan%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DJ.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DDopamine%2520D%25282%2529%252FD%25283%2529%2520agonists%2520with%2520potent%2520iron%2520chelation%252C%2520antioxidant%2520and%2520neuroprotective%2520properties%253A%2520potential%2520implication%2520in%2520symptomatic%2520and%2520neuroprotective%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D991%26epage%3D995%26doi%3D10.1002%2Fcmdc.201100140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Structure-activity relationship study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydroben zo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5826</span><span class="NLM_x">–</span> <span class="NLM_lpage">5840</span><span class="refDoi"> DOI: 10.1021/jm300268s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300268s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsF2gurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5826-5840&author=M.+Johnsonauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Structure-activity+relationship+study+of+N%286%29-%282-%284-%281H-Indol-5-yl%29piperazin-1-yl%29ethyl%29-N%286%29-propyl-4%2C5%2C6%2C7-tetrahydroben+zo%5Bd%5Dthiazole-2%2C6-diamine+analogues%3A+development+of+highly+selective+D3+dopamine+receptor+agonists+along+with+a+highly+potent+D2%2FD3+agonist+and+their+pharmacological+characterization&doi=10.1021%2Fjm300268s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization</span></div><div class="casAuthors">Johnson, Mark; Antonio, Tamara; Reith, Maarten E. A.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5826-5840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In our effort to develop multifunctional drugs against Parkinson's disease, a structure-activity-relationship study was carried out based on our hybrid mol. template targeting D2/D3 receptors.  Competitive binding with [3H]spiroperidol was used to evaluate affinity (Ki) of test compds.  Functional activity of selected compds. in stimulating [35S]GTPγS binding was assessed in CHO cells expressing either human D2 or D3 receptors.  Our results demonstrated development of highly selective compds. for D3 receptor (for (-)-40 (I) Ki, D3 = 1.84 nM, D2/D3 = 583.2; for (-)-45Ki, D3 = 1.09 nM, D2/D3 = 827.5).  Functional data identified (-)-40 (EC50, D2 = 114 nM, D3 = 0.26 nM, D2/D3 = 438) as one of the highest D3 selective agonists known to date.  In addn., high affinity, nonselective D3 agonist (-)-19 (EC50, D2 = 2.96 nM and D3 = 1.26 nM) was also developed.  Lead compds. with antioxidant activity were evaluated using an in vivo PD animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6RjEg-1KqXbVg90H21EOLACvtfcHk0lj_WRXUyHfaDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsF2gurk%253D&md5=3b8cfcd3f1e19da405875c342ba3abdc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300268s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300268s%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520N%25286%2529-%25282-%25284-%25281H-Indol-5-yl%2529piperazin-1-yl%2529ethyl%2529-N%25286%2529-propyl-4%252C5%252C6%252C7-tetrahydroben%2520zo%255Bd%255Dthiazole-2%252C6-diamine%2520analogues%253A%2520development%2520of%2520highly%2520selective%2520D3%2520dopamine%2520receptor%2520agonists%2520along%2520with%2520a%2520highly%2520potent%2520D2%252FD3%2520agonist%2520and%2520their%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5826%26epage%3D5840%26doi%3D10.1021%2Fjm300268s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Santra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">D-512 and D-440 as novel multifunctional dopamine agonists: characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson’s disease animal model</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1382</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span><span class="refDoi"> DOI: 10.1021/cn400106n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400106n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SisbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1382-1392&author=S.+Santraauthor=L.+Xuauthor=M.+Shahauthor=M.+Johnsonauthor=A.+Dutta&title=D-512+and+D-440+as+novel+multifunctional+dopamine+agonists%3A+characterization+of+neuroprotection+properties+and+evaluation+of+in+vivo+efficacy+in+a+Parkinson%E2%80%99s+disease+animal+model&doi=10.1021%2Fcn400106n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">D-512 and D-440 as Novel Multifunctional Dopamine Agonists: Characterization of Neuroprotection Properties and Evaluation of In Vivo Efficacy in a Parkinson's Disease Animal Model</span></div><div class="casAuthors">Santra, Soumava; Xu, Liping; Shah, Mrudang; Johnson, Mark; Dutta, Aloke</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1382-1392</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this Article, we have demonstrated the in vivo efficacy of D-512 and D-440 in a 6-OHDA-induced unilaterally lesioned rat model expt., a Parkinson's disease animal model.  D-512 is a novel highly potent D2/D3 agonist, and D-440 is a novel highly selective D3 agonist.  We evaluated the neuroprotective properties of D-512 and D-440 in the dopaminergic MN9D cells.  Cotreatment of these two drugs with 6-OHDA and MPP+ significantly attenuated and reversed 6-OHDA- and MPP+-induced toxicity in a dose-dependent manner in the dopaminergic MN9D cells.  The inhibition of caspase 3/7 and lipid peroxidn. activities along with the restoration of tyrosine hydroxylase levels by D-512 in 6-OHDA-treated cells may partially explain the mechanism of its neuroprotective property.  Furthermore, studies were carried out to elucidate the time-dependent changes in the pERK1/2 and pAkt, two kinases implicated in cell survival and apoptosis, levels upon treatment with 6-OHDA in presence of D-512.  The neuroprotective property exhibited by these drugs was independent of their dopamine-agonist activity, which is consistent with our multifunctional drug-development approach that is focused on the generation of disease-modifying symptomatic-treatment agents for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAHJ2ZjHMCALVg90H21EOLACvtfcHk0ljxwkm_F4ldKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SisbvL&md5=a50aaf8e29fa94a3257d51ef217a9836</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcn400106n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400106n%26sid%3Dliteratum%253Aachs%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DD-512%2520and%2520D-440%2520as%2520novel%2520multifunctional%2520dopamine%2520agonists%253A%2520characterization%2520of%2520neuroprotection%2520properties%2520and%2520evaluation%2520of%2520in%2520vivo%2520efficacy%2520in%2520a%2520Parkinson%25E2%2580%2599s%2520disease%2520animal%2520model%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1382%26epage%3D1392%26doi%3D10.1021%2Fcn400106n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voshavar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shurubor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1111/jnc.12767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1111%2Fjnc.12767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=24848702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2nu7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2014&pages=74-85&author=M.+Shahauthor=S.+Rajagopalanauthor=L.+Xuauthor=C.+Voshavarauthor=Y.+Shuruborauthor=F.+Bealauthor=J.+K.+Andersenauthor=A.+K.+Dutta&title=The+high-affinity+D2%2FD3+agonist+D512+protects+PC12+cells+from+6-OHDA-induced+apoptotic+cell+death+and+rescues+dopaminergic+neurons+in+the+MPTP+mouse+model+of+Parkinson%E2%80%99s+disease&doi=10.1111%2Fjnc.12767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease</span></div><div class="casAuthors">Shah, Mrudang; Rajagopalan, Subramanian; Xu, Liping; Voshavar, Chandrashekhar; Shurubor, Yevgeniya; Beal, Flint; Andersen, Julie K.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-85</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In this study, in vitro and in vivo expts. were carried out with the high-affinity multifunctional D2/D3 agonist D-512 to explore its potential neuroprotective effects in models of Parkinson's disease and the potential mechanism(s) underlying such properties.  Pre-treatment with D-512 in vitro was found to rescue rat adrenal Pheochromocytoma PC12 cells from toxicity induced by 6-hydroxydopamine administration in a dose-dependent manner.  Neuroprotection was found to coincide with redns. in intracellular reactive oxygen species, lipid peroxidn., and DNA damage.  In vivo, pre-treatment with 0.5 mg/kg D-512 was protective against neurodegenerative phenotypes assocd. with systemic administration of MPTP, including losses in striatal dopamine, redns. in nos. of DAergic neurons in the substantia nigra (SN), and locomotor dysfunction.  These observations strongly suggest that the multifunctional drug D-512 may constitute a novel viable therapy for Parkinson's disease.  Neuroprotective properties of dopamine D2/D3 agonist D-512 was evaluated both in vitro and in vivo models of Parkinson's disease (PD).  D-512 rescued PC12 cells from toxicity induced by 6-hydroxydopamine (6-OHDA).  D-512 reduced intracellular reactive oxygen species and lipid peroxidn. as well as protection of DNA damage from toxicity of 6-OHDA.  D-512 was protective against neurodegenerative phenotypes induced by MPTP in mouse.  Our studies strongly suggest that D-512 with its multifunctional property may constitute a novel viable therapy for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAfJdHZ9ekY7Vg90H21EOLACvtfcHk0ljxwkm_F4ldKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2nu7%252FN&md5=3219f1a318d7dc556b9441dbd8530091</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12767%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%26aulast%3DRajagopalan%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DVoshavar%26aufirst%3DC.%26aulast%3DShurubor%26aufirst%3DY.%26aulast%3DBeal%26aufirst%3DF.%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DThe%2520high-affinity%2520D2%252FD3%2520agonist%2520D512%2520protects%2520PC12%2520cells%2520from%25206-OHDA-induced%2520apoptotic%2520cell%2520death%2520and%2520rescues%2520dopaminergic%2520neurons%2520in%2520the%2520MPTP%2520mouse%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D131%26spage%3D74%26epage%3D85%26doi%3D10.1111%2Fjnc.12767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Modi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Structural modifications of neuroprotective anti-Parkinsonian (−)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobe nzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1572</span><span class="refDoi"> DOI: 10.1021/jm401883v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401883v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1557-1572&author=G.+Modiauthor=T.+Antonioauthor=M.+Reithauthor=A.+Dutta&title=Structural+modifications+of+neuroprotective+anti-Parkinsonian+%28%E2%88%92%29-N6-%282-%284-%28biphenyl-4-yl%29piperazin-1-yl%29-ethyl%29-N6-propyl-4%2C5%2C6%2C7-tetrahydrobe+nzo%5Bd%5Dthiazole-2%2C6-diamine+%28D-264%29%3A+an+effort+toward+the+improvement+of+in+vivo+efficacy+of+the+parent+molecule&doi=10.1021%2Fjm401883v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm401883v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401883v%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DG.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DStructural%2520modifications%2520of%2520neuroprotective%2520anti-Parkinsonian%2520%2528%25E2%2588%2592%2529-N6-%25282-%25284-%2528biphenyl-4-yl%2529piperazin-1-yl%2529-ethyl%2529-N6-propyl-4%252C5%252C6%252C7-tetrahydrobe%2520nzo%255Bd%255Dthiazole-2%252C6-diamine%2520%2528D-264%2529%253A%2520an%2520effort%2520toward%2520the%2520improvement%2520of%2520in%2520vivo%2520efficacy%2520of%2520the%2520parent%2520molecule%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1557%26epage%3D1572%26doi%3D10.1021%2Fjm401883v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Modi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voshavar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogoi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span><span class="refDoi"> DOI: 10.1021/cn500084x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500084x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVaksrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=700-717&author=G.+Modiauthor=C.+Voshavarauthor=S.+Gogoiauthor=M.+Shahauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Multifunctional+D2%2FD3+agonist+D-520+with+high+in+vivo+efficacy%3A+modulator+of+toxicity+of+alpha-synuclein+aggregates&doi=10.1021%2Fcn500084x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional D2/D3 Agonist D-520 with High in Vivo Efficacy: Modulator of Toxicity of Alpha-Synuclein Aggregates</span></div><div class="casAuthors">Modi, Gyan; Voshavar, Chandrashekhar; Gogoi, Sanjib; Shah, Mrudang; Antonio, Tamara; Reith, Maarten E. A.; Dutta, Aloke K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">700-717</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed a series of dihydroxy compds. and related analogs based on our hybrid D2/D3 agonist mol. template to develop multifunctional drugs for symptomatic and neuroprotective treatment for Parkinson's disease (PD).  The lead compd. (-)-24b (D-520) exhibited high agonist potency at D2/D3 receptors and produced efficacious activity in the animal models for PD.  The data from thioflavin T (ThT) assay and from transmission electron microscopy (TEM) anal. demonstrate that D-520 is able to modulate aggregation of alpha-synuclein (αSN).  Addnl., coincubation of D-520 with αSN is able to reduce toxicity of preformed aggregates of αSN compared to control αSN alone.  Finally, in a neuroprotection study with dopaminergic MN9D cells, D-520 clearly demonstrated the effect of neuroprotection from toxicity of 6-hydroxydopamine.  Thus, compd. D-520 possesses properties characteristic of multifunctionality conducive to symptomatic and neuroprotective treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn9f2avCxAqbVg90H21EOLACvtfcHk0ljxwkm_F4ldKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVaksrjJ&md5=5660e1b61a029716a21ee7e156a75100</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcn500084x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500084x%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DG.%26aulast%3DVoshavar%26aufirst%3DC.%26aulast%3DGogoi%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DMultifunctional%2520D2%252FD3%2520agonist%2520D-520%2520with%2520high%2520in%2520vivo%2520efficacy%253A%2520modulator%2520of%2520toxicity%2520of%2520alpha-synuclein%2520aggregates%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D700%26epage%3D717%26doi%3D10.1021%2Fcn500084x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments: binding activity at D2 and D3 receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.1016/S0960-894X(01)00820-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0960-894X%2801%2900820-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=619-622&author=A.+K.+Duttaauthor=X.+S.+Feiauthor=M.+E.+Reith&title=A+novel+series+of+hybrid+compounds+derived+by+combining+2-aminotetralin+and+piperazine+fragments%3A+binding+activity+at+D2+and+D3+receptors&doi=10.1016%2FS0960-894X%2801%2900820-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900820-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900820-4%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DFei%26aufirst%3DX.%2BS.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DA%2520novel%2520series%2520of%2520hybrid%2520compounds%2520derived%2520by%2520combining%25202-aminotetralin%2520and%2520piperazine%2520fragments%253A%2520binding%2520activity%2520at%2520D2%2520and%2520D3%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D619%26epage%3D622%26doi%3D10.1016%2FS0960-894X%2801%2900820-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolhatkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4361</span><span class="NLM_x">–</span> <span class="NLM_lpage">4373</span><span class="refDoi"> DOI: 10.1016/j.bmc.2004.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.bmc.2004.06.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4361-4373&author=A.+K.+Duttaauthor=S.+K.+Venkataramanauthor=X.+S.+Feiauthor=R.+Kolhatkarauthor=S.+Zhangauthor=M.+E.+Reith&title=Synthesis+and+biological+characterization+of+novel+hybrid+7-%5B%5B2-%284-phenyl-piperazin-1-yl%29-ethyl%5D-propyl-amino%5D-5%2C6%2C7%2C8-tetrahydro-naphthalen-2-ol+and+their+heterocyclic+bioisosteric+analogues+for+dopamine+D2+and+D3+receptors&doi=10.1016%2Fj.bmc.2004.06.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DVenkataraman%26aufirst%3DS.%2BK.%26aulast%3DFei%26aufirst%3DX.%2BS.%26aulast%3DKolhatkar%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DSynthesis%2520and%2520biological%2520characterization%2520of%2520novel%2520hybrid%25207-%255B%255B2-%25284-phenyl-piperazin-1-yl%2529-ethyl%255D-propyl-amino%255D-5%252C6%252C7%252C8-tetrahydro-naphthalen-2-ol%2520and%2520their%2520heterocyclic%2520bioisosteric%2520analogues%2520for%2520dopamine%2520D2%2520and%2520D3%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4361%26epage%3D4373%26doi%3D10.1016%2Fj.bmc.2004.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Markey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, C. J.</span><span> </span><span class="NLM_article-title">A new route to alpha-carbolines based on 6pi-electrocyclization of indole-3-alkenyl oximes</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6306</span><span class="NLM_x">–</span> <span class="NLM_lpage">6308</span><span class="refDoi"> DOI: 10.1021/ol403191k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol403191k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=6306-6308&author=S.+J.+Markeyauthor=W.+Lewisauthor=C.+J.+Moody&title=A+new+route+to+alpha-carbolines+based+on+6pi-electrocyclization+of+indole-3-alkenyl+oximes&doi=10.1021%2Fol403191k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fol403191k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol403191k%26sid%3Dliteratum%253Aachs%26aulast%3DMarkey%26aufirst%3DS.%2BJ.%26aulast%3DLewis%26aufirst%3DW.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DA%2520new%2520route%2520to%2520alpha-carbolines%2520based%2520on%25206pi-electrocyclization%2520of%2520indole-3-alkenyl%2520oximes%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D6306%26epage%3D6308%26doi%3D10.1021%2Fol403191k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Practical, asymmetric synthesis of aromatic-substituted bulky and hydrophobic tryptophan derivatives</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">7717</span><span class="NLM_x">–</span> <span class="NLM_lpage">7719</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)01626-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0040-4039%2801%2901626-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsV2ku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=7717-7719&author=W.+Wangauthor=C.+Xiongauthor=J.+Yangauthor=V.+J.+Hruby&title=Practical%2C+asymmetric+synthesis+of+aromatic-substituted+bulky+and+hydrophobic+tryptophan+derivatives&doi=10.1016%2FS0040-4039%2801%2901626-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Practical, asymmetric synthesis of aromatic-substituted bulky and hydrophobic tryptophan derivatives</span></div><div class="casAuthors">Wang, Wei; Xiong, Chiyi; Yang, Jianqing; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">7717-7719</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An efficient method for the synthesis of novel arom. substituted, bulky and hydrophobic tryptophan derivs. has been developed.  Asym. hydrogenations of α-enamide (I) using Burk's DuPHOS-based catalysts generated high enantiomerically pure D- and L-α-amino acid derivs., which subsequently underwent Suzuki cross couplings with boronic acid derivs. to afford arom. substituted D- and L-tryptophan derivs. (II; Ar = Ph, MeO-4-C6H4-, 1-naphthyl) in high yields.  The method can allow for the prepn. of such amino acids in large-scales for extensive structure-activity studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYQXdd5_07Vg90H21EOLACvtfcHk0lik9rpneYyjIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsV2ku7w%253D&md5=792e44d5a38c3d4ed735aab2f08c7b4a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2901626-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252901626-4%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DPractical%252C%2520asymmetric%2520synthesis%2520of%2520aromatic-substituted%2520bulky%2520and%2520hydrophobic%2520tryptophan%2520derivatives%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D7717%26epage%3D7719%26doi%3D10.1016%2FS0040-4039%2801%2901626-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Parikh, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doering, W. v. E.</span><span> </span><span class="NLM_article-title">Sulfur trioxide in the oxidation of alcohols by dimethyl sulfoxide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5507</span><span class="refDoi"> DOI: 10.1021/ja00997a067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00997a067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaF1cXjtV2q" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1967&pages=5505-5507&author=J.+R.+Parikhauthor=W.+v.+E.+Doering&title=Sulfur+trioxide+in+the+oxidation+of+alcohols+by+dimethyl+sulfoxide&doi=10.1021%2Fja00997a067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfur trioxide in the oxidation of alcohols by dimethyl sulfoxide</span></div><div class="casAuthors">Parikh, Jekishan R.; Doering, William v. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5505-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A soln. of pyridine-SO3 complex in Me2SO is used to oxidize p-nitrobenzyl alc., l-menthol, and many steroidal alcs. to the corresponding aldehydes and ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ2qbwXRJMT7Vg90H21EOLACvtfcHk0lik9rpneYyjIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXjtV2q&md5=fa83f740ef49cb695547ae90c1ae291a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja00997a067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00997a067%26sid%3Dliteratum%253Aachs%26aulast%3DParikh%26aufirst%3DJ.%2BR.%26aulast%3DDoering%26aufirst%3DW.%2Bv.%2BE.%26atitle%3DSulfur%2520trioxide%2520in%2520the%2520oxidation%2520of%2520alcohols%2520by%2520dimethyl%2520sulfoxide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1967%26volume%3D89%26spage%3D5505%26epage%3D5507%26doi%3D10.1021%2Fja00997a067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Schneider, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierau, J.</span><span> </span><span class="NLM_article-title">Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.1021/jm00386a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00386a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=494-498&author=C.+S.+Schneiderauthor=J.+Mierau&title=Dopamine+autoreceptor+agonists%3A+resolution+and+pharmacological+activity+of+2%2C6-diaminotetrahydrobenzothiazole+and+an+aminothiazole+analogue+of+apomorphine&doi=10.1021%2Fjm00386a009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00386a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00386a009%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DC.%2BS.%26aulast%3DMierau%26aufirst%3DJ.%26atitle%3DDopamine%2520autoreceptor%2520agonists%253A%2520resolution%2520and%2520pharmacological%2520activity%2520of%25202%252C6-diaminotetrahydrobenzothiazole%2520and%2520an%2520aminothiazole%2520analogue%2520of%2520apomorphine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D494%26epage%3D498%26doi%3D10.1021%2Fjm00386a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Mancuso, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swern, D.</span><span> </span><span class="NLM_article-title">Oxidation of long-chain and related alcohols to carbonyls by dimethyl sulfoxide ″activated″ by oxalyl chloride</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2480</span><span class="NLM_x">–</span> <span class="NLM_lpage">2482</span><span class="refDoi"> DOI: 10.1021/jo00406a041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00406a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaE1cXkt1elu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=2480-2482&author=A.+J.+Mancusoauthor=S.-L.+Huangauthor=D.+Swern&title=Oxidation+of+long-chain+and+related+alcohols+to+carbonyls+by+dimethyl+sulfoxide+%E2%80%B3activated%E2%80%B3+by+oxalyl+chloride&doi=10.1021%2Fjo00406a041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of long-chain and related alcohols to carbonyls by dimethyl sulfoxide "activated" by oxalyl chloride</span></div><div class="casAuthors">Mancuso, Anthony J.; Huang, Shui-Lung; Swern, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2480-2</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Higher alkanols and alkenols, farnesol, lower alkynols, and cholesterol were oxidized to the resp. carbonyl compds. by Me2SO-(COCl)2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPghc3oGz-GrVg90H21EOLACvtfcHk0lh0U038P7dd5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXkt1elu74%253D&md5=346ac457db6d8a6ff8d5b3c1e826701a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo00406a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00406a041%26sid%3Dliteratum%253Aachs%26aulast%3DMancuso%26aufirst%3DA.%2BJ.%26aulast%3DHuang%26aufirst%3DS.-L.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DOxidation%2520of%2520long-chain%2520and%2520related%2520alcohols%2520to%2520carbonyls%2520by%2520dimethyl%2520sulfoxide%2520%25E2%2580%25B3activated%25E2%2580%25B3%2520by%2520oxalyl%2520chloride%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D2480%26epage%3D2482%26doi%3D10.1021%2Fjo00406a041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Correction to structure-activity relationship study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydroben zo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1021/jm301634c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301634c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=589-590&author=M.+Johnsonauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Correction+to+structure-activity+relationship+study+of+N%286%29-%282-%284-%281H-Indol-5-yl%29piperazin-1-yl%29ethyl%29-N%286%29-propyl-4%2C5%2C6%2C7-tetrahydroben+zo%5Bd%5Dthiazole-2%2C6-diamine+analogues%3A+development+of+highly+selective+D3+dopamine+receptor+agonists+along+with+a+highly+potent+D2%2FD3+agonist+and+their+pharmacological+characterization&doi=10.1021%2Fjm301634c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm301634c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301634c%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DCorrection%2520to%2520structure-activity%2520relationship%2520study%2520of%2520N%25286%2529-%25282-%25284-%25281H-Indol-5-yl%2529piperazin-1-yl%2529ethyl%2529-N%25286%2529-propyl-4%252C5%252C6%252C7-tetrahydroben%2520zo%255Bd%255Dthiazole-2%252C6-diamine%2520analogues%253A%2520development%2520of%2520highly%2520selective%2520D3%2520dopamine%2520receptor%2520agonists%2520along%2520with%2520a%2520highly%2520potent%2520D2%252FD3%2520agonist%2520and%2520their%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D589%26epage%3D590%26doi%3D10.1021%2Fjm301634c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Langlois, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouilhès, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Génin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andriamialisoa, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, N.</span><span> </span><span class="NLM_article-title">New approaches to the synthesis of eburnane alkaloids</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3755</span><span class="NLM_x">–</span> <span class="NLM_lpage">3761</span><span class="refDoi"> DOI: 10.1016/S0040-4020(01)88616-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0040-4020%2801%2988616-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1983&pages=3755-3761&author=Y.+Langloisauthor=A.+Pouilh%C3%A8sauthor=D.+G%C3%A9ninauthor=R.+Z.+Andriamialisoaauthor=N.+Langlois&title=New+approaches+to+the+synthesis+of+eburnane+alkaloids&doi=10.1016%2FS0040-4020%2801%2988616-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2988616-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252988616-6%26sid%3Dliteratum%253Aachs%26aulast%3DLanglois%26aufirst%3DY.%26aulast%3DPouilh%25C3%25A8s%26aufirst%3DA.%26aulast%3DG%25C3%25A9nin%26aufirst%3DD.%26aulast%3DAndriamialisoa%26aufirst%3DR.%2BZ.%26aulast%3DLanglois%26aufirst%3DN.%26atitle%3DNew%2520approaches%2520to%2520the%2520synthesis%2520of%2520eburnane%2520alkaloids%26jtitle%3DTetrahedron%26date%3D1983%26volume%3D39%26spage%3D3755%26epage%3D3761%26doi%3D10.1016%2FS0040-4020%2801%2988616-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallis, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisholm, J. D.</span><span> </span><span class="NLM_article-title">Tandem oxidation/halogenation of aryl allylic alcohols under Moffatt–Swern conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">7054</span><span class="NLM_x">–</span> <span class="NLM_lpage">7057</span><span class="refDoi"> DOI: 10.1021/jo0711992</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0711992" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=7054-7057&author=J.+Yinauthor=C.+E.+Gallisauthor=J.+D.+Chisholm&title=Tandem+oxidation%2Fhalogenation+of+aryl+allylic+alcohols+under+Moffatt%E2%80%93Swern+conditions&doi=10.1021%2Fjo0711992"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo0711992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0711992%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DGallis%26aufirst%3DC.%2BE.%26aulast%3DChisholm%26aufirst%3DJ.%2BD.%26atitle%3DTandem%2520oxidation%252Fhalogenation%2520of%2520aryl%2520allylic%2520alcohols%2520under%2520Moffatt%25E2%2580%2593Swern%2520conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D7054%26epage%3D7057%26doi%3D10.1021%2Fjo0711992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Živec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anžič, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">A novel scalable synthesis of pramipexole</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1129</span><span class="refDoi"> DOI: 10.1021/op1000989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op1000989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=1125-1129&author=M.+%C5%BDivecauthor=B.+An%C5%BEi%C4%8Dauthor=S.+Gobec&title=A+novel+scalable+synthesis+of+pramipexole&doi=10.1021%2Fop1000989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fop1000989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop1000989%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25BDivec%26aufirst%3DM.%26aulast%3DAn%25C5%25BEi%25C4%258D%26aufirst%3DB.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DA%2520novel%2520scalable%2520synthesis%2520of%2520pramipexole%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2010%26volume%3D14%26spage%3D1125%26epage%3D1129%26doi%3D10.1021%2Fop1000989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Brown, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrington, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthale n-2-ol: effect on affinity and selectivity for dopamine D3 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3933</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.04.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.bmc.2009.04.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3923-3933&author=D.+A.+Brownauthor=M.+Mishraauthor=S.+Zhangauthor=S.+Biswasauthor=I.+Parringtonauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Investigation+of+various+N-heterocyclic+substituted+piperazine+versions+of+5%2F7-%7B%5B2-%284-aryl-piperazin-1-yl%29-ethyl%5D-propyl-amino%7D-5%2C6%2C7%2C8-tetrahydro-naphthale+n-2-ol%3A+effect+on+affinity+and+selectivity+for+dopamine+D3+receptor&doi=10.1016%2Fj.bmc.2009.04.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BA.%26aulast%3DMishra%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DParrington%26aufirst%3DI.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DInvestigation%2520of%2520various%2520N-heterocyclic%2520substituted%2520piperazine%2520versions%2520of%25205%252F7-%257B%255B2-%25284-aryl-piperazin-1-yl%2529-ethyl%255D-propyl-amino%257D-5%252C6%252C7%252C8-tetrahydro-naphthale%2520n-2-ol%253A%2520effect%2520on%2520affinity%2520and%2520selectivity%2520for%2520dopamine%2520D3%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3923%26epage%3D3933%26doi%3D10.1016%2Fj.bmc.2009.04.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: comparison with functional GTPgammaS assays</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2015.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.jneumeth.2015.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=25840364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtFSjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2015&pages=7-15&author=J.+Zhenauthor=T.+Antonioauthor=S.+Aliauthor=K.+A.+Neveauthor=A.+K.+Duttaauthor=M.+E.+Reith&title=Use+of+radiolabeled+antagonist+assays+for+assessing+agonism+at+D2+and+D3+dopamine+receptors%3A+comparison+with+functional+GTPgammaS+assays&doi=10.1016%2Fj.jneumeth.2015.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: Comparison with functional GTPγS assays</span></div><div class="casAuthors">Zhen, Juan; Antonio, Tamara; Ali, Solav; Neve, Kim A.; Dutta, Aloke K.; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-15</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cell-based drug screening assays are essential tools for drug discovery and development targeting G protein-coupled receptors, which include dopamine D3 receptors.  D3 is notorious for its poor coupling to G protein in most heterologous cell lines, and therefore D3 agonist-stimulated binding of [35S]GTPγS to G protein cannot be obsd. in many "non-functional" D3 expressing cell lines.  The present work explores the use of an alternate method for assessing agonist activity, consisting of measuring the difference in agonist competition between [3H]spiperone bound to low-affinity states of the receptor and that with radioligand bound to high-affinity states (GTP shift assay).  The current study describes the detn. of GTP shifts in [3H]spiperone binding assays for the assessment of agonists' potencies (at D2 and D3) and efficacies (at D3).  Compared with GTP35γS binding assays, the new method removes the cumbersome need of functional D3 cell lines and limited project duration due to short half-life of isotope 35S.  The new method allows the estn. of potency (D2 and D3) and efficacy (D3) at the level of receptor and G protein activation in a simple fashion from shifts in monophasic-inhibition curves.  Moreover, it does not require [35S]GTPγS binding assays with functional D3 cells.  This method will have wide applicability for D3-selective agonist screening.  It may also be useful for other GPCRs circumventing the need for functional assays and offering the ability to detect agonist activity regardless of the particular signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCV3v1p95VarVg90H21EOLACvtfcHk0lgKMkz1BT9GOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtFSjtb0%253D&md5=5810dda72377ec553967c99dc8dc1a65</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2015.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2015.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DUse%2520of%2520radiolabeled%2520antagonist%2520assays%2520for%2520assessing%2520agonism%2520at%2520D2%2520and%2520D3%2520dopamine%2520receptors%253A%2520comparison%2520with%2520functional%2520GTPgammaS%2520assays%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2015%26volume%3D248%26spage%3D7%26epage%3D15%26doi%3D10.1016%2Fj.jneumeth.2015.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Giros, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martres, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Gene cloning of human dopaminergic D3 receptor and identification of its chromosome</span> <span class="citation_source-journal">C. R. Acad. Sci. III</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=2129115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK38XhsVym" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=1990&pages=501-508&author=B.+Girosauthor=M.+P.+Martresauthor=P.+Sokoloffauthor=J.+C.+Schwartz&title=Gene+cloning+of+human+dopaminergic+D3+receptor+and+identification+of+its+chromosome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the human dopaminergic D3 receptor gene and its chromosome identification</span></div><div class="casAuthors">Giros, Bruno; Martres, Marie Pascale; Sokoloff, Pierre; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Comptes Rendus de l'Academie des Sciences, Serie III:  Sciences de la Vie</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">501-8</span>CODEN:
                <span class="NLM_cas:coden">CRASEV</span>;
        ISSN:<span class="NLM_cas:issn">0764-4469</span>.
    </div><div class="casAbstract">The coding region of the human dopaminergic D3 receptor gene was cloned and sequenced.  The deduced amino acid sequence displays a global homol. of 78% with rat D3 receptor with a deletion of 46 residues within the third intracytoplasmic loop.  Southern anal. assigned the human gene to chromosome 3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt_FAWtR59PLVg90H21EOLACvtfcHk0lgKMkz1BT9GOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVym&md5=1167dbd5978fd1eb528ad7f097fc5204</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DMartres%26aufirst%3DM.%2BP.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DGene%2520cloning%2520of%2520human%2520dopaminergic%2520D3%2520receptor%2520and%2520identification%2520of%2520its%2520chromosome%26jtitle%3DC.%2520R.%2520Acad.%2520Sci.%2520III%26date%3D1990%26volume%3D311%26spage%3D501%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stofko, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frothingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke-Howie, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Server, A. C.</span><span> </span><span class="NLM_article-title">Cloning of the cDNA and gene for a human D2 dopamine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">9762</span><span class="NLM_x">–</span> <span class="NLM_lpage">9766</span><span class="refDoi"> DOI: 10.1073/pnas.86.24.9762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1073%2Fpnas.86.24.9762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=2532362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaK3cXksFegtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=9762-9766&author=D.+K.+Grandyauthor=M.+A.+Marchionniauthor=H.+Makamauthor=R.+E.+Stofkoauthor=M.+Alfanoauthor=L.+Frothinghamauthor=J.+B.+Fischerauthor=K.+J.+Burke-Howieauthor=J.+R.+Bunzowauthor=A.+C.+Server&title=Cloning+of+the+cDNA+and+gene+for+a+human+D2+dopamine+receptor&doi=10.1073%2Fpnas.86.24.9762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the cDNA and gene for a human D2 dopamine receptor</span></div><div class="casAuthors">Grandy, David K.; Marchionni, Mark A.; Makam, Haripriya; Stofko, Renata E.; Alfano, Mario; Frothingham, Leslie; Fischer, James B.; Burke-Howie, Kathleen J.; Bunzow, James R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9762-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A clone encoding a human D2 dopamine receptor was isolated from a pituitary cDNA library and sequenced.  The deduced protein sequence is 96% identical with that of the cloned rat receptor with one major difference: the human receptor contains an addnl. 29 amino acids in its putative third cytoplasmic loop.  Southern blotting demonstrated the presence of only 1 human D2 receptor gene.  Two overlapping phage contg. the gene were isolated and characterized.  DNA sequence anal. of these clones showed that the coding sequence is interrupted by 6 introns and that the addnl. amino acids present in the human pituitary receptor are encoded by a single exon of 87 base pairs.  The involvement of this sequence in alternative splicing and its biol. significance are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8flaLZHH5TrVg90H21EOLACvtfcHk0lgKMkz1BT9GOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFegtb8%253D&md5=08f829fb8ae6ab0d4e522525e94858a5</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.86.24.9762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.86.24.9762%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DMarchionni%26aufirst%3DM.%2BA.%26aulast%3DMakam%26aufirst%3DH.%26aulast%3DStofko%26aufirst%3DR.%2BE.%26aulast%3DAlfano%26aufirst%3DM.%26aulast%3DFrothingham%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DBurke-Howie%26aufirst%3DK.%2BJ.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DServer%26aufirst%3DA.%2BC.%26atitle%3DCloning%2520of%2520the%2520cDNA%2520and%2520gene%2520for%2520a%2520human%2520D2%2520dopamine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1989%26volume%3D86%26spage%3D9762%26epage%3D9766%26doi%3D10.1073%2Fpnas.86.24.9762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2010.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.jneumeth.2010.01.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=20122961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2010&pages=32-38&author=J.+Zhenauthor=T.+Antonioauthor=A.+K.+Duttaauthor=M.+E.+Reith&title=Concentration+of+receptor+and+ligand+revisited+in+a+modified+receptor+binding+protocol+for+high-affinity+radioligands%3A+%5B3H%5DSpiperone+binding+to+D2+and+D3+dopamine+receptors&doi=10.1016%2Fj.jneumeth.2010.01.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors</span></div><div class="casAuthors">Zhen, Juan; Antonio, Tamara; Dutta, Aloke K.; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-38</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In receptor binding assays with ultra-high-affinity radioligands, it is difficult, in practice, to adhere the golden rule that the receptor concn. in the assay should be substantially (at least 10-fold) lower than the dissocn. const. (K d) of the radioligand and inhibition const. (K i) of compd.  Esp. for low specific activity radioligands (usually tritiated ligands of a couple of TBq/mmol), routinely applied in concns. at around or below the K d, the use of extremely small amts. of receptor protein per assay will result in low levels of bound radioactivity; the alternative use of larger assay vols. will make it difficult to apply 96-well filtration devices.  For assessing the inhibition const. (K i) of competitive inhibitors under conditions violating the above golden rule, equations are available incorporating both [receptor] and [ligand] vs. K d; however, their application requires precise knowledge of [receptor] or initial bound/free [radioligand] ratio.  In this study, we present the theor. basis for detg. the K i for a competitive inhibitor in a new protocol at high [protein] and high [radioligand] with the simple Cheng-Prusoff correction without the need to correct for [receptor] or initial bound/free [radioligand] ratio.  In addn., we present results on the binding of the ultra-high-affinity ligand [3H]spiperone to dopamine D2 and D3 receptors validating the K i values calcd. with the new protocol for competitive inhibitors as compared with those calcd. with the most comprehensive equation available to date, that of .  Binding was measured at varying [radioligand] and [receptor], test compds. (including (-)5-OH-DPAT, (±)7-OH-DPAT, and ropinirole) were run with varying [receptor], and simulations were done at vastly varying [radioligand] for inhibitors with vastly different K is.  The modified high [radioligand] protocol presented here removes a major hindrance in the proper execution of binding assays with ultra-high-affinity tritiated ligands with K d values in the sub-nanomolar range, allowing the use of 96-well plates with small vols. of 100-200 μl per binding assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2qiImQ-s3ErVg90H21EOLACvtfcHk0ljZPXyJkaITBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKlu7c%253D&md5=ba058c5367570106bc335eddc32bc8ab</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2010.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2010.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DConcentration%2520of%2520receptor%2520and%2520ligand%2520revisited%2520in%2520a%2520modified%2520receptor%2520binding%2520protocol%2520for%2520high-affinity%2520radioligands%253A%2520%255B3H%255DSpiperone%2520binding%2520to%2520D2%2520and%2520D3%2520dopamine%2520receptors%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2010%26volume%3D188%26spage%3D32%26epage%3D38%26doi%3D10.1016%2Fj.jneumeth.2010.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopishetty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Further delineation of hydrophobic binding sites in dopamine D(2)/D(3) receptors for N-4 substituents on the piperazine ring of the hybrid template 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthale n-2-ol</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5661</span><span class="NLM_x">–</span> <span class="NLM_lpage">5674</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.bmc.2010.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5661-5674&author=B.+Ghoshauthor=T.+Antonioauthor=B.+Gopishettyauthor=M.+Reithauthor=A.+Dutta&title=Further+delineation+of+hydrophobic+binding+sites+in+dopamine+D%282%29%2FD%283%29+receptors+for+N-4+substituents+on+the+piperazine+ring+of+the+hybrid+template+5%2F7-%7B%5B2-%284-aryl-piperazin-1-yl%29-ethyl%5D-propyl-amino%7D-5%2C6%2C7%2C8-tetrahydro-naphthale+n-2-ol&doi=10.1016%2Fj.bmc.2010.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DGopishetty%26aufirst%3DB.%26aulast%3DReith%26aufirst%3DM.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DFurther%2520delineation%2520of%2520hydrophobic%2520binding%2520sites%2520in%2520dopamine%2520D%25282%2529%252FD%25283%2529%2520receptors%2520for%2520N-4%2520substituents%2520on%2520the%2520piperazine%2520ring%2520of%2520the%2520hybrid%2520template%25205%252F7-%257B%255B2-%25284-aryl-piperazin-1-yl%2529-ethyl%255D-propyl-amino%257D-5%252C6%252C7%252C8-tetrahydro-naphthale%2520n-2-ol%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5661%26epage%3D5674%26doi%3D10.1016%2Fj.bmc.2010.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Das, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Dopamine d3 agonists in the treatment of Parkinson’s disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">926</span><span class="refDoi"> DOI: 10.2174/156802661510150328223428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.2174%2F156802661510150328223428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=25832718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1akt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=908-926&author=B.+Dasauthor=G.+Modiauthor=A.+Dutta&title=Dopamine+d3+agonists+in+the+treatment+of+Parkinson%E2%80%99s+disease&doi=10.2174%2F156802661510150328223428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 Agonists in the Treatment of Parkinson's Disease</span></div><div class="casAuthors">Das, Banibrata; Modi, Gyan; Dutta, Aloke</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">908-926</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is t he second most common form of neurodegenerative disorders that results from the progressive loss of dopaminergic neurons in the midbrain substantia nigra pars compacta (SNpc) triggering profound motor perturbation, as well as cognitive, sensory and mood deficits.  Although these symptoms can be improved using currently available dopamine replacement strategies, they are not able to slow the neurodegenerative process that underlies PD progression.  Following the discovery of the D3 receptor from mol. cloning, it has gained much attention as a potential therapeutic target for the treatment of PD due to their localization in the limbic regions of the brain as well as pharmacol. similarity to the D2 receptor subtype.  Of particular interest, D3 receptor- selective agonists appear to have neuroprotective effects apart from their ability to relieve PD symptoms.  Owing to the distinct significance of D3 receptor in mediating diverse neurol. effects, it represents a unique target for therapeutic intervention in PD with much less undesirable side effects.  Herein, we review progress in the development of D3 receptor selective agonist mols. having a broad spectrum of affinities, selectivities as well as unique pharmacol. properties directed at slowing the neurodegeneration process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vO7t50SK9rVg90H21EOLACvtfcHk0ljZPXyJkaITBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1akt7w%253D&md5=46885592d050d099cbad73ba7ef8e61b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F156802661510150328223428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802661510150328223428%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DB.%26aulast%3DModi%26aufirst%3DG.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DDopamine%2520d3%2520agonists%2520in%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D908%26epage%3D926%26doi%3D10.2174%2F156802661510150328223428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Tadori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuade, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span> </span><span class="NLM_article-title">Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">607</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2009.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2Fj.ejphar.2009.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=19217900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=607&publication_year=2009&pages=35-40&author=Y.+Tadoriauthor=R.+A.+Forbesauthor=R.+D.+McQuadeauthor=T.+Kikuchi&title=Receptor+reserve-dependent+properties+of+antipsychotics+at+human+dopamine+D2+receptors&doi=10.1016%2Fj.ejphar.2009.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors</span></div><div class="casAuthors">Tadori, Yoshihiro; Forbes, Robert A.; McQuade, Robert D.; Kikuchi, Tetsuro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">607</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">35-40</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aripiprazole is the first dopamine D2/D3 receptor partial agonist approved for use in the treatment of psychiatric disorders including schizophrenia, bipolar disorder, and unipolar depression in the US.  Aripiprazole has demonstrated a relatively favorable side effect profile compared to other commonly prescribed antipsychotics, including a low propensity for treatment-limiting extrapyramidal symptoms, hyperprolactinemia, and body wt. gain.  In an effort to elucidate aripiprazole's pharmacol. activity in relation to clin. relevant fluctuation of dopamine D2 receptor reserves, we compared the properties of aripiprazole to other antipsychotics, quetiapine, clozapine, olanzapine, ziprasidone, risperidone and haloperidol, a dopamine D2 receptor partial agonist, bifeprunox, dopamine D3 receptor modulators, BP897 (N-[4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl]naphthalene-2-carboxamide) and GR103691 (4'-Acetyl-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]biphenyl-4-carboxamide), and a 5-HT1A partial agonist, buspirone using forskolin-stimulated cAMP accumulation in clonal Chinese hamster ovary cell lines expressing low and high densities of human dopamine D2S receptors (hD2S-Low and hD2S-High, resp.).  In hD2S-Low cells lacking receptor reserves for dopamine, all drugs antagonized dopamine responses, and their potencies correlated well with resp. affinities.  In hD2S-High cells possessing receptor reserves, all antipsychotics except aripiprazole antagonized dopamine responses, and their antagonist potencies were less than those in hD2S-Low cells treated with the equal dopamine concn.  In contrast, aripiprazole and bifeprunox acted as full agonists.  BP897, GR103691 and buspirone acted as partial agonists.  These data suggest that the level of receptor reserves influences antagonist potencies and side effects assocd. with antipsychotics.  Aripiprazole's unique receptor reserve dependent properties may account for its favorable tolerability in the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofSL8HTaf5hrVg90H21EOLACvtfcHk0ljiICoeiRaFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFWltr4%253D&md5=e1f85ac39e7fad2e3ab36e9ae33feebb</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DTadori%26aufirst%3DY.%26aulast%3DForbes%26aufirst%3DR.%2BA.%26aulast%3DMcQuade%26aufirst%3DR.%2BD.%26aulast%3DKikuchi%26aufirst%3DT.%26atitle%3DReceptor%2520reserve-dependent%2520properties%2520of%2520antipsychotics%2520at%2520human%2520dopamine%2520D2%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D607%26spage%3D35%26epage%3D40%26doi%3D10.1016%2Fj.ejphar.2009.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Reith, M. E. A.; Zhen, J.; Antonio, T.; Jacob, J. C.; Grandy, D.; Dutta, A. K.; Selley, D. E.</span><span> </span><span class="NLM_article-title">Influence of aromatic moieties linked to piperazine ring of tetrahydrobenzo[<i>d</i>]-thiazole based hybrid compounds impacts efficacy of dopamine D2/D3 agonists at D3 receptors</span>. <span class="NLM_conf-name">Society for Neuroscience Meeting</span>, <span class="NLM_conf-loc">Chicago</span>, <span class="NLM_conf-date">October 17–21, 2015</span>; in: abstract viewer and itinerary planner, Society for Neuroscience, online, no. 678.04.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Reith%2C+M.+E.+A.%3B+Zhen%2C+J.%3B+Antonio%2C+T.%3B+Jacob%2C+J.+C.%3B+Grandy%2C+D.%3B+Dutta%2C+A.+K.%3B+Selley%2C+D.+E.+Influence+of+aromatic+moieties+linked+to+piperazine+ring+of+tetrahydrobenzo%5Bd%5D-thiazole+based+hybrid+compounds+impacts+efficacy+of+dopamine+D2%2FD3+agonists+at+D3+receptors.+Society+for+Neuroscience+Meeting%2C+Chicago%2C+October+17%E2%80%9321%2C+2015%3B+in%3A+abstract+viewer+and+itinerary+planner%2C+Society+for+Neuroscience%2C+online%2C+no.+678.04."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26atitle%3DInfluence%2520of%2520aromatic%2520moieties%2520linked%2520to%2520piperazine%2520ring%2520of%2520tetrahydrobenzo%255Bd%255D-thiazole%2520based%2520hybrid%2520compounds%2520impacts%2520efficacy%2520of%2520dopamine%2520D2%252FD3%2520agonists%2520at%2520D3%2520receptors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Sally, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsin, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuvelis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span> </span><span class="NLM_article-title">Identification of a novel ″almost neutral″ micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1002/syn.20723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1002%2Fsyn.20723" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2010&pages=280-288&author=E.+J.+Sallyauthor=H.+Xuauthor=C.+M.+Derschauthor=L.+W.+Hsinauthor=L.+T.+Changauthor=T.+E.+Prisinzanoauthor=D.+S.+Simpsonauthor=D.+Giuvelisauthor=K.+C.+Riceauthor=A.+E.+Jacobsonauthor=K.+Chengauthor=E.+J.+Bilskyauthor=R.+B.+Rothman&title=Identification+of+a+novel+%E2%80%B3almost+neutral%E2%80%B3+micro-opioid+receptor+antagonist+in+CHO+cells+expressing+the+cloned+human+mu-opioid+receptor&doi=10.1002%2Fsyn.20723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20723%26sid%3Dliteratum%253Aachs%26aulast%3DSally%26aufirst%3DE.%2BJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26aulast%3DChang%26aufirst%3DL.%2BT.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DSimpson%26aufirst%3DD.%2BS.%26aulast%3DGiuvelis%26aufirst%3DD.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DJacobson%26aufirst%3DA.%2BE.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DBilsky%26aufirst%3DE.%2BJ.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26atitle%3DIdentification%2520of%2520a%2520novel%2520%25E2%2580%25B3almost%2520neutral%25E2%2580%25B3%2520micro-opioid%2520receptor%2520antagonist%2520in%2520CHO%2520cells%2520expressing%2520the%2520cloned%2520human%2520mu-opioid%2520receptor%26jtitle%3DSynapse%26date%3D2010%26volume%3D64%26spage%3D280%26epage%3D288%26doi%3D10.1002%2Fsyn.20723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindqvist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, T.</span><span> </span><span class="NLM_article-title">3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="refDoi"> DOI: 10.1038/1801200a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1038%2F1801200a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=13483658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADyaG1cXis1Kjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=1957&pages=1200&author=A.+Carlssonauthor=M.+Lindqvistauthor=T.+Magnusson&title=3%2C4-Dihydroxyphenylalanine+and+5-hydroxytryptophan+as+reserpine+antagonists&doi=10.1038%2F1801200a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists</span></div><div class="casAuthors">Carlsson, Arvid; Lindqvist, Margit; Magnusson, Tor</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1200</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Male mice, 16 hrs. after reserpine injection, markedly tranquillized and showing complete ptosis of the eyelid, were intraperitoneally injected with 5-hydroxytryptophan (I), 3,4-dihydroxyphenylalanine (II), or a mixt. of both amino acids (DL-form).  In doses up to 1000 mg./kg. I was unable to antagonize the tranquillizing action of reserpine.  Response to an injection of 500-1000 mg./kg. of II was dramatic.  The animals resumed normal behavior and ptosis disappeared within 15-30 min.  The effect lasted approx. 1 hr. followed by return to the former tranquillized condition.  Equal amts., 250-500 mg./kg., of I and II injected at the same time produced a more complete and longer-lasting effect than did II alone.  Intravenous injection of II (200 mg./kg.) in rabbits was very effective in overcoming the effect of reserpine injection.  Tranquillization as well as ptosis and meiosis disappeared within 10-15 min. after injection of II.  Injection of iproniazid (100 mg./kg.) 2 hrs. prior to injection of II markedly reduced the amt. of II needed to overcome the effects of reserpine, however, it had no effect without II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5al1bdzjz_LVg90H21EOLACvtfcHk0ljiICoeiRaFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXis1Kjuw%253D%253D&md5=72d0b819b514e9db1e2707b5d230fb2e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2F1801200a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1801200a0%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindqvist%26aufirst%3DM.%26aulast%3DMagnusson%26aufirst%3DT.%26atitle%3D3%252C4-Dihydroxyphenylalanine%2520and%25205-hydroxytryptophan%2520as%2520reserpine%2520antagonists%26jtitle%3DNature%26date%3D1957%26volume%3D180%26spage%3D1200%26doi%3D10.1038%2F1801200a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Skalisz, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijamini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joca, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vital, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Cunha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreatini, R.</span><span> </span><span class="NLM_article-title">Evaluation of the face validity of reserpine administration as an animal model of depression--Parkinson’s disease association</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">883</span><span class="refDoi"> DOI: 10.1016/S0278-5846(01)00333-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0278-5846%2801%2900333-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=12369260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVCitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2002&pages=879-883&author=L.+L.+Skaliszauthor=V.+Beijaminiauthor=S.+L.+Jocaauthor=M.+A.+Vitalauthor=C.+Da+Cunhaauthor=R.+Andreatini&title=Evaluation+of+the+face+validity+of+reserpine+administration+as+an+animal+model+of+depression%2D%2DParkinson%E2%80%99s+disease+association&doi=10.1016%2FS0278-5846%2801%2900333-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the face validity of reserpine administration as an animal model of depression-Parkinson's disease association</span></div><div class="casAuthors">Skalisz, Luana L.; Beijamini, Vanessa; Joca, Samia L.; Vital, Maria A. B. F.; Da Cunha, Claudio; Andreatini, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">879-883</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aim of the present study was to develop an animal model for the study of depressive symptoms assocd. with Parkinson's disease (PD).  Mice treated i.p. with reserpine (RES), 2.0 and 1.0 mg/kg, or its vehicle (VEHIC) were submitted to the sucrose soln. (2%) consumption test (a model employed to mimic the depressive symptoms found in PD) and to the spontaneous locomotor activity test (a model employed to mimic the motor impairment found in PD).  All animals were submitted to both tests.  Twenty-four hours after treatment, only RES 2.0-treated animals showed a significantly decreased preference for the sucrose soln. (mean ± S.E.M. RES 2.0=54.4±4.1%, RES 1.0=68.5±2.5%, VEHIC=62.3±4.1%).  There was no significant difference among groups in water, sucrose or total fluid consumption.  Locomotor activity was significantly decreased by both RES doses (no. of beam interruptions: RES 2.0=59.9±11.4, RES 1.0=82.2±9.7, VEHIC=116.8±8.2).  Thus, RES 2.0 administration to mice induced depressive (anhedonia) and motor (decreased locomotor activity) symptoms of depression-PD assocn.  This suggests that the RES model shows an important aspect of face validity for the depressive state assocd. with PD, i.e., phenomenol. similarities between the model and the situation being modeled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx-zmSPZjpsrVg90H21EOLACvtfcHk0ljiICoeiRaFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVCitb4%253D&md5=4e91964eed89eeab89a6ddb82cdd17db</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0278-5846%2801%2900333-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0278-5846%252801%252900333-5%26sid%3Dliteratum%253Aachs%26aulast%3DSkalisz%26aufirst%3DL.%2BL.%26aulast%3DBeijamini%26aufirst%3DV.%26aulast%3DJoca%26aufirst%3DS.%2BL.%26aulast%3DVital%26aufirst%3DM.%2BA.%26aulast%3DDa%2BCunha%26aufirst%3DC.%26aulast%3DAndreatini%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520the%2520face%2520validity%2520of%2520reserpine%2520administration%2520as%2520an%2520animal%2520model%2520of%2520depression--Parkinson%25E2%2580%2599s%2520disease%2520association%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2002%26volume%3D26%26spage%3D879%26epage%3D883%26doi%3D10.1016%2FS0278-5846%2801%2900333-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissou, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benabid, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verna, J. M.</span><span> </span><span class="NLM_article-title">Extracellular toxicity of 6-hydroxydopamine on PC12 cells</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1016/S0304-3940(00)00948-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1016%2FS0304-3940%2800%2900948-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2000&pages=193-196&author=D.+Blumauthor=S.+Torchauthor=M.+F.+Nissouauthor=A.+L.+Benabidauthor=J.+M.+Verna&title=Extracellular+toxicity+of+6-hydroxydopamine+on+PC12+cells&doi=10.1016%2FS0304-3940%2800%2900948-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2800%2900948-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252800%252900948-4%26sid%3Dliteratum%253Aachs%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DTorch%26aufirst%3DS.%26aulast%3DNissou%26aufirst%3DM.%2BF.%26aulast%3DBenabid%26aufirst%3DA.%2BL.%26aulast%3DVerna%26aufirst%3DJ.%2BM.%26atitle%3DExtracellular%2520toxicity%2520of%25206-hydroxydopamine%2520on%2520PC12%2520cells%26jtitle%3DNeurosci.%2520Lett.%26date%3D2000%26volume%3D283%26spage%3D193%26epage%3D196%26doi%3D10.1016%2FS0304-3940%2800%2900948-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermida-Ameijeiras, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Patino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labandeira-Garcia, J. L.</span><span> </span><span class="NLM_article-title">Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0741605.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1046%2Fj.1471-4159.2000.0741605.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10737618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVegtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=1605-1612&author=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Hermida-Ameijeirasauthor=A.+M.+Munoz-Patinoauthor=J.+L.+Labandeira-Garcia&title=Autoxidation+and+neurotoxicity+of+6-hydroxydopamine+in+the+presence+of+some+antioxidants%3A+potential+implication+in+relation+to+the+pathogenesis+of+Parkinson%E2%80%99s+disease&doi=10.1046%2Fj.1471-4159.2000.0741605.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Hermida-Ameijeiras, Alvaro; Munoz-Patino, Ana Maria; Labandeira-Garcia, Jose Luis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">6-Hydroxydopamine (6-OHDA) is a dopaminergic neurotoxin putatively involved in the pathogenesis of Parkinson's disease (PD).  Its neurotoxicity has been related to the prodn. of reactive oxygen species.  In this study, the authors examine the effects of the antioxidants ascorbic acid (AA), glutathione (GSH), cysteine (CySH), and N-acetyl-CySH (NAC) on the autoxidn. and neurotoxicity of 6-OHDA.  In vitro, the autoxidn. of 6-OHDA proceeds rapidly with the formation of H2O2 and with the participation of the H2O2 produced in the reaction.  The presence of AA induced a redn. in the consumption of O2 during the autoxidn. of 6-OHDA and a negligible presence of the p-quinone, which demonstrates the efficiency of AA to act as a redox cycling agent.  The presence of GSH, CySH, and NAC produced a significant redn. in the autoxidn. of 6-OHDA.  In vivo, the presence of sulfhydryl antioxidants protected against neuronal degeneration in the striatum, which was particularly remarkable in the case of CySH and was attributed to its capacity to remove the H2O2 produced in the autoxidn. of 6-OHDA.  These results corroborate the involvement of oxidative stress as the major mechanism in the neurotoxicity of 6-OHDA and the putative role of CySH as a scavenger in relation to PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWrhSqHMH12bVg90H21EOLACvtfcHk0liUYtrPn01OjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVegtbc%253D&md5=a2466276b0c39d97aa728c7f1beb5fc1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0741605.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0741605.x%26sid%3Dliteratum%253Aachs%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DHermida-Ameijeiras%26aufirst%3DA.%26aulast%3DMunoz-Patino%26aufirst%3DA.%2BM.%26aulast%3DLabandeira-Garcia%26aufirst%3DJ.%2BL.%26atitle%3DAutoxidation%2520and%2520neurotoxicity%2520of%25206-hydroxydopamine%2520in%2520the%2520presence%2520of%2520some%2520antioxidants%253A%2520potential%2520implication%2520in%2520relation%2520to%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D1605%26epage%3D1612%26doi%3D10.1046%2Fj.1471-4159.2000.0741605.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Bardiot, D.; Carlens, G.; Dallmeier, K.; Kaptein, S.; McNaughton, M.; Marchand, A.; Neyts, J.; Smets, W.</span><span> </span><span class="NLM_article-title">1,2-Amino-1-(indolyl)ethanone derivatives as viral replication inhibitors and their preparation of Flaviviridae infections</span>. PCT Int. Appl. WO2013045516,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+Bardiot&author=G.+Carlens&author=K.+Dallmeier&author=S.+Kaptein&author=M.+McNaughton&author=A.+Marchand&author=J.+Neyts&author=W.+Smets&title=1%2C2-Amino-1-%28indolyl%29ethanone+derivatives+as+viral+replication+inhibitors+and+their+preparation+of+Flaviviridae+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBardiot%26aufirst%3DD.%26atitle%3D1%252C2-Amino-1-%2528indolyl%2529ethanone%2520derivatives%2520as%2520viral%2520replication%2520inhibitors%2520and%2520their%2520preparation%2520of%2520Flaviviridae%2520infections%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crossman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocco, M.</span><span> </span><span class="NLM_article-title">S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1124/jpet.103.062414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1124%2Fjpet.103.062414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=14978195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=921-935&author=M.+J.+Millanauthor=B.+Di+Caraauthor=M.+Hillauthor=M.+Jacksonauthor=J.+N.+Joyceauthor=J.+Brotchieauthor=S.+McGuireauthor=A.+Crossmanauthor=L.+Smithauthor=P.+Jennerauthor=A.+Gobertauthor=J.+L.+Peglionauthor=M.+Brocco&title=S32504%2C+a+novel+naphtoxazine+agonist+at+dopamine+D3%2FD2+receptors%3A+II.+Actions+in+rodent%2C+primate%2C+and+cellular+models+of+antiparkinsonian+activity+in+comparison+to+ropinirole&doi=10.1124%2Fjpet.103.062414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">S32504, a novel naphthoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole</span></div><div class="casAuthors">Millan, Mark J.; Di Cara, Benjamin; Hill, Michael; Jackson, Michael; Joyce, Jeffrey N.; Brotchie, Jonathan; McGuire, Steve; Crossman, Alan; Smith, Lance; Jenner, Peter; Gobert, Alain; Peglion, Jean-Louis; Brocco, Mauricette</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">921-935</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">These studies evaluated the potential antiparkinsonian properties of the novel dopamine D3/D2 receptor agonist S32504 [(+)-trans-3,4,4a,5,6,10b-hexahydro-9-carbamoyl-4-propyl-2H-naphth[1,2-b]-1,4-oxazine] in comparison with those of the clin. employed agonist ropinirole.  In rats with a unilateral, 6-hydroxydopamine lesion of the substantia nigra, S32504 (0.0025-0.04 mg/kg, s.c.) more potently elicited contralateral rotation than S32601 [(-)-trans-3,4,4a,5,6,10b-hexahydro-9-carbamoyl-4-propyl-2H-naphth-[1,2-b]-1,4-oxazine (its less active enantiomer)], ropinirole, and L-3,4-dihydroxyphenylalanine (L-DOPA).  Rotation elicited by S32504 was blocked by the D2/D3 receptor antagonists haloperidol and raclopride and by the D2 antagonist L741,626 [4-(4-chlorophenyl)-1-(1H-indol-3-yl-methyl)piperidin-4-ol], but not by the D3 antagonist S33084 [(3aR,9bS)-N-[4-(8-cyano-1,3a,4,9b-tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2-yl)-butyl]-(4-phenyl)benzamide].  As assessed by dialysis in both lesioned and nonlesioned animals, S32504 (0.04-2.5 mg/kg, s.c.) reduced striatal levels of acetylcholine.  This effect was blocked by raclopride, haloperidol, and L741,626 but not S33084.  In rats treated with reserpine, hypolocomotion was reversed by S32504 and, less potently, by ropinirole.  In "unprimed" marmosets treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, both s.c. (0.01-0.04 mg/kg) and p.o. (0.04-1.25 mg/kg) administration of S32504 dose-dependently and rapidly (within 10 min) increased locomotor activity and reduced disability.  Furthermore, S32504 dose-dependently reversed bradykinesia and improved posture in "L-DOPA-primed" animals, whereas eliciting less pronounced dyskinesia than L-DOPA.  Finally, in terminally differentiated SHSY5Y cells presenting a dopaminergic phenotype, S32504, but not S32601, abrogated the neurotoxic effects of 1-methyl-4-phenylpyridinium, an action inhibited by raclopride and S33084 but not L741,626.  Ropinirole was weakly neuroprotective in this model.  In conclusion, S32504 displays potent and stereospecific activity in rodent, primate, and cellular models of antiparkinsonian properties.  Although activation of D2 receptors is crucial to the motor actions of S32504, engagement of D3 receptors contributes to its neuroprotective properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMwGUJPMC4erVg90H21EOLACvtfcHk0liUYtrPn01OjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCnsbw%253D&md5=5854c162ece5869dfc437b6c54e70a95</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062414%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BCara%26aufirst%3DB.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DM.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26aulast%3DBrotchie%26aufirst%3DJ.%26aulast%3DMcGuire%26aufirst%3DS.%26aulast%3DCrossman%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DPeglion%26aufirst%3DJ.%2BL.%26aulast%3DBrocco%26aufirst%3DM.%26atitle%3DS32504%252C%2520a%2520novel%2520naphtoxazine%2520agonist%2520at%2520dopamine%2520D3%252FD2%2520receptors%253A%2520II.%2520Actions%2520in%2520rodent%252C%2520primate%252C%2520and%2520cellular%2520models%2520of%2520antiparkinsonian%2520activity%2520in%2520comparison%2520to%2520ropinirole%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D921%26epage%3D935%26doi%3D10.1124%2Fjpet.103.062414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">McCall, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lookingland, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, R. M.</span><span> </span><span class="NLM_article-title">Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson’s disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">1248</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span><span class="refDoi"> DOI: 10.1124/jpet.105.084202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=10.1124%2Fjpet.105.084202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=15980060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1248-1256&author=R.+B.+McCallauthor=K.+J.+Lookinglandauthor=P.+J.+Bedardauthor=R.+M.+Huff&title=Sumanirole%2C+a+highly+dopamine+D2-selective+receptor+agonist%3A+in+vitro+and+in+vivo+pharmacological+characterization+and+efficacy+in+animal+models+of+Parkinson%E2%80%99s+disease&doi=10.1124%2Fjpet.105.084202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Sumanirole, a highly dopamine D2-selective receptor agonist: In vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease</span></div><div class="casAuthors">McCall, Robert B.; Lookingland, Keith J.; Bedard, Paul J.; Huff, Rita M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1248-1256</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The purpose of this study is to demonstrate that sumanirole is a novel dopamine receptor agonist with high in vitro and in vivo selectivity for the D2 receptor subtype.  Sumanirole, (R)-5,6-dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Z)-2-butenedioate (1:1), is unique; it has greater than 200-fold selectivity for the D2 receptor subtype vs. the other dopamine receptor subtypes in radioligand binding assays.  In cell-based assays, sumanirole is a fully efficacious agonist, with EC50 values between 17 and 75 nM.  In animals, sumanirole elicits many physiol. responses attributed to D2-like receptor function.  In rats, sumanirole is a full agonist for elevation of striatal acetylcholine levels (ED50 = 12.1 μmol/kg i.p.).  Sumanirole s.c. dose dependently decreased plasma prolactin levels and depressed dopamine neuron firing rates in the substantia nigra pars compacta with an ED50 of 2.3 μmol/kg i.v.  This high selectivity for D2 receptors translates into excellent locomotor stimulant activity in animal models of Parkinson's disease.  In reserpinized, α-methyl-para-tyrosine-treated rats, sumanirole caused a significant and sustained increase in horizontal activity at doses ≥12.5 μmol/kg s.c.  In unilateral 6-hydroxydopamine-lesioned rats, sumanirole caused profound, sustained rotational behavior and was substantially more efficacious than any other agonist tested.  Sumanirole-stimulated rotational behavior was blocked by the dopamine receptor antagonist haloperidol.  Sumanirole dose dependently improved disability scores and locomotor activities of two of three 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned monkeys.  In summary, sumanirole is the first published selective D2 receptor agonist.  The compd. has activity in animal models of dopamine hypofunction and has a high level of efficacy in animal models of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxa0W5oALaLbVg90H21EOLACvtfcHk0lgXFSjSJk8tbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLc%253D&md5=792585b571abe46c833a2238ab9213ae</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.084202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.084202%26sid%3Dliteratum%253Aachs%26aulast%3DMcCall%26aufirst%3DR.%2BB.%26aulast%3DLookingland%26aufirst%3DK.%2BJ.%26aulast%3DBedard%26aufirst%3DP.%2BJ.%26aulast%3DHuff%26aufirst%3DR.%2BM.%26atitle%3DSumanirole%252C%2520a%2520highly%2520dopamine%2520D2-selective%2520receptor%2520agonist%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%2520and%2520efficacy%2520in%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1248%26epage%3D1256%26doi%3D10.1124%2Fjpet.105.084202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01031">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_31516"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01031">10.1021/acs.jmedchem.5b01031</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Details of in vitro antioxidant assay procedures and results; physicochemical properties of the compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_001.pdf">jm5b01031_si_001.pdf (1.44 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01031/suppl_file/jm5b01031_si_002.csv">jm5b01031_si_002.csv (1.29 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01031&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01031%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-23%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01031" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ab437e8523d9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
